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SECTION 1 INTRODUCTION 
SUMMARY 
Shiga toxin and the Escherichia coli Shiga-like toxins (SLTs) 
are type 2 ribosome inactivating proteins (RIPs), exhibiting a 
specific RNA N-glycosidase activity comparable to that of the 
plant toxin ricin (Endo et al. 1988). Not only do they possess 
the same enzymatic activity as a plant toxin, but on 
examination at the molecular level, they may be seen to be 
classic bipartite toxins. The present study examines in detail 
the RNA N-glycosidase activity of Shiga-like toxin I (SLT I) 
ie, the 
ribosomes 
susceptibility 
to the toxin, 
of a range 
the exact 
of different eukaryotic 
site of SLT I-catalysed 
depurination of yeast ribosomal RNA and the kinetics of such 
depurination. The cytotoxic effect of SLT I on Vero cells is 
also examined. In addition to its characterisation and 
subsequent comparison to ricin, an attempt has been made to 
correlate certain structure - function aspects of SLT I. By 
structural comparison with other bacterial toxins it has been 
proposed that proteolytic cleavage wi thin an arginine rich, 
trypsin sensitive, disulphide-bonded loop structure is 
essential for expression of cytotoxicity. Examination of the 
enzymatic activity and cytotoxicity of a 'protease insensitive' 
mutant SLT I A subunit (SLT lA) generated in the present study 
has led to the conclusion tha t proteolytic processing wi thin 
this disulphide-bonded loop is not essential, but that 
processing may occur at alternative sites within SLT lA to 
compensate for loss cleavage at the proposed target sites. 
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SECTION 1.1 History and disease. 
It was Kiyoshi Shiga, a Japanese microbiologist, who in 1898 
first described a bacterium to be the causative agent of a type 
of dysentery distinct to that of amoebic dysentery. He called 
the bacterium Bacillus dysenteriae which was later renamed 
Shigella dysenteriae and the disease shigellosis. It was the 
continued work of Shiga and his colleagues on bacterial 
extracts that led eventually to the discovery by Conradi, in 
1903, of the associated, highly potent cytotoxin - Shiga toxin 
(ST). However, although work by Shiga and his colleagues had 
shown that crude preparations of the toxin when given 
parenterally to mice and rabbits caused hind limb paralysis and 
eventual death, the role of Shiga toxin in pathogenesis was not 
understood for many years and remained a matter of conjecture. 
Indeed, for many years Shiga toxin was regarded to be a 
neurotoxin until improvements in purification and toxin yield 
allowed a closer examination of its cytotoxic effects. These 
studies demonstrated that, the neurological manifestations 
were a secondary effect of the toxin wi th direct damage to 
vascular endothelial cells in the central nervous system (CNS) 
being the primary effect. 
Konawalchuk ~ al. (1977) first described an E.coli toxin which 
was cytotoxic to Vero cells and distinct from other E. coli 
toxins such as the heat labile and heat stable toxins. O'Brien 
et al. (1982), la ter screened E. coli isolates known to cause 
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infantile diarrhoea which were also known to be cytotoxic for 
Vero and HeLa cells. They screened for neutralisation of 
cytotoxic activity using rabbit antisera raised against ST. 
Neutralisation of the cytotoxic effect confirmed their 
hypothesis that certain strains of E.coli, which were non 
invasive and which produced neither heat stable nor heat labile 
toxin, produced a Shiga - like toxin (SLT). On closer 
examination, it was found that two types of SLT were produced; 
one which could be neutralised wi th anti SI antisera and one 
which could not. The former was designated SLT I and the latter 
antigenically distinct version, SLT II (Strockbine et al. 
1986) • 
Human infection with a Shiga-like toxin (SLT)-producing strain 
of E.coli, defined by Levine et al. (1987) as an 
enterohaemorrhagic E.coli (EHEC), may manifest itself in a 
range of different disease symptoms (Hunt et al. 1989). These 
range from an asymptomatic infection to a mild non bloody form 
of diarrhoea to' the more complex and in some cases life 
threatening haemorrhagic colitis (HC) , haemolytic uremic 
syndrome (HUS) and thrombocytopenic purpura (Karmali, 1989). 
Not only is there a spectrum of disease as a result of EHEC 
infection, but it would also appear to be the case that the 
type of people susceptible to infection is indefinable. EHEC 
have been associa ted wi th the above mentioned diseases in 
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infants, children and adults in both developed and developing 
countries (Riley, 1987). 
A variety of EHEC serotypes are also involved. Riley ~ al. 
(1983) first implicated E.coli 0157 in an outbreak of 
haemorrhagic colitis with patients suffering severe abdominal 
, 
pain and an afebrile diarrhoea which progressed to bloody 
diarrhoea. In Chi le, studies revealed three different EHEC 
serotypes to be most often involved in causing HUS in children 
(Cordovez et al. 1992); whilst an Italian study revealed 
serotype 0157 to be the most prevalent in paediatric HUS 
(Capriolini ~ al. 1992) • In cases of infantile diarrhoea 
serotype 026 was isolated with the most frequency (Scotland et 
al. 1990). 
The actual role of ST and SLTs in pathogenesis remains unclear. 
Work was initially focused on dysentery resulting from 
infection with S.dysenteriae type 1 after the finding that 
patients with this organism suffered a more severe form of 
dysentery than did those infected with other Shigella species. 
Indeed it was also found to be the case that S.dysenteriae type 
1 associated HUS was of a more severe nature than that as a 
result of EHEC infection (O'Brien and Holmes, 1987). 
Investigations into the role ST plays in dysentery have 
involved the use of mutant strains of S.dysenteriae type 1. 
Levine et al. (1973) found that volunteers fed with a low toxin 
producing mutant strain of S.dysenteriae type 1 suffered a less 
severe form of the disease than did the volunteers fed the 
highly toxigenic non mutant strain. ST appeared in some way to 
exacerbate the effects of the infection. In support of this, 
Fontaine ~ al. (1988) noted significant differences in disease 
manifestations when they infected macaque monkeys with a tox-
strain of S.dysenteriae type 1 or with the wild type toxin 
producing strain. Less bloody stools and less inflammation and 
ulceration of the colonic mucosa were observed following 
infection with the tox strain. With regard to the role played 
by SLT in HC, Pai ~ al. (1986), induced diarrhoea in infant 
rabbits, found that a non toxin producing strain did not result 
in diarrhoea, a low toxin producer resul ted in some of the 
rabbits developing diarrhoea, whilst all of those infected with 
0157: H7 displayed colon damage and diarrhoea symptoms. Thus 
results strongly implicate ST and SLT in the pathogenesis of 
dysentery and HC respectively. 
Donohue-Rolfe ~ al. (1986) were able to detect free toxin in 
the faeces of patients infected with S.dysenteriae type 1. It 
is suggested that free toxin in the gut may bind to and 
directly damage colonic epi thelial cells. The resul tant 
ulceration of the colonic mucosa may then allow leakage of 
blood , inflammatory elements and alteration of the homeostatic 
capaci ty of the colon (Ifale, 1991). Sekizaki et al. (1987), 
later demonstrated that, both ST and SLT were indeed cytotoxic 
to human colon epithelial cells. 
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The mechanisms by which Shigella spp. and EHEC deliver ST or 
SLT to the target cells are very different, since Shigella spp. 
are invasive and E.coli are not. Shigella spp. penetrate the 
colonic epithelial cells, mUltiplying intracellularly and 
spreading to adjacent cells and tissues. However, whilst ST 
plays little or no role in proliferation and survival of the 
bacterium (Brunton, 1990) it is delivered to the cells in 
highly concentrated doses (Tesh and O'Brien 1991), as is SLT by 
non-invasive adherence of EHEC. 
Karch et al. (1987) were able to detect attachment in vitro of 
serotype 0157, the serotype most commomly associated with HC. 
Further to this, Scotland ~ al. (1990), found that 13 out of 
the 14 isolates tested by Karch et al. (1987) were capable of 
attachment to a line of hUman intestinal cells (Intestine 407 
cells). Tiporizi et a1. (1987, 1989), found complete 
degeneration of the mucosal surface of the colon to be 
associated with the formation of attaching, effacing lesions by 
0157:H7 in studies on gnotobiotic piglets with 0157:H7 induced 
diarrhoea. SLT production was not, however, a prerequisite for 
formation of these lesions, since a tox- mutant of 0157:H7 
still caused lesions, demonstrating that SLT is not the only 
factor involved in mediating damage to the colon. 
Levine et al. (1987), on examination of 0157:H7 serotypes from 
HC and HUS patients observed that the E.coli possessed 
fimbriae. Possession of such fimbriae correlated with the 
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possession of a 60HDa plasmid, the loss of which resul ted in 
the loss of capaci ty of 0157 isolates to attach to Intes tine 
407 cells. More recently, the eae gene responsible for 
attaching and effacing by EHEC has been identified and cloned 
(Yu and Kaper, 1992). In comparison with the ~ gene of 
enteropathogenic E.co1i (EPEC), which are also capable of 
forming attaching and effacing lesions on epithelial cells, the 
~ gene of EHEC was found to have a high degree of homology at 
both nucleotide and amino acid levels. It has been proposed 
that the ~ gene encodes a 94KDa protein adhesin (Yu and Kaper 
et al. 1992). 
The role of ST and SLT in dysentery and HC remains to be 
clarified, although strong evidence suggests that the toxins in 
some way serve to exacerbate the disease manifestations. 
Haemolytic uremic syndrome (HUS) is a further and more complex 
manifestation of EHEC or Shigella infection. Once again the 
role played by ST and SLT in pathogenesis remains unclear. 
Indeed it is thought that the disease 
factors (Karmali, 1989). 
involves multiple 
HUS is of highest incidence in children, causing haemolytic 
anaemia, thrombocytopenia and acute renal failure (Karmali, 
1989). There exists no animal model for HUS, thus links between 
EHEC infection and HUS are mainly on an epidemiological basis 
(Brunton, 1990). However, other evidence does suggest a link 
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between the two. Studies by Lopez et al. (1989) on Argentine 
children, sugges t tha t of those children infected wi th EHEC, 
those with bloody diarrhoea are more likely to develop HUS than 
those who do not display bloody diarrhoea. Patients are often 
found to display symptoms similar to those of He prior to 
development of HUS (Karma1i, 1989). It has been suggested that 
this may allow leakage of free ST or SLT into the bloodstream 
with the result of direct damage to vascular endothelial cells 
(Karmali et al, 1985). Levine et al. (1992) propose tha t if 
this is the case, then toxin must be liberated in quantities 
large enough to exert their biological effect but too small to 
ellicit an immune response, since on examining the sera of 18 
Thai patients in both acute and convalescent phases of 
infection with S.dysenteriae type 1, only a minority had 
antibody to ST. Such behaviour is similar to that of tetanus 
toxin. 
Glomerular endothelial cells in particular are thought to be a 
target for direct damage by ST and SLT. Histopathological 
studies on the kidneys of HUS patients are found to have a 
large degree of structural damage to their glomeruli (Tesh and 
O'Brien, 1991). In support of this Obrig ~ al. (1988), have 
shown the cytotoxic effect of ST on human umbilical vein 
endothelial cells (HUVEC). However, other factors such as 
bacterial lipopolysaccharide (LPS) have been implicated in 
augmenting damage to the kidney by ST and SLT (Koster, 1984). 
Louise and Obrig (1992), report the synergystic cytotoxic 
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effect of ST plus LPS on HUVEC suggesting a role for LPS in 
development of HUS with regard to human vascular endothelial 
cell damage. The role of LPS in HUS is, however, unclear. Tesh 
et al. (1991), report that LPS does not augment the cytotoxic 
effect of ST on HUVEC. They do not, however, rule out the 
involvement of LPS in HUS noting that glomerular endothelial 
cells and vascular endothelial cells are very different both 
morphologically and functionally. 
The type of SLT produced by the bacterium is also seen to be a 
factor in the development of EHEC-induced HUS. SLT 11 
production would seem to be the predominant factor in 
development of renal disease. Ostroff ~ al. (1988), found that 
patients infected with EHEC producing both SLT I and SLT 11 or 
SLT 11 alone developed renal problems, whilst those infected 
with an SLT I only producer did not. 
It would appear that the multifactorial nature of HUS does not 
currently allow clear definition of the role played by ST and 
SLT in the development of the disease. 
SI and the SLTs have not only been implicated in the diseases 
described above, but it has also been suggested that ST may 
play a role in the neurological disorders experienced by some 
sufferers of shigellosis. Recent work by Ashkenazi et al. 
(1990), has shown tha t other toxic products of Shigella spp. 
may be responsible for the neurological manifestations of 
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shigellosis, since the toxin isolated from infected patients' 
stools was not neutralised by antisera to purified ST. The 
toxin was not however, found to be SLT I or SLT 11. In 
addition to this, Shigella spp. isolated from such patients did 
not carry the structural genes for ST. The cytotoxin isolated 
was suggested to be a protein of approximately 100 - 125KDa, 
crude preparations of which, when injected into mice resulted 
in neurological symptoms similar to those seen during 
shigellosis. Ashkenazi et al. (1990), conclude that ST 
production is not necessary for the neurological manifestations 
of shigellosis. 
ST and SLT are implicated in a range of disease manifestations 
the specific nature of their involvement remains to be 
clarified. 
SECTION 1.2 Structural comparison of ST and the SLTs. 
Classically ST and the SLTs, of which ST is considered the type 
their member, were classified according to 
properties. This encompassed their ability 
accumu1 a tion in 1iga ted rabbi t ileal loops, 
Vero and HeLa cells and their ability to 
biological 
cause fluid to 
cytotoxicity to 
cause hind limb 
paralysis and eventual death to mice and rabbits when injected 
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intraparentally. This latter property initially led ST to be 
considered as a neurotoxin. However, until the toxins could be 
purified to homogeneity, it was unclear whether such mUltiple 
activities were attributable to a single toxin or to multiple 
contaminating toxins (Eiklid and Olsnes, 1983). 
More recently, advances in molecular technology have allowed 
classification of ST and the SLTs with regard to their 
immunological, genetic and biochemical properties. 
Extensive immunological and biochemical studies have revealed 
that SLT I is essentially identical to ST (OlBrien and LaVeck 
1982); whilst SLT 11, although sharing 55% homology at the 
nucleotide level with ST and SLT I (Jackson ~ al. 1987), is 
antigenically distinct (Strockbine et al. 1986). SLT I, in 
contrast, is completely neutralised by ST antisera (OlBrien and 
LaVeck, 1982, Marques ~ al. 1986). 
Cloning and sequencing of the genes encoding ST and SLT I 
(Calderwood ~ al. 1987, DeGrandis ~ al. 1987, Kurazono ~ al. 
1987, Strockbine et al. 1988) has further facilitated the 
comparison between ST and SLT I (FIG 1.2.1). 
Existing in a single copy located in the !E£ - ElEF region of 
the Shigella chromosome, ST is encoded by a bicistronic operon 
(Strockbine ~ al. 1988) encoding both the A and B subunits of 
the toxin. 
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FIG 1.2.1 Nucleotide sequence of the genes encoding the A and 
B subunits of Shiga toxin and Shiga-like toxin I (Stockbine et 
al. 1988). 
Nucleotides are numbered above the sequence. Differences in the 
nucleotide sequence of Shiga-like toxin I (5LT I) compared to 
that of Shiga toxin (ST) are indicated above the sequence 
(nucleotide 223 = G (SLT I), T (ST), nucleotide 359 - T (SLT 
I), A (ST), nucleotide 850 = C (SLT I), T (ST». Nucleotide 
substitution at position 359 results in an amino acid 
substitution from threonine in ST to serine in SLT I. This is 
indica ted below the nucleotide sequence. IATG I indica tes START 
codons. Horizontal lines above the sequence indicate putative 
ribosome binding sites. In addition -10 and -35 above the 
sequence indicates promoter recognition sites. 
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50 
TGACCAGATATGTTAAGGTTCGAGCTCTCTTTGAATATGATTATCATTTTCATTACGTTATTG 
100 
TTACGTTTATCCGGTGCGCCGTAAAACGCCGTCCTTCAGGGCGTGGAGGATGTCAAGAATATA 
150 
GTTATCGTATGGTGCTCAA-GG-A-G-T'ATTGTGTAAT IATGI AAA ATA ATT TTT AGA GTG 
200 G 
CTA ACT TTT TTC TTT GTT ATC TTT TCA Gn AAT GTG GTT GCG AAG GAA 
250 
TTT ACC TTA GAC TTC TCG ACT GCA AAG ACG TAT GTA GAT TCG CTG AAT 
300 
GTC ATT CGC TCT GCA ATA GCT ACT CCA TTA CAG ACT ATT TCA TCA GGA 
350 T 
GCT ACG TCT TTA CTG ATG ATT GAT AGT GGC ACA GGG GAT AAT TTG TTT 
400 Serne 
GCA GTT GAT GTC AGA GGG ATA GAT CCA GAG GAA GGG CGG TTT AAT AAT 
450 
CTA CGG CTT ATT GTT GA! CGA AAT AAT TTA TAT GTG ACA GGA TTT GTT 
500 
AAC AGG ACA AAT AAT GTT TTT TAT CGC TTl GCT GAT TTT TeA CAT GTT 
550 
ACC TTT CCA GGT ACA ACA GCG GTT ACA TTG TCT GCT GAC AGT AGC TAT 
600 
ACC ACG TTA CAG CGT GTT GCA GGG ATC AGT CGT ACG GGG ATG CAG ATA 
650 
AAT cec CAT TCG TTG ACT ACT TeT TAT CTe GAT TTA ATG TeG CAT AGT 
700 
GGA ACC TCA CTG ACG CAG TCT GTG GCA AGA GCG ATG TTA CGG TTT GTT 
750 
ACT GTG ACA GCT GAA GCT TTA CGT TTT CGG Cll ATA CAG AGG GGA TIT 
800 
CGT ACA ACA CTG GAT GAT CTC AGT GGG CGT TCT TAT GTA ATG ACT GCT 
C 
Gll GAT GTT GAT cn ACA nG AAC TGG GGA AGG TTG AGT AGT GTC CTG 
900 
CC'l GAC 'lAT CAT GGA CAA .GAC TCT GTT CGT GTA GCA AGA ATT TeT TTT 
950 
GCA AGC ATT AAT GCA ATT CTG GGA AGC GTG GCA TTA ATA CTG UT TGT 
1000 
CAT CAT CAT GCA TCG CGA GTT GCC AGA ATG GCA TCT GAT GAG TTT CCT 
TCT ATG TGT CCG GCA GAT GGA AGA GTC CGT GGG ATT ACG CAC UT AAA 
1050 
ATA TTG TGG GAT TCA TCC ACT CTG CGG GCA ATT CTG ATG CGC AGA ACT 1100 _I __ 
ATT AGC AGT TGA GGG GCT AAA ~ AAA AAA ACA TTA TTA ATA GCT GCA 
1150 
TCG CTT TCA TTT TTT TCA GCA AGT GCG CTG GCG ACG CCT GAT IGT GTA 
1200 
ACT GC! AAG GTG GAG TAT ACA AAA TAT AAT GAT GAC GAT ACC TTT ACA 
1200 
GTT AAA GTG GGT GAT AAA GA! TTA TTT ACC AAC AGA TGG AAT CTT CAG 
1300 
TCT CT! CIT CTC AGT GCG CAA ATT ACG GGG ATG ACT GTA ACC ATT AAA 
1350 
ACT AAT GCC TGT CAT AAT GGA GGG GGA nc AGC GAA GTT An TTT CGT 
1400 
TGA CTCAGAATAGCTCAGTGAAAATAGCAGGCGGAGATTCATAAATGTTAAATACATCTCAA 
1450 1500 
TTCAGTCAGTTGTTGCCGGTTCTGATAATAGAIGTGTTAGAAAATTTCTGCATG 
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In the case of SLT I a short intergenic region of 12 base pairs 
exists between the two regions encoding SLT lA and SLT IB 
(Calderwood et al. 1987). SLTs are, however, encoded by 
temperate, lambda-like bacteriophages (Williams-Smith et al. 
1983, New1and ~ al. 1985, Strockbine ~ al. 1986, Kurazono ~ 
al. 1987, Koz1ov et al. 1988). Expre ssion of the genes are 
controlled by the binding of an iron-Fur corepressor complex to 
the promoter of the gene (Calderwood and Mekalanos, 1987, 
Weins tein et al. 1988). Thus express ion is con trolled a t the 
level of transcription. 
Nucleotide and amino acid sequence analysis have revealed that 
the ST B subuni t (ST B) and SLT I B subuni t (SLT IB) are 
identical in their amino acid sequence (Calderwood et al. 
1987, DeGrandis et al. 1987) (FIG 1.2.2). Most groups 
(Calderwood et al. 1987, DeGrandis et al. 1987, Strockbine ~ 
al. 1988) report the only difference between the ST A subunit 
(ST A) and the SLT lA subunit (SLT lA) is the substitution at 
position 45 of the amino acid threonine in ST A for a serine 
residue in SLT IA (FIG 1.2.3). Takao ~ al. (1988) report their 
own finding that residue 45 of SLT IA is also a threonine 
residue and not serine. From this they suggest that the 
structural gene encoding ST in S.dysenteriae type 1 has been 
transferred in an identical form to certain strains of E.co1i. 
This has led them (Takao ~ al. 1988) and others (O'Brien and 
LaVeck, 1982, Strockbine et al. 1988) to conclude that ST and 
SLT I are essentially the same. 
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FIG 1.2.2 Amino acid sequence of the B subunit of Shiga toxin 
I Shiga-like toxinI(Stockbine ~~. 1988). 
-20 1 
M K K T L L I A A S L S , F SAS A L A T P D C V T G K V E Y T 
20 
K Y N D D D T F T V K V G D K ELF T N R W N L Q S L L L S A Q 
~ 
I T GMT V T I K T N A C H N G G G F S E V I F R 
Bold type indicates proposed signal peptide 
Residues are numbered above the sequence 
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FIG 1.2.3 Amino acid sequence of the A subunit of Shiga toxin 
/ Shiga-like toxinl(Stockbine et ~. 1988). 
-22 1 
K K I I I F I V L T F F F V IFS V M V V A KEF T L D F S T A 
20 
K T Y V D S L N V I R 5 A I G T P L Q T I S S G G T S L L M I D 
60 S G[J D N L F A V D V R G I D P EEG R F N N L R L I V ERN 
80 100 
N L Y V T G F V N R T N N V F Y R FAD F S H V T F P G T T A V 
120 
T L S G D S 5 Y T T L Q R V A G I 5 R T G M Q I N R H S L T T S 
1:40 160 
Y L D L M S H 5 G T S L T Q 5 V A R A MLR F V T V A E A L R F 
180 200 
R Q I Q R G F R T T L D D L. 5 G R S Y V M T A E D V D L T L N W 
220 
G R L S S V L P D Y H G Q D S V R V G R I S F G SIN A I L S G 
240 260 
V A L I L N C H H HAS R V A R M A 5 D E F P S Mep A D G R V 
280 
R G I T H N K I L W D S S T L G A I L M R R T I S S 
c=Jindicates differences between 5LT I A and ST A 
bold type indicates proposed SIGNAL PEPTIDE 
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Nucleotide sequence analysis of the SLT I operon predicts the 
mature SLT lA subunit to have 293 amino acids with a molecular 
weight of 34,804; whilst the ma ture B subuni t comprises 69 
amino acids and a molecular weight of 7,692 (Calderwood ~ al. 
1987). In both cases the 81T I subunits are synthesised as 
precursor forms, each possessing a signal peptide of 22 amino 
acids in the case of 81T lA and 20 amino acids in the case of 
SLT lB. The separate A and B subunits are then translocated to 
the periplasm for holotoxin assembly as is the case wi th 
Escherichia coli heat labile toxin (LT) and cholera toxin 
(Hirst ~ al 1984a, Hofstra and Witholt, 1984). Treatment of 
the A subunit with protease and reduction has demonstrated that 
the A subunit comprises two peptides; Al and A2 , of 
approximately 27 - 28KDa and 4 - 5KDa respectively (O'Brien and 
LaVeck, 1983). Following treatment with protease, these remain 
linked together by a disulphide bond. Calderwood et al. (1987) 
propose tha t fragments of the sizes observed by 0' Brien and 
LaVeck (1983) ie 27 - 28KDa and 4 - 5KDa would result following 
proteolytic cleavage of 8LT lA wi thin the region flanked by 
cysteine residues 242 and 261 of SLT lA: residues capable of 
forming a disulphide bridge. 
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SECTION 1.3 Comparison of the putative active site of ST I SLT 
I with that of ricin 
Endo ~ al. (1988) demonstrated that ST and SLT 11 were single 
site RNA-specific N-glycosidases with the capacity to 
depurinate 28S or 26S rRNA and irreversibly inactivate 
eukaryotic ribosomes in a manner analogous to that of the plant 
toxin, ricin. Indeed the degree of amino acid homology 
observed between SLT lA and ricin A subunit (RA), shown by 
Calderwood et al. (1987) and DeGrandis et al. (1987), has 
allowed the putative active site of SLT lA to be defined based 
on current knowledge of the putative active site of RA 
(Montfort ~ al. 1987, Katzin ~ al. 1991). Alignment of the 
putative active sites of RA and SLT lA revealed 32% of residues 
to be identical (Calderwood et al. 1987) (FIG 1.3.1). On this 
basis the relative importance of amino acid residues within the 
'active site' of SLT lA has been investigated with regard to 
those of RA. This has involved mutation of residues seen to be 
conserved between the two; working on the basis that residues 
of enzymatic importance are probably those which appear to have 
been conserved. Hovde et a1. (1988), mutated glutamic acid 
(Glu) residue 167 of SLT I A subunit to aspartic acid (Asp) 
based on knowledge from the crystallographic structure of RA 
which shows glutamic acid residue 177 to lie within the active 
site cleft. Mutation of this residue in SLT lA resulted in a 
1000 fold decrease in in vi tro RNA N-glycosidase acti vi ty of 
SLT lA. By comparison, conversion of this residue in RA to Asp 
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FIG 1.3.1 Homology comparison of the putative active sites of 
Shiga-like toxin I A subunit (SLT lA) and ricin A subunit (RA) 
153 173 
SVARA-ML R F VTVTAEAL RFR - - - - QI 
.., TLARS - F I le IQMIS EAARFQ- - - - Y I 
163 
198 207 
.DLTLN--WGRLS 5 
T ITLENS-WGRLS 5 
208 215 
Shiga-like toxin I A subunit • 
ricin A subunit .., 
Numbers relate to amino acid sequence in each case 
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183 
resulted in an 80 fold decrease in activity (Schlossman ~ al. 
1988), whilst its conversion to glutamine or alanine resulted 
in a 1000 fold and 20 fold decrease in enzymatic activity 
respectively (Ready ~ al. 1991 and Schlossman et a1. 1989 
respectively). It is also interesting to note that glutamic 
acid is also to be found at the active sites of the bacterial 
toxins Pseudomonas exotoxin A (Caroll and Collier, 1987), 
pertussis toxin (Cortina and Barbieri, 1989), diphtheria toxin 
(Tweten et al. 1985, Wilson et al. 1990) and SLT 11. Mutation 
-- --
of the 'active site' glutamic acid residues of these various 
bacterial toxins has shown them to play an important role in 
enzymatic activity. Conversion of Glu 553 in Pseudomonas 
exotoxin A to Asp reduced the in vitro enzymatic activity by 
10,000 fold (Douglas and Collier, 1987). Tweten et al. (1985) 
reported that conversion of Glu 148 to Asp in diphtheria toxin 
resulted in a mutant with only 0.6% the activity of the wild 
type; whilst Jackson et al. (1990), demonstrate a 100 fold 
reduction in activi ty of SLT 11 on conversion of Glu 166 to 
Asp. 
More recently Frankel et al. (1989), have suggested that two 
regions of sequence homology between SLT lA and RA appear to 
be involved in RNA N-glycosidase activity of the RA and SLT lA 
subuni ts. Wi th regard to this, when muta ted to serine (Ser), 
tyrosine (Tyr) residue 77 in SLT I A has been found to cause a 
1000 fold reduction in activity (Deresiewics et al. 1992). This 
residue may be seen to be conserved across the RNA N-
20 
glycosidases of which ricin is the type member (Ready ~ al. 
1988). Mutation of the corresponding tyrosine residue (Tyr 80) 
in RA to phenylalanine (Phe) resulted in a 15 fold reduction 
in activity (Ready ~ al. 1991). Such a reduction in activity 
compares favourably with the observed reduction in activity (10 
-20 fold) of SLT lA on conversion of Tyr 77 to Phe 
(Deresiewics et al. 1992). Deresiewics et al. (1992) feel that 
Tyr 77 plays an important role in the enzymatic activity of SLT 
lA. They do not however, eliminate a change in conformation 
resulting from mutation of Tyr 77 as a reason for the observed 
reduction in activity of SLT lA. Molecular modelling reveals 
that the phenolic ring of Tyr 77 is one of three in a cluster 
close to the proposed active site cleft of SLT lA. Molecular 
modelling of RA has revealed that the corresponding Tyr 80 
residue is also one of three aromatic residues in the putative 
active site cleft of RA. 
SECTION 1.4 RNA N-glycosidase activity of ricin and ST I SLT I 
Of particular interest to this study is the RNA N-glycosidase 
activity of ST A subunit, which has been shown to be comparable 
to that of the plant toxin ricin (Endo et al. 1987, Endo and 
Tsurugi, 1987, Endo et al. 1988), leading to an irreversible 
inhibition of protein synthesis in eukaryotic cells and 
eventual cell death. 
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Reisbig ~~. (1981), had previously demonstrated that the Al 
fragment of ST was capable of inactivating salt washed rabbit 
reticulocyte and salt washed rat liver ribosomes at a rate of 
40 ribosomes per minute by selectively inactivating the 60S 
ribosomal subunits. Endo et al. 1988 went on to examine this 
inactivation at the molecular level on the basis of his own 
observations with regard to the action of ricin on eukaryotic 
ribosomes. Nucleotide sequence analysis of the 3' terminal 
fragment released from rat liver 28S rRNA following 
modifica tion by ST and SLT 11 and aniline cleavage revealed 
that both specifically removed adenine residue 4324 (A4324) of 
ra t liver 28S rRNA. Thi s was achieved by cleavage of the N-
glycosidic bond between the adenine residue at position 4324 
and the connecting ribose sugar of the 28S rRNA. The observed 
depurination of the 28S rRNA of rat liver ribosomes at (A4324) 
by ST and SLT 11 was exactly the same as that previously 
observed to be the case with ricin (Endo et al. 1987, Endo and 
Tsurugi, 1987) (FIG 1.4.1). 
Further comparisons between ST, SLT 11 and ricin were made by 
Saxena et al. (1989) • Ricin, ST and SLT I I were all 
microinjected into Xenopus oocytes in order to study their 
effects in living cells. Nucleotide sequencing of the rRNA 
extracted from the modified oocyte ribosomes revealed that in 
each case the same adenine residue - 3732 had been removed from 
the 28S rRNA, thus augmenting the fact that the RNA N-
glycosidase activity demonstrated by ricin, ST and SLT 11 is 
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FIG 1.4.1 Site of depurination of rat liver 285 ribosoaal RNA 
(rRNA) by the action of ricin A 8ubunit 
285 rRNA 
C G A G A 
4322 4323 4324 4325 4326 
Site of action 
of ricin A subunit 
•• 
C G G A 
4322 4323 4325 4326 
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highly specific. 
Since these studies reveal that ST and SLT 11 have an identical 
action on rRNA then it is reasonable to assume that they ought 
to have an identical effect on the partial reactions of protein 
synthesis. 
ST had been shown to inactivate eukaryotic protein synthesis 
both in vivo (Brown et al. 1980) and in in vitro systems (Brown 
--- --
et al. 1980, 01snes et al. 1981) by inhibiting peptide 
elongation (Brown et al. 1980). Obrig ~ al. (1987) then went 
on to examine the mechanism by which ST inhibited the process 
of peptide elongation demonstrating that the action of ST on 
ribosomes direc t1y inhibi ts elongation factor 1 (EF1)-
dependant transfer of aminoacy1-tRNA. It is suggested from 
their findings that the action of ST on the ribosome actually 
causes some structural changes to the ribosome in the region of 
the ribosome normally concerned with binding of elongation 
factor 1. Igarashi ~ al. (1987) confirmed that this was also 
the case with SLT I from their studies on the ability of hybrid 
(ribosomes in which ei ther the 60S or 40S ribosomal subuni ts 
had been treated with SLT I) to synthesise po1ypheny1a1aninej 
(po1yPhe) finding that only those ribosomes containing a SLT I 
treated 60S subunit gave a significant decrease in polypeptide 
synthesis. They concluded that SLT I behaved in a manner 
identical to that observed with ST inactivation of eukaryotic 
ribosomes. More recently Furu tani et al. (1992) compared the 
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mechanisms by which ricin and SLT 11 inhibited protein 
synthesis. Their overall conclusion was that SLT II and ricin 
both inhibi t protein synthesis in exactly the same way - by 
interfering with the process of binding of the aminoacyl-tRNA 
to the ribosomes. Results revealed that both toxins inhibited 
EFl- and GTP-dependant aminoacyl-tRNA binding to ribosomes and 
in addition, were found to inhibit the EFl-dependant GTPase 
activity during binding of the above mentioned aminoacyl-tRNAs 
to the ribosomes. 
In most cases however, these studies were performed using non 
physiological systems involving salt washed ribosomes and the 
addition of elongation factors and translation of polyPhe RNA 
(a transcript which cannot undergo physiological initiation). 
In addition, problems which may be encountered in the use of 
such systems include cross contamination of elongation factors 
and failure to add factors to saturation. 
Originally RA was thought to affect both EFl and EF2-dependent 
stages of protein synthesis. However, recent studies by Osborn 
and Hartley (1990) to examine the effect of RA on the partial 
reactions of translation of globin messenger RNA (mRNA) in a 
reticulocyte lysate system (a physiological translation 
system), have shown the primary block by RA to be the EF2-
dependent stage. It is presumed therefore, that this is also 
the case with inhibition of protein synthesis by ST , SLT I and 
SLT 11. Osborn and Hartley (1990) clearly demonstrated that RA 
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modification of the 60S subunit reduced the rate of association 
of that subunit with the 40S preinitiation complex by a factor 
of six and that the EF2-dependant translocation step was 
completely blocked. This confirms the earlier view of Nilsson 
and Nygard (1986) but is inconsistent with the findings of 
Igarashi ~ al. (1987) whose work on ST and SLT I as described 
above, revealed that ST and SLT I modification of ribosomes 
inhibi ted the binding of aminoacyl-tRNA to ribosomes but did 
not affect the translocation step. 
Recent studies have examined the kinetics of RA-catalysed 
depurination of eukaryotic ribosomes. Depending upon the source 
of ribosomes and the assay conditions RA has been found to have 
Km values of 0.1 - 2. 6uM and kca t values of 201 - 1500min-l 
(Endo and Tsurugi, 1988, Osborn, 1990, Chaddock, 1991, Ready ~ 
al. 1991). Little kinetic investigation into ST / SLT I / SLT 
II-catalysed depurination of ribosomes has been carried out. 
Reisbig ~ al. (1981) do however, report the Al fragment of the 
ST A subuni t to catalyse the depurination of 40 ribosomes 
min- l • 
It may be seen that most comparisons have been made between the 
activities of ST and ricin. Since SLT I is regarded to be 
virtually identical to ST (O'Brien and LaVeck, 1982), and thus 
information relating to the activity of SLT I has been derived 
from knowledge of the activity of ST. This present study 
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directly addresses a comparison between the catalytic activity 
of ricin and SLT I. 
SECTION 1.5 Structural coaparison of ST I SLT I vi th other 
bacterial toxins 
Further to this study are the structural comparisons which may 
be made by comparing 5LT I with other bacterial toxins such as 
cholera toxin (CT) and E.coli heat labile toxin (LT) in 
addition to DT and PE. Such comparisons allow the delegation of 
specific roles to each domain of 5LT I. 
The bipartite nature of 5T and SLT I is typical of many 
bacterial toxins, comprising an enzymatically active A domain 
and a cell binding B domain (Olsnes et al. 1981) (FIG 1.5.1). 
The holotoxin has a molecular mass of approximately 70KDa. It 
comprises a single A subunit (5LT lA) of molecular weight 32KDa 
non covalently associated with multiple copies of a B subunit. 
Each B subunit is of approximately 7.7KDa in size, as deduced 
from the nucleotide sequences of stxA and stxB respectively 
(Kozlov et al. 1988, 5trockbine et al. 1988). The B subunits 
are thought to associate with the single A subunit as a 
pentameric structure (Olsnes ~ al. 1981, Donohue -Rolfe et al. 
1984, O'Brien and Holmes 1987, Stein et al. 1992) comparable to 
that of CT (Gill, 1976) and LT (Sixma et al 1991). From 
examination of the crystal structure of the B subunit (Stein et 
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FIG 1.5.1 Proposed subunit arrangement of Shiga-like toxin I 
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al. 1992) suggest that this conveys five potential binding 
sites per molecule of ho1otoxin. Alternatively, it is 
suggested by Hart g al. (1991) from high resolution X-ray 
analysis of crystallised SLT lB that the B subunits associate 
with the SLT lA subunit in the form of a tetramer. 
Examination of the crystal structure of the SLT I B subunit by 
Stein et al. (1992) revealed that although there is no primary 
sequence homology between SLT lB and the B subunit of LT, both 
subunits adopt a similar structural fold, if allowance is made 
for the larger size of LT B (103 amino acids) compared to SLT 
IB (69 amino acids) (Spangler, 1992) (FIG 1.5.2) • The 
similari ties in three-dimensional structure led Stein et al. 
(1992) to suggest that the B subunits may have diverged from a 
common ancestoral pentameric protein. This protein they 
suggest, may not have originated from another toxin, instead it 
may originally have been involved in the recogni tion of cell 
surface carbohydrate moieties. From their results Stein et al. 
(1992) conclude that a distant evolutionary relationship may 
exist between the Shiga toxin and cholera toxin families. 
Considerable structural similarities are seen to exist between 
CT, LT and ST / SLT I. All are comprised of a single 
enzymatically active A subuni t with the mul tiple B subuni ts 
responsible for cell binding being non covalently associated 
with the A2 peptide (Gill, 1976, Sixma ~ al. 1991 and Olsnes 
~ al. 1981 respectively). It is with regard to these apparent 
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FIG 1.5.2 Amino acid sequences of Shiga-like toxin I B subunit 
and Escherichia coli heat labile toxin (human isolate). 
Residues are numbered above sequence 
Amino acid sequence SLT IB (Strockbine ~ al. 1988) 
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similarities that we may speculate on the role of the A2 region 
of ST / SLT 1. 
On closer examination both CT and LT may be regarded as 
tripartite molecules (Gill ~ al. 1981 and Sixma ~~. 1991 
respectively) each clearly comprising a single enzymatica11y 
active Al peptide, a pentamer of B subuni ts responsible for 
binding of the toxin to the cell surface receptor ganglioside 
GM1 , plus an AZ peptide which has been proposed to play an 
important role in membrane trans10ca tion of the A subuni t 
(Gill ~ al. 1981). In addition, it is with the A2 region that 
the B subunit pentamer associates non cova1ently (Gill, 1976, 
and Sixma ~ al. 1991). Recent studies on the AZ regions of CT 
(Job1ing and Ho1mes, 1992) and LT (Strea tfie1d et al. 1992) 
have strongly implicated the A2 region in the stable 
association of the relative B subunit pentamers with the A 
subunit to form holotoxin. 
Keusch (1981) has proposed tha t ST / SLT I should also be 
regarded as a tripartite molecule. He has suggested that the A2 
peptide may be responsible for translocation of the 
enzyma tica11y active Al peptide to its intracellular target, 
following the successful binding and endocytic uptake of the 
ho1otoxin. However, it should be stated that even as yet, there 
is no direct evidence for A2 playing a role in protein 
translocation. In addition and far more likely, the A2 peptide 
may also be considered to play an important structural role 
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with regard to its interaction with the multiple B subunits • 
In this sense, it would be similar to the equivalent portion of 
CT and LT. 
SECTION 1.6 Binding and entry of ST I SLT I 
As is the case with other bacterial toxins for example PE and 
DT, it is necessary for the A subunit of ST and SLT I to enter 
the cell in order to gain access to its cytosolically located 
subs tra te; in this case, the ribosome. It has been suggested 
(Middlebrook and Dorland, 1984) that intracellularly acting 
bacterial toxins such as ST and S1T I may in fact utilise the 
cellular glycolipid receptors which would normally facilitate 
the binding of glycoprotein hormones. 
Entry of ST and S1T I is mediated by binding of the B subunit 
to a cell-borne glycolipid receptor globotriosylceramide 
(Gb3) ie a GalCX 1-4Gal,s l-4Glu trisaccharide linked to a 
ceramide (Cohen ~ al. 1987, 1indberg et al. 1987, 1ingwood ~ 
al. 1987), facili tating receptor mediated endocytosis (RME). 
Binding of the S1T IB to the Gb 3 receptor is highly specific 
requiring that at least the terminal disaccharide Gal~1-4Gal~ 
be available (Tesh and 0' Brien, 1991). 1indberg ~ al. (1987) 
found that the insensitivity of certain cell lines was afforded 
by ·a lack of Gal .... On-4Gal~terminating glycolipid receptors 
required for the high specificity binding of ST. 
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Once bound to the cell, the next requirement is for entry of 
the enzymatically active A subunit into the cell cytosol. 
Keusch (1981), proposed receptor media ted endocytosis as the 
mechanism by which the ST A subuni t accesses the cytosol. 
Sandvig and Brown (1987) and Sandvig ~ al. (1989) have 
demonstrated entry of ST to be via endocytosis through clathrin 
coated pits. Sandvig ~ al. (1991) then presented evidence to 
suggest that a proportion of internalised ST was transported to 
the trans Golgi network (TGN) as had previously been seen to 
be the case with ricin (Van Deurs ~ al. 1986). Sandvig ~ al. 
(1992) have recently visualised ST wi thin the lumen of the 
endoplasmic reticulum (ER) and nuclear envelope of chemically 
stimulated A431 cells. It has therefore been suggested that the 
early Golgi or even ER itself, may be the compartments 
physiologically important for the subsequent membrane 
translocation step which precedes ribosome inactivation. This 
hypothesis has been proposed by Pe1ham ~ al. (1992). 
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SECTION 1.7 Intracellular processing and translocation of ST I 
SLT I compared with that of other bacterial toxins 
In common with many other bacterial toxins is the presumed 
requirement for proteolytic processing of endocytosed ST and 
SLT I in order to generate an enzymatically active particle. It 
remains unclear as to where such processing occurs within the 
target cell, but such processing is presumed to be obligatory 
(Olsnes et al. 1981, Reisbig et al. 1981). 
-- --
Many bacterial toxins are secreted as inactive precursor forms 
requiring a certain degree of proteolytic processing in order 
to 'activate' them. Such a requirement is seen in not only ST 
(Olsnes ~ al. 1981) and SLT I but also in PE (Leppla ~ al. 
1978, Ogata ~ al. 1990, Fryling ~ al. 1992), DT (Collier, 
1975, Sandvig and Olsnes, 1981, Moskaug ~ al. 1989), CT (Gill, 
1976), tetanus toxin (Helting and ZWisler, 1974), E.co1i heat 
labile toxin (Spicer and Noble, 1982, Yamamoto ~ al. 1987) and 
pertussis toxin (Burns, 1988). In ST and SLTs the processing 
site is found within the A subunit. 
The enzymatically active A subunit of SI and SLT I is comprised 
of two regions, designated Al and A2 • The two are separated by 
a protease sensitive linker region; treatment with trypsin 
yielding a 'nicked' A subunit analogous to that seen in DT, CT 
and LT. However, only under reducing conditions are the 
constituent Al (27.5KDa) and A2 (4.5KDa) peptides completely 
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separated, since they are bridged by a single disulphide bond 
formed between cysteine (Cys) residues 242 and 261, which flank 
the arginine (Arg)-rich protease-sensitive linker region (FIG 
1.7.1). Proteolytic cleavage within an Arg rich region flanked 
by Cys residues is also evident in DT (Collier, 1975, Moskaug 
et al. 1989) and PE (Ogata ~ al. 1990). Possession of a 
protease sensitive region is commonly found amongst the 
bacterial toxins; examples include tetanus toxin (Hel ting and 
Zwisler, 1974), DT (Collier, 1975, Moskaug ~ al. 1989, Choe et 
al. 1992) CT (Gill, 1976, Gill et al. 1981), LT ( Gill ~ al. 
1981, Spicer and Noble, 1982, Yamamoto et al. 1984) and PE 
(Ogata ~ al. 1990) (FIG 1.7.2). 
DT, secreted by tS lysogenised strains of Corynebacterium 
diphtheriae as a single polypeptide proenzyme of 58KDa, yields 
an enzymatic A subunit of 21KDa and a B subunit of 37KDa on 
treatment with trypsin and reducing agent. The B subunit is 
responsible for cell binding and translocation (Carol1 ~ al. 
1988). Cleavage occurs within a 14 residue loop structure 
(residues 187 - 200) (Choe et al. 1992) (FIG 1.7.3). This 
region may be seen to be arginine-rich. Indeed, cleavage is 
thought to occur at arginine residues 190, 192 or 193 (Moskaug 
et al. 1989). After cleavage (nicking) the A and B subunits 
remain covalently linked by a single disulphide bond between 
cysteine residues 186 and 201 (Choe ~ al. 1992). It is thought 
that reduction. of this disulphide bond liberating the free A 
and B subunits, occurs on exposure of the nicked toxin to the 
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Protease Sensitive 
Linker Region 
CHHHAS RVARMASDEFPSMC 
242 261 
FIG 1.7.1 The proposed Shiga-like toxin I A subunit (SLY lA) 
protease sensitive region. 
The amino acid sequence for this region is detailed with the 
cysteine residues which form a disulphide bridge at this region 
denoted c. 
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FIG 1.7.2 Amino acid sequence at proposed sites of proteolytic 
processing for diphtheria toxin (DT). Shiga-like toxin I (SLT 
I) and Escherichia coli heat labile toxin (LT) (human isolate) 
186 C A G N R V R R S P G I R N H C 201 DT 
242 C H H HAS R V A R M A S D E F P S M C 261 SLT I 
187 C G N S S R TIT G D T C 198 LT 
Numbers relate to amino acid sequence in each case 
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FIG 1.7.3 Proposed site of proteolytic cleavage of diphtheria 
toxin (DT) 
s-s 
OTA OTB 
186 C A G N I V I I S P G I R N H C 201 
S-S denotes a disulphide bond. 
DTA and DTB denote diphtheria toxin A and B fragments 
respectively. 
reducing environment of the cytosol during membrane 
translocation (Sandvig and Olsnes, 1981). 
Proteolytic cleavage and reduction of PE, a 66KDa polypeptide, 
releases a 37KDa enzymatically active fragment (Jinno ~ al. 
1989, Ogata et al. 1990, Fryling et al. 1992). Again 
proteolytic cleavage may be seen to take place at an arginine-
rich region flanked by cysteine residues (residues 265 and 287) 
within domain 11 of PE (residues 252 - 364). The importance of 
proteolytic processing at this site was demonstrated by Jinno 
et al. (1989). On mutation of Arg 276 and Arg 279 whilst the 
mutant molecule demonstrated unchanged enzymatic and cell 
binding properties, its cytotoxicity was greatly reduced. Using 
radiolabelled PE Ogata et al. (1990) followed the intracellular 
processing of PE and identified the site of proteolytic 
cleavage within domain 11 as being close to Arg 279 within the 
disulphide loop region bounded by cysteine residues 265 and 
287. 
Again, a requirement for proteolytic processing has been 
demonstrated with CT and the closely related E.coli heat labile 
toxin (LT). Synthesised as a single polypeptide precursor 
(Gill, 1976), proteolysis generates peptide of 
approximately 21KDa which Gill et al. (1981), have reported as 
displaying the highest in vitro activity and an A2 peptide of 
approximately 5KDa. During secretion CT becomes nicked by 
haemagglutinin/protease (Booth ~ al. 1984). In contrast LT is 
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not secreted from E.coli but remains in an unnicked state in 
the periplasm (Hirst ~ al. 1984a). Following secretion the CTA 
fragments remain linked by a disulphide bond between Cys 
residues 187 and 198 of CT A subunit. As previously discussed 
wi th regard to DT (Sandvig and Olsnes, 1981) the fragments 
remain linked in this unreduced and essentially inactive state 
until the toxin enters a cell (Spangler, 1992). With regard to 
generation of an enzymatically active Al peptide in vivo; 
Janicot et al. (1991) put forward the sugges tion, based on 
their findings, that processing of the eT A subunit takes place 
wi thin an acidic endosomal compartment. It is then from this 
compartment that the enzymatically active Al peptide is 
released. This location would be compatible therefore, with the 
findings of Ogata ~ al. (1990) and Fryling ~ al. (1992) that 
the PE processing enzyme is enriched in endosomal fractions. 
Location of a protease known to be responsible for the 
intracellular processing of PE (Fryling ~ al. 1992) suggests 
that the same protease may be responsible for the processing of 
other toxins. Its endosomal location has not however, been 
convincingly demonstrated. The presence of such a protease in 
all eukaryotic cells is also an unknown factor. 
DTA has also been shown to be released from an endosomal 
compartment (Papini, 1987, 110skaug _e_t _a_I. 1991). Following 
binding of the DT B subunit (DTB) to a cell-borne receptor, the 
toxin is endocytosed to endosomes where the toxin undergoes 
conformational changes. Such conformational changes are thought 
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to promote insertion and formation of an ion-selective channel 
in the endosomal membrane allowing translocation of DTA into 
the cytosol (Papini, 1987, Moskaug ~ al. 1991). It is thought, 
although as yet unknown, that the low pH environment of the 
endosome may trigger conformational changes in the DT molecule 
leading to its insertion into the endosomal membrane (Choe et 
al. 1992). 
The contribution of the AZ peptide of ST and SLT I to the 
enzymatic activity remains unclear, since Olsnes ~ al. (1981) 
and Reisbig ~ al. (1981), demonstrate that in the case of ST, 
the Al peptide alone, is approximately six times more active 
in vi tro than the unnicked, non reduced ST A subuni t. A 
further report (unpublished) suggests that A2 is not necessary 
for activity of the A subunit (Paige Anderson, Boston HA); 
whilst Kongmuang et al. (1988) have demonstrated that there is 
no difference in the cytotoxic na ture of ei ther nicked or 
unnicked SLT I. However, the necessi ty for proteolysis and 
reduction in order to release an enzymatically active subunit, 
suitable for efficient membrane translocation has been 
demonstrated in other intracellularly acting bacterial toxins 
such as PE and DT. It may be rationalised that if the 
structural arrangement of SLT I is as shown in FIG 1.5.1, then 
proteolysis in the hypersensitive region and reductive cleavage 
would afford a means of releasing a catalytically active Al 
fragment from the rest of the toxin. This would make the 
release of Al analogous to that of the release of the A 
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fragment from the B fragment of DT (Sandvig and Olsnes, 1981, 
Moskaug ~ al. 1989) and domain III from the N terminal portion 
of PE (Ogata ~ al. 1990, Fryling et al. 1992) (FIG 1.7.4), ie 
the active enzyme can be released from the cell binding portion 
of the toxin to cross the membrane and effect ribosome 
inactivation. Alternatively, it may be necessary to cleave the 
A subunit in order to allow full expression of Al catalytic 
activity, and have nothing to do with allowing effective 
membrane translocation to access the cytosol in the absence of 
the cell binding domain. 
In order to examine the proposed contribution of the SLT I A2 
peptide to translocation of the enzymatically active Al subunit 
experiments similar to those carried out to define the proposed 
translocation domain of PE could be undertaken. Of the three 
functional domains constituting PE, it is domain II (residues 
253 - 364) which has been shown to be an essential requirement 
for translocation of the enzymatically active domain III (Hwang 
et al. 1987) across the cell membrane (Jinno ~ al. 1989). 
Perhaps the most conclusive evidence for the translocation role 
of domain II of PE comes from the work of Prior ~ al. (1992) 
who by construction of a fusion protein comprising PE domain II 
and barnase (the extracellular ribonuclease of Bacillus 
amyloliguefaciens) successfully demonstrated the translocation 
of a foreign protein to the cell cytosol. They concluded that 
domain II, essentially independent of other PE domains, was 
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FIG 1.7.4 Schematic representation of Pseudo.onas exotoxin A 
(PE), diphtheria toxin (DT), Shiga-like toxin I (SLT I) and 
ricin. 
Pseudomonas exotoxin A [SS] 
1 REDLK I -• • • I- -11: x lib I • • la III • • • • • • 1 252 364 ADP RIBOSYLATION 613 
Diphtheria toxin 
[SS] 
I I I-/ X B· 1- x • A .... • )( • • . )( • 1- • x 
1 ADP RIBOSYLATION 194 535 
Shiga-like toxin I [SS] X5 I Al I ~ I I: B : I 
1 RNA N-GLYCOSIDASE 293 1 tf} 
Ricin ]551 : I A • • B·· •• • • • • • • • • 
1 RNA M-GLYCOSIDASE 267 1 262 
CELL BINDING 
TRANSLOCATION 
sufficient for translocation of a soluble enzyme to the cell 
cytosol. 
The contribution of the ST / SLT I AZ peptide to the enzymatic 
activity of the toxin is also pertinent to this study. 
Comparison of SLT I to other bacterial toxins may suggest what 
this role may be, but as yet this remains unclear. The need for 
proteolytic processing of SLT lA into Al and AZ will therefore 
be investigated by studying the effects of a non cleavable, 
recombinant SLT lA on ribosomes in vitro and on cultured cells. 
Comparisons will be made with a recombinant wild type SLT lA. 
It is hoped that a clearer picture will emerge as to the 
contributions (advantageous, neutral or deleterious) of AZ 
towards the in vitro enzymatic activity of SLT lA. The 
cytotoxic effects of a holotoxin containing such a non 
cleavable A subunit will also address the issue of whether 
proteolytic processing is essential for cell killing. 
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SECTION 1.8 Project Aims 
1. Production of biochemically pure SLT I in order to allow a 
direct comparison to be made between the RNA N-glycosidase 
activity of SLT I and ricin. 
2. Production, by oligonucleotide site directed mutagenesis, of 
SLT lA subuni t mutants in order to examine any contributory 
role of the AZ peptide in RNA N-glycosidase activity of SLT lA 
and to examine the necessity of the proteolytic processing step 
for the expression of cytoxicity. 
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SrCTION 2 MATERIALS AND METHODS 
SECTION 2.1 MATERIALS 
The majority of analytical grade chemicals used were 
obtained from either BDH Chemicals Ltd. or FSA/Fisons 
where available. The sources of other specific 
reagents are detailed below. 
Amersham International PLC, 
Buckinghamshire. 
AmplifyTM 
[~5S] dATP (lOmCi/ml, >1200Ci/mmol) 
L-[35 S] methionine (15mCi/ml, >lOOOCi/mmol) 
Biocarb AB, S-223 70 Lund, Sweden. 
Globotriose-Fractogel TSK gel matrix 
Bio-Rad Laboratories Ltd. , Hemel 
Hertfordshire. 
Amersham, 
Hempstead, 
Bio-Rad Assay protein determina t ion ki t, low range 
SDS PAGE molecular weight standards 
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Boehringer Mannheim (UK) Ltd., Lewes, East Sussex. 
calf intestinal phosphatase, creatine kinase, 
creatine phosphate, deoxyribonucleotides, 
dideoxyribonucleotides 
DIFCO Laboratories, Basingstoke, Hampshire. 
Bacto-agar, 
extract 
Bacto-peptone, Bacto-tryptone, yeast 
FSA/Fisons, FSA Laboratory Supplies, Loughborough, 
Leicestershire. 
ace t ic acid (glacial), acids and organic sol ven t s, 
2-mercaptoethanol, urea 
GIBCO/BRL, Life Technologies Ltd, Paisley, 
Renfrewshire, Scotland. 
T4 DNA ligase, SP6 RNA polymerase, T7 RNA polymerase, 
ultra-pure RNAse free sucrose 
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Kodak Ltd., Hemel Hempstead, Hertfordshire. 
N,N'-methylenebisacrylamide (electrophoresis grade) 
Life Sciences Inc., St Petersburg, Florida, USA. 
AJN reverse transcriptase 
LKB-Produkter AB, Bromma, Sweden. 
Ultropac TSK DEAE-SPW HPLC column 
MERK/BDH BDH Chemicals Ltd., Poole, Dorset. 
acrylamide {Electran™), aniline, bromophenol blue, 
Duolite MB6113 mixed resin, sodium dodecyl sulphate, 
polyethylene glycol 6000, triton X-lOO 
Northumbria Biologicals Ltd. , Cramlington, 
Northumberland. 
restriction endonuclease ~ I 
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Pharmacia (OK) Ltd., Milton Keynes, Buckinghamshire. 
m7G(5')ppp(5')G (CAP), restriction endonucleases 
Promega Biotechnology, 
Liverpool, Merseyside. 
P&S Biochemical Ltd., 
RNasin, rabbit reticulocyte lysate 
Sigma Chemical Company Ltd., Poole, Dorset. 
ampicillin, bovine serum albumen (BSA), 
brilliant blue, dithiothreitol (DTT), 
Coomassie 
ethidium 
bromide, L-amino acids, phenylmethylsulphonyl 
fluoride (PMSF), polymyxin B sulphate, sephadex GIOO-
120, TPCK trypsin 
United States Bioscience, 
Cambridge. 
Cambridge Bioscience, 
Sequenase™ DNA sequencing kit, T7-GEN™ in vitro 
mutagenesis kit, T4 polynucleotide kinase 
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Whatman International Ltd., Maidstone, Kent. 
3MH chromatography paper 
Recombinant ricin A subuni t used in this study was 
obtained from ICI, Alderley Edge, Cheshire. The 
non-glycosylated, recombinant protein is identical in 
primary amino acid sequence to native, plant purified 
ricin A subunit. It does however, contain an N-
terminal methionine prior to the native N-terminal 
isoleucine residue. 
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SECTION 2.2 GROWTH AND MAINTENANCE OF BIOLOGICAL 
MATERIALS AND BIOCHEMICALS. 
2.2.1 Bacterial cultures. 
All bacterial strains used in the following study are 
listed in Appendix 1. 
(i) Maintenance. 
o 
Stock laboratory cultures were maintained at 4C on 
minimal media/glucose plates: lxM9 salts (10x M9 
salts is 60g/L Na2HP04t 30g/L KH2P04t 10g/L NH4CI, 
5g/L NaCI) lmM MgS04 ,lmM thiamine HCI, O.lmM CaCI2' 
0.2% w/v glucose, 1.5% Bacto-agar. In this way 
bacterial cultures could be stored for up to one 
month prior to replating. 
(ii) Growth and short term storage on solid media. 
L-broth (1% w/v Bacto-tryptone, 0.5% w/v yeast 
extract, 1% w/v NaCI) solidified with 1.5% w/v Bacto-
agar (L-agar) provided short term maintenance of 
bacterial strains. Supplemented with ampicillin to a 
final concentration of 100ug/ml this provided 
sel~ction for cells transformed with plasmid DNA 
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carrying antibiotic resistance to ampicillin. Plates 
o 
were then incubated inverted at 37C overnight. 
Transformant colonies were then streaked on to fresh 
o 
L-ampicillin plates, where following growth at 37C 
o 
they were maintained at 4C for up to 2 weeks. 
(iii) Growth in liquid media. 
10mls of L-broth inoculated with a single colony was 
• incubated at 37C in an orbital shaker (200rpm) 
overnight, resulting in an overnight culture. 
Addi tion of ampicillin to a final concentration of 
100ug/ml again providing a means of selection for 
growth of transformant colonies. 
2.2.2 Yeast cultures 
ABYS 1, a vacuolar protease deficient strain of yeast 
(Achstetter et al., 1984) was used for the production 
of yeas t ribosomes. Liquid cultures were grown at 
3~C in an orbital shaker at 200rpm in YPD ( 1% w/v 
yeast extract, 2% w/v Bacto-peptone, 2% w/v glucose) 
supplemented with 1% v/v uracil and 1% v/v adenine 
each originally a Img/ml stock. Cells were 
maintained on YPD plates (YPD solidified with 2% w/v 
o Bac to-agar) at 4C for up to 4 weeks. Growth and 
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storage of yeast cultures was as described by Sherman 
et a1. (1986). 
2.2.3 Storage of Ribosome Inactivating Proteins • 
• Shiga-like toxin I was stored at -20C in PBS (8g/L 
NaCl, 0.2g/L KCl, 1.44g/L Na2HP04' 0.24g/L KH2P04' 
pH7 .2). Ricin and recombinant ricin A chain (rRA) 
(ICI) were stored at 4C. 
SECTION 2.3 PREPARATION OF RIBOSOMES. 
(i) Yeast ribosomes. 
A 500ml overnight culture of yeast ABYS 1 was grown 
as detailed in section 2.2.2 to an OD of 2 at 600nm • 
• This was then harvested at 5,000 x g, 4C for 5mins. 
The resultant cell pellet was washed twice by 
resuspending in sterile dis tilled wa ter (SDW). The 
washed pellet was then resuspended in 3 pellet 
volumes of lysis buffer (100mM KOAc, 2mM MgOAc, 20mM 
HEPES-KOH pH7.4, 20% v/v glycerol with the addition 
of 0.005 volumes 20mg/ml PMSF prior to use). 0.5 
volumes of acid washed glass beads (40 mesh) were 
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• then added and the mixture vortexed at 4C until >50% 
cell lysis could be seen on microscopic inspection. 
The glass beads and cell debris were then pelleted 
and the ribosome containing supernatant centrifuged 
• at 15,000 x g, 4C for 20mins in order to pellet the 
mitochondria. The resultant supernatant then 
• underwent ultracentrifugation at 50,000 x g, 4C for 3 
hours which yielded a pellet of ribosomes. The 
ribosome pellet was washed in 500ul Endo buffer (25mM 
Tris HCI pH7.6, 25mM KCI, 5mM MgC12) and gently 
resuspended in 500ul of the same buffer using an acid 
washed glass rod. The ribosome concentration was 
calculated using the formula that 1mg/ml of ribosomes 
is equivalent to 12.5 OD units at 260nm. 
(ii) Salt washed wheatgerm ribosomes. 
20g of high grade, milled wheatgerm was ground 
thoroughly in 100mls grinding buffer (200mM Tris HCI 
pH9, 200mM KCI, 35mM MgCI2 , 25mM EGTA, 200mM RNase-
free sucrose) plus 0.5 volumes sterile, crushed glass 
at 4·C using a pre-chilled, alkali-washed pestle and 
mortar. The debris was pelleted by centrifugation at 
• 5,000 x g, 4C, 10mins. The resultant supernatant 
(excluding the surface layer of fat) was then 
centrifuged again (15,000 x g, 0 4C, 15mins ) in order 
to pellet unwanted nuclei and mitochondria. The 
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ribosome-containing supernatant was layered over a 
20ml sucrose pad (lM RNase-free sucrose, 40mM Tris 
HCl pH9, 200mM KCl, 30mM Mg C12' SmM EGTA) and 
centrifuged at 50,000 x g, • 4C, for 3 hours. The 
resulting ribosome pellet was washed and resuspended 
in SOOul Endo buffer as in section 2.3(i). 
(iii) Rabbit liver ribosomes. 
Rabbit liver ribosomes were prepared using a 
modification of the methods described by Martin et 
al. (1969) and Moldave and Sadnik (1979). 
109 fresh rabbit liver was homogenised in 23mls 
Medium A (SOmM Tris HCl, 12.SmM MgC12' 80mM KC1, pH7 
plus 0.2SM sucrose) Martin ~ al. (1969). Cell debris 
was removed by centrifugation of the homogenate at 
10,000 x g, (C for lSmins foll~wed by filtering the 
supernatant through cheesecloth. The filtrate then 
underwent ultracentrifugation (SO,OOO x g, (C for 
1. S hours) in order to produce a crude ribosome 
pellet which was washed and resuspended in 2ml Medium 
A. This was then spun through a IM sucrose cushion 
o (lM sucrose in Medium A) at 40,000 x g, 10C for 4 
hours. The resultant ribosome pellet was resuspended 
in SOOul Endo buffer as previously described 
(2.3(i». 
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Ribosomes isolated from tobacco leaf, E.coli, and 
rabbit reticulocytes were kind gifts from Or Martin 
Hartley and Andrea Massiah (Warwick). 
SECTION 2.4 ISOLATION OF NUCLEIC ACIDS. 
2.4.1 Extraction of RNA from ribosomes and cell free 
translation systems. 
Extraction of total RNA from such reaction mixes was 
achieved by the addition of 0.1 volumes 10% (w/v) 
sodium dodecylsulphate (SDS) and an equal volume of 
TE (10mM Tris Hel pH 8, lmM EDTA) equilibrated phenol 
chloroform (1:1 v/v). The further addition of 0.1 
volumes of 2M NaOAc/acetic acid, pH 6 and 2.5 volumes 
100% ethanol to the resultant top aqueous layer 
• followed by incubation at -20C for from 2 hours to 
overnight, allowed precipi ta tion of the RNA. The 
RNA was then pelleted by centrifugation at 11,000 x 
g at R' in a microcentrifuge and the resultant pellet 
washed with 70% v/v ethanol and dried in vacuo. The 
pellet was then redissolved in 10 - 20ul of sterile 
o 
dis tilled water and stored at -70C. The ribosomal 
RNA (rRNA) concentration was determined using the 
assumption that at 260nm the optical density (OD) of 
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a lmg/ml solution of RNA is 25 (Maniatis et al., 
1982). 
2.4.2 Preparation of plasmid DNA 
(i) Small scale preparation - 'mini-preps'. 
The alkaline lysis method as described by Maniatis et 
al. (1989) provided a rapid means of preparing 
plasmid DNA for the screening of transformant 
colonies. 
(ii) Large scale preparation. 
A modified version of the method described by Holmes 
and Quigley (1981), was used. 400mls of SOB (2% w/v 
Bacto-tryptone, 0.5% yeast extract, 10mM NaCl, 10mM 
MgC12' 2.5% KCl) with ampicillin added to a final 
concentration of 100ug/ml, was inoculated with an 
overnight culture of the plasmid bearing transformant 
of interest. The culture was incubated overnight at 
37C as previously described in section 2.2.1(iii). 
o Cells were then pelleted at 5,000 x g and 4C for 
10mins before being resuspended in 7.2mls of SET 
(25mM Tris-HCl pH8, 10mM EDTA, 15% w/v sucrose). 7.2 
mls of a 4mg/ml solution of lysozyme in SET was then 
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added and incubated for Smins at room temperature 
prior to the further addi tion to the suspension of 
12mls of 10% w/v Tri ton X-lOO. The solution was 
then briefly boiled over a bunsen flame until it 
became gelatinous. The flask containing the 
gelatinous mixture was then plunged first into a 
boiling water bath and then into icy water. The 
flask contents were then subjected to centrifugation 
at 20,000 x g for 30mins at 4~. In order to 
precipitate unwanted proteins 0.5 volumes of 7.SM 
ammonium acetate was then added to the resultant 
supernatant and the mixture left on ice for 20mins. A 
o 
further centrifugation - 15,000 x g for 10mins at 4C 
pelleted the protein precipitate which was then 
discarded. Precipitation of the nucleic acids was 
achieved by the addition to the supernatant of 0.7 
volumes of isopropanol • for and incubation at -20C 
• 10mins followed by centrifugation at 15,000 x g , 4C 
for lOmins. The nucleic acid pellet was then drained 
and re suspended in 4mls of low TE (lOmM Tris HCl pH8, 
O.lmM EDTA). 
A caesium chloride gradient allowed purification of 
the required supercoiled plasmid DNA from the 
remaining intrinsic nucleic acids present at this 
stage. To the 4mls of nucleic acid was added 4. 3g 
caesium chloride and O.Sml (Smg/ml in water) ethidium 
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bromide. Sealing of the solution in a Beckman 4.5ml 
'quick seal' ultracentrifuge tube allowed 
centrifugation in a Beckman Vti 65 rotor at 50,000 x 
o g at 20C for 6 hours. The resultant lower band of 
supercoiled plasmid DNA was removed from the 
ultracentrifuge tube by syringe and the ethidium 
bromide extracted from the DNA with isopropanol 
equilibrated with caesium chloride-saturated TE. 
Precipitation of the plasmid DNA was by the addition 
of 4 volumes of Low TE to the ethidium free aqueous 
phase, the addition of 0.1 volume 3M sodium acetate 
and addition of 2 volumes of 100% ethanol followed by 
... . prec1p1tat1on at -20C for 2 hours to overnight. 
The precipitated DNA was pelleted at 15,000 x g, 4C 
for 10mins, washed wi th 70% ethanol and dried in 
vacuo and resuspended in 400ul TE. Storage of such 
DNA was at -2cfc. 
(iii) Preparation of bacteriophage M13 replicative 
form (RF) DNA. 
SOul of an overnight cuI ture of TG2 cells plus a 
single M13 plaque were used to inoculate 5mls of 2YT 
broth (Bacto Tryptone 1.6% wlv, yeast extract 1% wlv, 
o 
NaCI 1% w/v) and incubated at 37C, 200rpm overnight. 
This was then used to inoculate a further 200mls 2YT 
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broth with incubation and shaking as before until the 
culture reached an OD of 0.5 at 550nm. The culture 
was then shaken at 300rpm, 3tC for a further 4 hours. 
Preparation of M13 RF DNA was as described for large 
scale preparation of plasmid DNA. 
(iv) Preparation of bacteriophage M13 single-stranded 
(ss) DNA. 
The method of Schreier and Cortese (1979) describes 
the way in which the positive (+) ss form of M13 
(Messing, 1986) vector and M13 derived cloning 
constructs were prepared. Briefly, a single plaque 
was used to inoculate 1.5ml of 2YT media containing 
100ul exponential phase E. coli JM101. The culture 
o 
was then incubated wi th shaking at 37C for 5 - 6 
hours. Centrifugation of the culture (11,000 x g at 
• 4C for 10min) resulted in a single-stranded phage-
containing supernatant. The addition of 0.25 
supernatant volumes of 20% polyethylene glycol 800 in 
3.5M Na acetate allowed precipitation of the ss DNA 
by incubation at room temperature for 30min. This was 
then centrifuged once again (11,000 x g at R- for 
10min) in order to pellet the ss DNA. Following 
thorough removal of the resultant supernatant, the ss 
DNA pellet was extracted and precipitated (2.4.3) and 
the final pellet resuspended in 20 - 40ul TE. 
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2.4.3 Extraetion and preeipitation of DNA. 
Following restriction with restriction endonucleases, 
DNA was extracted with an equal volume of TE 
equilibrated phenol chloroform (1:1 v/v) as 
described by Maniatis .!! al. (1989). DNA was then 
precipitated by the addition of 0.1 volumes 3M 
NaOAc/acetic acid pH 6 plus 2 volumes 100% ethanol as 
described by Maniatis et a1. (1989). DNA was then 
pelleted by centrifugation , washed , dried and 
resuspended as described by Maniatis et al. (1989). 
2.4.4 Isolation of DNA following gel eleetrophoresis. 
Following gel electrophoresis of restriction digested 
DNA on an Agarose - TBE gel (see below) required 
fragments were isolated by elution on to dialysis 
membrane. Long wave UV light allowed visualisation of 
the required DNA band and an incision to be made 
directly ahead of it. Into this cut was inserted a 
piece of Whatman 3MM paper with a dialysis membrane 
backing soaked in 1 x TBE buffer. Electrophoresis of 
the gel at 60mA was then continued this time with the 
gel unsubmerged. This was continued until the 
required band had migrated into the paper 
prevented from leaving it by the dialysis membrane. 
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Both were then placed in a 1.Sml Eppendorf tube with 
a hole pierced in the bottom. This was then placed in 
a 2ml Eppendorf tube and centrifuged for 1min in a 
microcentrifuge. 100ul of TE was added to the smaller 
tube and the centrifugation repeated. Addition of TE 
and centrifugation was repeated four times in total. 
The resultant eluate collected in the larger of the 
two tubes was then centrifuged for a further Smins in 
a microcentrifuge in order to pellet any debris. DNA 
was then precipi ta ted from the superna tan t as 
previously descibed (2.4.3) and then redissolved in 
an appropriate volume of 1 x TE (10 - 20ul). 
2.4.5 Spectophotometric quantitation of DNA. 
The concentration of DNA was estimated by measuring 
the absorbance at 260nm and calculated using the 
formula that 1 OD unit at 260nm is equivalent to 
40ug/ml of double stranded DNA or 30ug/ml single 
stranded DNA. 
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SECTION 2.5 MODIFICATION AND MANIPULATION OF NUCLEIC 
ACIDS. 
2.5.1 Treatment of modified rRNA with aniline 
reagent. 
Endo ~ al. (1987), first described the cleavage of 
ricin A chain modified rRNA. This method was however, 
modified by May et al. (1989) and was the method used 
in this study. 20ul aniline reagent (lM aniline-
acetic acid pH 4.5) was added to 2-4ug of modified 
rRNA con tained in a volume of 2-4ul. This was then 
. b 0 f h 1ncu ated at 60C for 2 minutes. Precipitation 0 t e 
rRNA was achieved by the addition of 0.1 volumes 7M 
NH40Ac and 2.5 volumes 100% ethanol followed by 
incuba tion on dry ice in the dark for 20mins. The 
rRNA was pelleted in a microcentrifuge at 11,000 x g 
• for 15mins at ~C and the pellet washed with 70% v/v 
ethanol prior to being dried in vacuo. The pellet was 
then resuspended in 20ul of 60% v/v formamide in 0.1 
x Endo buffer (3.6mM Tris, 3mM NaH2P04' O.2mM EDTA). 
2.5.2 Preparation of aniline reagent. 
Aniline was distilled twice and stored at -2~C in the 
dark until required. Iml of this aniline was then 
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mixed with 7ml H20 and O.sml glacial acetic acid in a 
glass universal previously acid washed in order to 
remove RNase. The pH of the aniline reagent was then 
made 4.5 with glacial acetic acid and made up to a 
final volume of 11ml. It could then be stored in the 
• dark at 4C for up to two months. 
2.5.3 Restriction endonuclease digestion of DNA. 
Restriction endonuclease digestion of plasmid and M13 
RF DNA was carried out using restriction enzymes and 
buffers supplied by Pharmacia. All digests were 
• incubated for 1.5-2 hours at 37C except for those 
involving Sma I, which were incubated at 3~C. 
2.5.4 Dephosphorylation of plasmid vector DNA. 
Removal of 5' phosphate groups from DNA in order to 
minimise self ligation of vector DNA was achieved by 
incuba ting DNA wi th calf intestinal phospha tase as 
in the method described by Maniatis et al. (1989). 
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2.5.5 Ligation of DNA. 
Ligation of DNA was achieved using T4 DNA ligase 
fromBRL Life Technologies Inc. using conditions 
recommended by the manufacturer. 
2.5.6 Phosphorylation of mutagenic oligonucleotides. 
Oligonucleotides used in site directed mutagenesis 
were phosphorylated exactly as described by the 
United States Biochemical (USB) T7-GEN™ 19 vitro 
mutagenesis system manual using T4 polynucleotide 
kinase. 
2.5.7 Site directed mutagenesis. 
The USB T7-GEN™ in vitro mutagenesis system is based 
on the work of Vandeyar ~ al. (1988) and serves to 
increase the percentage mutant progeny by eliminating 
non mutant parental template at an early stage in the 
procedure. The mutant strand is synthesised in the 
presence of 5-methyl-dCTP resulting in a methylated 
mutant strand. Selection for the mutant strand may 
then be accomplished by nicking of the parental non 
mutant strand with an enzyme - ~ I which nicks only 
non methylated DNA and, therefore, not the methylated 
mutant strand. The nicked strand is then removed by 
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the action of Exonuclease Ill, leaving only the 
mutant strand to act as template. Transformation of 
this methylated mutant strand into a host E.coli 
strain lacking the methylation dependant restriction 
systems mcrA and mcrB, which are ordinarily involved 
in the restriction of methylated DNA propagates the 
synthesis of methylated mutant strand DNA. Use of 
this method greatly enhances the efficiency of the 
mutagenesis process. 
Site directed mutagenesis of SLT lA subunit was 
achieved using the mutagenic oligonucleotides in FIG 
3.3.3 exactly as detailed by the USB T7-GEN™ in 
vitro mutagenesis system protocol. 
2.5.8 Dideoxy-sequencing of DNA. 
Dideoxy-sequencing of DNA was carried out using 
SEQUENASE™ (a modified form of T7 DNA polymerase) 
exactly as detailed in the United States Biochemical 
(USB) SEQUENASETM manual. 
(i) Dideoxy-sequencing of M13 ssDNA. 
This was carried out as detailed in the United States 
Biochemical (USB) SEQUENASE™ manual. 
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O.Spmoles of primer and lug of template DNA were 
mixed and incubated with 40mM Tris HCl pH7. S, 10mM 
o MgCl2' SOmM NaCl for at 6SC, 2min in a final volume 
of 10ul. This was then cooled slowly to a temperature 
o 
below 30C. lul OTT, 2ul labelling mix (1. SuM dGTP, 
1.SuM dCTP, 1.SuM dTTP) , O.Sul [ ~ _3S S]-dATP 
(lOuCi/ul) and 2ul Sequenase™ (diluted 1: 8 in TE) 
were then added to the annealed template/primer 
reaction mix and incubated for Smin at room 
tempera ture. 3. Sul of this was then trans ferred to 
2.Sul of each of the termination mixes (which had 
o • been pre-warmed to 37C) and incubated at 37C for a 
further Smin. To each termination reaction was added 
4ul of 95% v/v formamide, 20mM EDTA, 0.05% w/v 
bromophenol blue, 0.05% w/v xylene cyanol. Prior to 
gel electrophoresis the reaction mixes were heated to 
o 
80C for 2min. Typically 3ul of each reaction mix was 
loaded on to a sequencing gel (2.6.3). 
(ii) Dideoxy-sequencing of plasmid DNA. 
Prior to carrying out dideoxy-sequencing as detailed 
in the USB SEQUENASE manual, denaturation of the 
plasmid DNA was necessary. This involved the 
incubation at room temperature of lug DNA in 8ul H2O 
with 2ul of 2M NaOH for 10mins. The DNA was then 
ethanol precipitated as previously detailed and 
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resuspended in an amount of SDW relevant to the 
annealing of primer/template reaction as described by 
the USB SEQUENASE manual. 
2.5.9 Primer extension. 
The modified method of Moazed et al. (1986) as 
described by May et al. (1989) was used in the 
annealing of oligonucleotide primer to ribosomal RNA 
and its subsequent extension using reverse 
transcriptase in order to closely investigate the 
site of depurination of 28S rRNA by SLT lA. The 
procedure used was as described by May ~ al. (1989) 
except that the depurinated rRNA was extracted from 
yeast ribosomes following their exposure to toxin, 
that is, either recombinant ricin A subunit (RA) or 
Shiga like toxin I A subunit (SLT lA). 
SECTION 2.6 RESOLUTION OF NUCLEIC ACIDS BY GEL 
ELECTROPHORESIS. 
2.6.1 Formamide - Agarose gels. 
Resolution of aniline-treated ribosomal RNA was 
achieved using 1.2% w/v agarose in 0.1 x TPE buffer 
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(3.6mM Tris, 3mM NaH2P04' 0.2mM EDTA),50% formamide -
100ml in a 15 x 15cm gel former. 10ul aniline-treated 
o 
rRNA was heated to 65C for 5 mins in a denaturation 
step and cooled briefly on ice. 3ul sample buffer 
(50% v/v glycerol, 0.1% w/v bromophenol blue) was 
then added and the rRNA sample loaded on to the gel. 
Electrophoresis of the gel in 0.1 x TPE buffer, 
unsubmerged, at 20mA for 2-3 hours was then followed 
by staining of the gel in 2ug/ml ethidium bromide for 
10-20 mins and destaining in distilled water for a 
further 30 mins. Visualisation was by UV illumination 
of the gel. The gel was then photographed using a 
polaroid instant camera and polaroid 667 or 665 film. 
2.6.2 Agarose - TBE gels. 
Restricted DNA was fractionated on 1% w/v agarose in 
1 x TBE (10 x TBE comprises 108g/L Tris HCl, 55g/L 
Boric acid, 9.3g/L EDTA) as described by Maniatis et 
al. (1989). Gels were electrophoresed submerged in 1 
x TBE buffer containing 0.5ug/ml ethidium bromide at 
60mA for 2-3 hours. Visualisation of the resolved DNA 
was by UV illumination. 
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2.6.3 Polyacrylamide gels. 
Linear 6% w/v acrylamide gels as described by 
Maniatis et al. (19B9), were used to resolve the DNA 
produc ts of dideoxy-sequencing. For a gel of 
dimensions 20cm x 40cm 21g of urea was dissolved in 
Sml 10xTBE with the addition of 7.Sml 40% acrylamide 
(38g w/v acrylamide, 2g w/v N,N'-
methylenebisacrylamide, deionised with Duolite 
monobed resin MBll) and diluted with SDW to a final 
volume of SOmls. The gel mix was polymerised using 
2S0ul of 10% w/v ammonium persulphate and 2Sul TEMED 
and poured immediately. Prior to loading samples were 
denatured at BOC for 2mins in loading dye (95% 
formamide, 20mM EDTA, 0.1% w/v bromophenol blue, 0.1% 
w/v xylene cyanol). The gel was run at 40W constant 
power in 1 x TBE for 2 - 3 hours. The gel was fixed 
in 10% v/v methanol, 10% v/v acetic acid for 15 mins 
• • prior to being dried on Whatman 3MM paper at BOC 1n 
vacuo. Autoradiography was carried out using Fuji X-
ray film overnight. 
Products of primer extension were also resolved using 
this method. The gel was, however, B% w/v 
polyacrylamide. 
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SECTION 2.7 TRANSFORMATION OF BACTERIA. 
2.7.1 Preparation of competent cells. 
An overnight culture of E. coli was used to inoculate 
fresh L-broth and the culture incubated with shaking 
o 
at 37C until it reached exponential phase. SOml cells 
were then pelle ted at 5,000 x g for Smins at 4°C 
before being resuspended in 0.5 volumes of O.lM 
MgCl2. The cells were then repelleted as before and 
resuspended in 2mls O.lM CaCl2- Cells were then left 
on ice for a minimum of 2 hours before use. 
2.7.2 Transformation of E.coli with plasmid DNA. 
Transformation of E.coli with DNA was achieved by 
mixing 100ul of competent cells and approximately 
lOng of DNA, for 4Smin at (C on ice followed by heat 
° shock at 42C for 4Ssecs. The mixture was then 
returned to ice for a further 45 mins. Cells were 
then spread on L-agar plates containing the required 
antibiotic for selection of the plasmid DNA and the 
o plates incubated at 37C overnight. 
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2.7.3 Transformation of E.coli with H13 DNA. 
lng of M13 DNA was incubated on ice with 100ul 
competent cells (TG2) as above. Following the second 
incubation on ice for 45mins, the mixture of cells 
and DNA were added to 3ml molten H-top agar 
containing 40ul isopropyl-~-D-thiogalactopyranoside 
(IPTG) (20mg/ml), 40ul 5-bromo-4-chloro-3-indolyl~­
D-galactopyranoside (X-Gal) (20mg/ml in 
dimethylsulphonide) and 200ul of exponentially 
growing E.coli. This mixture was poured on to glucose 
• minimal media plates and incubated at 37C overnight. 
SECTION 2.8 IN VITRO EXPRESSION OF RECOMBINANT SLT 
lA SUBUNITS. 
2.8.1 in vitro transcription. 
Recombinant Shiga-like toxin I A subunits (rSLT IAs) 
resulting from site directed mutagenesis (SDM) were 
each cloned into plasmid vector pGEM2 (FIG 3.3.9) and 
orientated such that transcription was driven by the 
viral promoter T7. (A control vector used in 
subsequent in vitro experiments was under 
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transcriptional control of viral promoter SP6). The 
resultant plasmid was then linearised in each case 
with Eco RI and the linear DNA extracted with phenol-
chloroform, ethanol precipitated and resuspended in 
TE to a final concentration of lug/ul and used in the 
following reaction: 
Transcription reaction 
Linearised DNA (lug/ul) 
H20 
Transcription Premix 
RNasin 
SmM M-G(S')ppp(S')G (CAP) 
T7/SP6 polymerase 
TOTAL REACTION VOLUME 
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2.0ul 
2.Sul 
l2.0ul 
O.Sul 
l.Oul 
2.0ul 
20.0ul 
Transcription Premix 
10 x salts (20mM spermidine, 
400mM HEPES KOH pH7.S, 
60mM magnesium acetate) 
10mg/ml BSA 
SOOmM OTT 
SOmM rUTP, rATP, rCTP 
SmM rGTP 
H20 
TOTAL VOLUME 
o Stored at -70C. 
1000ul 
100ul 
100ul 
100ul 
200ul 
4500ul 
6mls 
o Transcription was carried out at 40C for 1 hour with 
the addition of 1ul 8mM rGTP in 20mM HEPES KOH pH7.6 
after 30 minutes. The resultant transcripts were then 
• stored at -70C. 
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2.8.2 in vitro translation. 
(i) Wheatgerm lysate. 
Wheatgerm lysate was a kind gift from Dr R. Wales 
(Warwick) and was used in the following reaction to 
translate in vitro transcripts previously 
synthesised. Translation reactions were assembled on 
ice and the components added in the following order: 
Wheatgerm translation reaction 
Wheatgerm Premix 
H20 
mRNA transcript (lug) 
35S-Methionine (15uCi) 
Wheatgerm lysate 
TOTAL REACTION VOLUME 
2.35ul 
4.40ul 
1.OOul 
1.OOul 
3.75ul 
l2.00ul 
NB Whea tgerm lysa te was defros ted, centrifuged and 
used immediately. 
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Wheatgerm Premix 
1M HEPES KOH pH7.6 
O.lM ATP 
0.4M Creatine Phosphate (CP) 
10mg/ml CP Kinase 
1.Smg/ml spermine pH7.0 
O.lM OTT 
3S0ul 
2S0ul 
SOOul 
100ul 
SOOul 
42Sul 
2mM GTP (40mM GTP/magnesium acetate stock pH7) 2S0ul 
SmM each amino acid mix 12Sul 
lM potassium acetate 2100ul 
H20 100ul 
TOTAL VOLUME 4.7ml 
Translation was carried out at 30°C for 60mins. The 
products were then analysed by SOS polyacrylamide gel 
electrophoresis (SDS PAGE) (2.10.3) and visualised by 
fluorography (2.10.3(iii). 
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(ii) Rabbit reticulocyte lysate 
Rabbit reticulocyte lysate was purchased from Promega 
and used as detailed in the instructions supplied by 
them. However, in most cases only half the prescribed 
reaction volumes were used, using 15uCi 35S_ 
methionine and lug in vitro transcribed mRNA per 
translation reaction. Translation was carried out at 
3d'C as before and the products analysd by SOS PAGE 
followed by fluorography to visualise them. 
SECTION 2.9 IN VIVO EXPRESSION OF RECOMBINANT SHIGA-
LIKE TOXIN I A SUBUNITS. 
Plasmid pSC25 (FIG 3.3.5) expressing the SLT lA 
subunit under control of the lacZ promoter of pUC19, 
was kindly donated by Or.S.B. Calderwood (Boston MA, 
USA). It was used to transform E.coli strain JM101 as 
previously described and grown exactly as described 
by Hovde !:..! al. (1988). IPTG induced expression of 
SLT lA was also achieved as described by Hovde et al. 
(1988). 
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2.9.1 Preparation of periplasmic extracts. 
Typically a lL culture of E.co1i strain JMI0l 
expressing SLT lA was grown under the conditions 
described by Hovde eta 1. (1988) • The cells were 
• harvested by centrifugation at 2500 x g and 4C for 
30mins. The cell pellet was then gently resuspended 
in 20 m1s Tris/Sucrose (lM Tris pH8, 0.5M EDTA pH8, 
IM MgCl2' 200g/L Sucrose) and the mixture incubated 
at room temperature for lOmins before a further 
centrifugation step 7500 x g, 4°C for 5mins. The 
resultant supernatant fluid was drained from the 
pellet and the pellet resuspended in 10m1s ImM Tris 
pH7.5. Incubation of the cells on ice for 10mins was 
o 
followed by a centrifugation step 19,000 x g, 4C for 
15mins. The resul tan t superna tan t in this case was 
the required SLT lA-containing periplasmic fraction. 
SECTION 2.10 ANALYSIS OF PROTEINS. 
2.10.1 Determination of protein concentration. 
Protein concentrations were determined using a 
commercially available Bio-Rad Assay. The assay is 
based on the Bradford dye-binding procedure 
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(Bradford, 1976) providing a simple colorimetric 
assay. Protein concentrations were determined by 
comparison to a standard curve using Bovine Serum 
Albumin (BSA) as the standard. The procedure was 
exactly as described by Bio-Rad. 
2.10.2 Treatment of protein products with trypsin. 
The trypsin sensitivity of in vitro translated, 
recombinant SLT lA subunits was determined by their 
incubation with increasing concentrations of L-1-
tosylamido-2-phenylethyl chloromethyl ketone-treated 
o (TPCK) trypsin (Sigma) (0 - 50ug/ml in PBS) at 37C 
for 15mins. The resultant protein products were 
analysed by SDS-PAGE. 
2.10.3 SDS-Polyacrylamide Gel Electrophoresis (SDS-
PAGE). 
Proteins were analysed using 12% or 15% SDS 
polyacrylamide gels as described by Laemmli (1970) 
under reducing and non reducing conditions the latter 
being achieved by the omission of 2-mercaptoethanol 
(0.75M) from the sample loading buffer. Protein bands 
could be visualised by two methods of staining: 
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(i) Coomassie Blue staining. 
Following electrophoresis, gels were immersed in a 
stain consisting of 0.25% w/v Coomassie Brilliant 
Blue R, 50% v/v methanol, 10% v/v acetic acid for 1 
hour prior to severa 1 washes in des tain (40% v/v 
methanol and 10% v/v acetic acid) in order to 
visualise the protein bands. 
(ii) Silver staining. 
Gels were silver stained as described by Merril !!. 
a1. (1981). 
(iii) Visualisation of radioactively labelled 
proteins following SDS-PAGE. 
Gels were firstly fixed in destain (above) for 30 
mins and then subjected to fluorography by immersion 
in 'Amplify' (Amersham) for 15 mins. Gels were then 
o dried by vacuum dessication at 80C on to 3MM paper 
and exposed to Fuj i RX X-Ray film in a light proof 
o 
cassette at -70C. 
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SECTION 2.11 DETERMINATION OF THE BIOLOGICAL 
ACTIVITIES OF SLT I HOLOTOXlN AND RECOMBINANT SLT lA 
SUBUNITS. 
2.11.1 RNA N-glycosidase activity. 
(i) Incubation with susceptible eukaryotic ribosomes. 
Potentially toxic extracts were incubated with 30ug 
of susceptible eukaryotic ribosomes - typically yeast 
ribosomes were used. Prior to incubation with 
susceptible ribosomes, SLT lA containing extracts 
were first incubated with 2-mercaptoethanol to a 
final concentration of 6mM • at 30C for 30min. 
Incubation with ribosomes at 30~ for 20mins in 1 x 
Endo buffer (25mM Tris Hel pH7.6, 25mM KCI, 5mM 
MgCl2) plus 2-mercaptoethanol to a final 
concentration of 6mM then followed. The ribosomal RNA 
was then extracted and subjected to aniline 
treatment, as described previously in SECTION 2.5. 
82 
(ii) Extraction and aniline treatment of ribosomal 
RNA following in vitro expression of recombinant SLT 
lA subunits. 
Following translation of potentially toxic mRNAs in a 
reticulocyte lysate cell free system exactly as 
detailed in the manual supplied by Promega, 
ribosomal RNA was extracted from the ribosomes 
involved in the translation and subjected to aniline 
cleavage as previously described in section 2.S. 
(iii) Examination of the ability of reticulocyte 
ribosomes to translate a 20 transcript. 
Translation of mRNA in a reticulocyte lysate cell 
free system was carried out exactly as described in 
the manual supplied by Promega. Following the initial 
translation of potentially toxic transcripts at 3~C 
for 1 hour, O.S-lug of a second transcript encoding a 
non toxic product was added to the reaction mix and 
incubated for a further 1 hour at 3cfc. Translation 
products were analysed by SDS-PAGE and visualised by 
autoradiography. 
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2.11.2 Cytotoxic activity of SLT I on Vero cells. 
Vero cells were plated out in 96 well flat bottomed 
tissue culture plates at a concentration of 
1.Sx104ce11s per well in Du1becco Modified Eagle' s 
Medium (DMEM) (DME plus 5% heat inactivated foetal 
calf serum, 2mM glutamine, SOIU/m1 penicillin, 
• 300ug/m1 steptomycin). Incubation at 37C overnight in 
a 5% CO2 incubator resu1 ted in the formation of a 
confluent monolayer of cells. The DMEM was removed 
from the wells and the mono layers washed once with 
PBS. Toxin diluted in 2Sul of PBS was then added to 
each well and the cells incubated for a further 1 
hour at 3fc, 5% CO2• 100ul DMEM was then added to the 
wells and intoxication of the cells left to proceed 
(I for 20-24 hours at 37C, 5% CO2• Toxin containing 
supernatant was removed at the end of this period and 
the cell mono layers washed once again with PBS. This 
was followed by the addition of luCi 3SS- methionine 
contained in SOul PBS to each well and a further 
• incubation at 37C, in 5% C02 for 2 hours. The 
supernatant was removed from the cells and the cell 
mono1ayers washed x3 with 5% trichloroacetic acid 
(TCA) and once with PBS. The addition of O.SM NaOH to 
each monolayer led to cell lysis over a period of 
4Smins at room temperature allowing the contents of 
each well to be mixed with liquid scinti11ant and the 
84 
incorporation of the isotope into cell proteins to be 
counted using a scintillation counter. Thus IC50 
values for SLT I could be determined. 
SECTION 2.12 PURIFICATION OF SHIGA-LIKE TOXIN I (SLT 
I). 
Shiga -like toxin I (SLT I) only producing E.coli 
serotype 026:Hll, strain E3787 was purchased from the 
National Type Culture Collection on the advice of Or 
S M Scotland (Public Health Laboratory Service, 
Collingdale). This was then grown in iron-depleted 
syncase medium (1.17g/L NH4Cl, 5g/L KH2P04' 5g/L 
Na2HP04' 0.2% glucose, 0.002% nicotinic acid, 0.04% 
tryptophan, Iml/L trace salts [5% MgS04' 0.5% MnC12in 
O.OOlM H2S04,pH8.0]) (O'Brien et al. 1982) as 2 x 
10L cultures in A Braun Biostat E glass fermenter for 
18 - 20 hours at 3fc with aeration 5L/min. This was 
carried out under Category 11 containment at PHLS, 
CAMR, Porton Down. Purification of SLT I followed the 
method described by Ryd et al. (1989) for 
purification of ST, with slight modification. 
Typically 4g cell paste was resuspended in 20mls PBS 
and sonicated using an MSE Soniprep 150 sonicator 10 
x 20sec bursts 
i (4'C, Centrifugat on 
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at amplitude setting 22. 
10,000 x g, 45 min) allowed 
separation of the cell debris from the supernatant 
which was then precipi ta ted wi th ammonium sulphate 
to 60% saturation Petric et al. (1987) (1 hour, 4·C 
with stirring). Centrifugation «(C, 10,000 x g, 
10min) allowed separation of the resultant ammonium 
sulphate precipitated proteins. These were then 
resuspended in 20ml PBS and dialysed against 3L PBS 
overnight at 4~ before being filter sterilised (Ryd 
et a1. 1989) and applied directly to a lml 
globotriose (Gb3)-Fractogel column (Biocarb) 
(equilibrated with PBS) at a constant temperature of 
• 4C. The column was then washed with approximately 40 
column volumes ie 40mls PBS in order to remove 
proteins which failed to bind. Elution of the 
affinity-bound proteins was as described by Ryd ~ 
• al. (1989) using 6M guanidine HCl pH6.7 at 4C. 6 x 
lml fractions were collected and dialysed immediately 
at :C against 3L PBS which was replaced at intervals 
of 1, 3 and 12 hours. Fractions were analysed by SDS 
polyacrylamide gel electrophoresis (2.10.3), Bio-Rad 
assay (2.10.1) and for RNA N-glycosidase activity 
(2.11.1(i». 
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2.12.1 Storage and preservation of globotriose-
Fractogel column. 
Following use the column was cleared of residual SLT 
I by applying approximately 10 column volumes of GM 
guanidine HCl pH6.7 through the column followed by 
approxima tely 40 column volumes of PBS. Microbial 
growth was prevented by storage of the column matrix 
in PBS containing 0.02% v/v sodium azide. The column 
o 
was then stored at 4C. 
Prior to use of the column in the purification of 
recombinant Shiga-like toxin I A subunit containing 
holotoxins it was analysed for the existence of 
residual SLT I or SLT IB by elution with GM guanidine 
HCl pH6.7. 7 - 8 x 1ml fractions were collected in 
each case and dialysed against PBS as previously 
described. Fractions were then analysed by SOS 
polyacrylamide gel electrophoresis (2.10.3) and for 
RNA N-glycosidase activity on yeast ribosomes 
(2.11.1(i». 
SECTION 2.13 PURIFICATION OF SLT IB SUBUNIT. 
Plasmid pSBC32 (FIG 3.4.1) contained in E.coli 
strain JM10S was kindly supplied by Or S B Calderwood 
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(Boston, USA). It was grown and expression of SLT IB 
induced as described by Calderwood ~ al. (1990). 
Following this step, the protocol was then modified. 
Firstly the preparation of periplasmic extract was 
achieved using method (2.9.1). Periplasmic extracts 
were then applied directly to the 1ml globotriose-
Fractogel column (Biocarb) as described (2.12). 
Elution and dialysis of SLT IB from this column was 
then achieved exactly as described for elution and 
dialysis of ST described by Ryd ~ al. (1989). 
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SECTION 3 RESULTS AND DISCUSSION 
CHAPTER 1 
SECTION 3.1 Purification of Shiga-like toxin I (StT I). 
Introduction 
Previously, many groups have attempted to purify Shiga toxin 
(ST), and Shiga-like toxins I and 11 (StT I and SLT 11) to 
homogenei ty wi th varying degrees of success. This may be 
attributed to the low level production of the toxins, which 
constitute less than 0.1% of the total cell proteins (Donohue-
Rolfe et al. 1991). 
In order to be able to compare the activity of SLT I with that 
of ricin, it was necessary firstly to purify the toxin. Initial 
attempts to purify SLT I were based on a combination of 
protocols developed and used successfully by others in the 
purification of both ST and SLT I. 
Purification of ST has been achieved by several groups (Brown 
et al. 1980, O'Brien et al. 
--
1980, Olsnes and Eiklid, 1980, 
Kongmuang ~ al. 1987) using a variety of methods including 
size frac tiona tion, isoelec tric focus sing (IEF), ion exchange 
chromatography and anti-ST affinity chromatography. Toxin 
yields were however, relatively low. For example, Kongmuang et 
al. (1987) reported a yield of only 0.32 - 0.75mg of purified 
toxin from a 5L culture. More recently Donohue-Rolfe et al. 
(1991) have presented a purification procedure yielding lmg of 
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ST from 4L of culture. In addition to the the use of Cibacron 
Blue, chromatofocussing and size fractionation chromatography, 
they have employed the high specifici ty binding of the ST B 
subunit to the disaccharide Ga~1-4Ga~l, which forms part of 
the terminal trisaccharide of glycoprotein PI' in their 
purification procedure. 
The production of many bacterial toxins may be seen to be 
regulated by iron. This is also seen to be the case with ST 
(0' Brien and LaVeck, 1982) and 5LT (0' Brien !:.! al. 1982, 
Calderwood et al. 1987, Weinstein g al. 1988). Weinstein et 
al. (1988) examined the effects of iron on production of 5LT I 
and 5T. The presence of iron in the growth medium was found to 
suppress production of SLT I. Under conditions of iron 
deprivation, large quantities of ST were detected 
extracellularly ie 79.5% of the toxin produced was detected 
extracellularly under conditions of iron deprivation compared 
to 29.5% in the presence of iron • However, iron depri va tion 
did not result in a massive increase in the release of SLT I 
from Escherichia coli. Weinstein et al. (1988) suggest that 
iron deprivation may in some way affect the integrity of the 
outer membrane of Shigella dysenteriae resulting in release of 
5T to the medium; an effect which is not so marked in the 5LT I 
producing E.coli. 
The role of iron in the regula tion of 5LT I expression was 
investigated by Calderwood and Mekalanos (1987). The expression 
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of certain E.coli genes, for example those involved in 
biosynthesis of iron-binding ligands, were known to be 
repressed by the presence of iron. A con trol gene, fur, the 
protein product of which acts as a negative regulator of 
transcription, was also implicated in repression of such genes 
in the presence of iron. Neilands (1982) proposed that this was 
achieved by binding of iron as a corerepressor in conjunction 
with the fur gene product repressor protein, to the operator 
sites of iron-regulated genes. Studies by Calderwood and 
Mekalanos (1987) revealed tha t in cases where the fur gene 
product was absent expression of SLT I was constitutively high 
even in the presence of iron. This observa tion led them to 
suggest that the SLT I promoter was regulated by the ~ gene 
product. In addition, comparison of the nucleotide sequence of 
the SLT I promoter region wi th those of other iron regula ted 
promoters also revealed significant sequence homology. 
Calderwood and Mekalanos (1987) suggested that this may 
represent a binding site for iron and the fur gene product and 
thus a mechanism for iron regulation of SLT I. 
Iron starvation has also been seen to enhance release of the 
periplasmically located (Hirst et al. 1984a) E.coli heat labile 
toxin (LT) (Hunt and Hardy, 1991). Thus yields of ST and SLT I 
have been improved in many purification protocols by the use of 
an iron deple ted growth medium (0' Brien et al. 1982, 0' Brien 
and LaVeck, 1983, Ryd ~ al. 1989, Donohue-Rolfe et al. 1991). 
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Methods to improve the release of ST and SLTs have also been 
investigated. Incubation of cells with polymyxin B sulphate was 
found to be a successful means of releasing the periplasmically 
located ST (Oonohue-Rolfe and Keusch, 1983, Griffin and Gemski, 
1983). Indeed, Oonohue-Rolfe and Keusch observed 80 - 90% of 
the ST produced to be released following trea tmen t of cells 
with polymyxin B. Incubation of cells with polymyxin B was also 
incorporated into the successful purification protocol of SLT 
I by Petric et al. (1987). 
The SLT I purification protocol developed by Petric ~ a1. 
(1987) was used as a starting point in the purification of SLT 
I in this study. 
Results and Discussion 
E.coli 026:Hll strain E3787 was purchased from the National 
Type Culture Collection (NTCC) on the advice of Or S M Scotland 
(PHLS Collingdale). This strain in particular was chosen, since 
it produces SLT I alone. 
A 1L culture of E.coli strain 026:H11 was grown in Penassay 
broth (Oifco) at 3fc with shaking (200rpm) for 5 hours as 
described by Petric ~ al. (1987). Following harvesting of the 
cells by centrifugation (5,000 x g, 10 min) the cell pellet was 
resuspended in a mixture of SOug/ml phenylmethylsulphonyl 
fluoride (PMSF) (Sigma) in 250ml phosphate buffered saline 
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(PBS) containing 0.2mg/ml polymyxin B sulphate (Sigma) and 
further incubated for 1 hour as described by Petric et al. 
(1987) prior to a centrifugation step (10,000 x g, 10min). The 
resultant supernatant underwent ammonium 
precipitation as detailed by Petric et al. (1987). 
sulphate 
At this 
stage the precipitated proteins were tested for the presence of 
active SLT I by the ability of the preparation to depurinate 
susceptible eukaryotic ribosomes (2.11.1), in this case rabbit 
reticulocyte ribosomes. With the addition of vanadyl 
ribonucleoside complex (VRC) to the crude protein preparation 
in order to inhibit the action of non-specific ribonucleases, 
the crude extract was incubated with the ribosomes. The 
ribosomal RNA (rRNA) was then extracted (2.4.1) and subjected 
to aniline treatment (2.5.1) prior to gel electrophoresis 
(2.6.1). This assay is based on the fact that depurinated rRNA 
is susceptible to aniline catalysed hydrolysis. Treatment of 
depurinated rRNA with acetic-aniline results in the release of 
a fragment of approximately 390 bases from the 3' end of the 
large subunit rRNA. FIG 3.1.1 reveals that the crude protein 
preparation did indeed contain active SLT I showing the release 
of a 390 base fragment diagnostic of toxin catalysed 
depurination of rRNA (lane 4). The rRNA fragment is comparable 
in size to that resulting from the depurination of rRNA by 
ricin A subunit (RA) (lane 2). 
A size fractionation step was then introduced in order to 
continue the purification process. The crude preparation was 
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FIG 3.1.1 Examination of the use of polymyxin B sulphate in 
the extraction of biologically active Shiga-like toxin I. 
2ul of periplasmic extract produced by incubation of Shiga-like 
toxin producing Escherichia coli with polymyxin B sulphate as 
described by Petric et al (1983), was incuba ted wi th 30ug 
rabbit reticulocyte ribosomes for 20min at 3cfc (2.11.1(i». 
Vanadyl ribonucleoside complex (VRC) was also included at this 
stage (2mM final concentration) in order to reduce non-specific 
degradation of the ribosomal RNA (rRNA). The resultant rRNA was 
then extracted (2.4.1) and subjected to aniline cleavage 
(2.5.1). Fractionation and visualisation of the resultant rRNA 
was then carried out (2.6.1). 
Lane 2 = positive control: resultant rRNA following incubation 
with recombinant ricin A subunit (rRA). 
Lane 4 shows resul tant rRNA following incuba tion wi th 
periplasmic extract. 
+ indica tes trea tment of extracted rRNA wi th aniline reagent 
(lanes 2 and 4). 
indicates non treatment of extracted rRNA with aniline 
reagent (lanes 1 and 3). 
~indicates the characteristic fragment released following 
aniline cleavage of toxin-modified rRNA. 
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applied to a 1.5 x 80cm Sephadex Gl00 -120 (Sigma) column. The 
proteins were eluted using 1 x Endo buffer (2.3(i» and the 
resultant fractions tested for SLT I activity by the ability to 
depurinate rabbit reticulocyte ribosomes (2.11.1 (i). No such 
activity was detected. Following several repeated attempts 
using size fractionation in the purification protocol, it was 
decided that this step would be replaced by high performance 
liquid chromatography (HPLC) resolution using a DEAE ion 
exchange column. 
1 x Endo buffer pH 7.6 (2.3(i» had been used to equilibrate 
ULtropac TSK DEAE - 5PW HPLC column (LKB) and also to elute 
proteins which failed to bind to the column matrix. A linear 
gradient of KCl (50mM to 0.5M) in 1 x Endo buffer was then used 
to elute the bound proteins (pI SLT I = 6.72 (Petric ~ al. 
(1987». 24 fractions each of 3ml were collected. FIG 3.1.2 
shows the resultant elution profile. Fractions 4, 8 and 12 from 
each of the three peaks were tested for SLT I activity by 
incubation with ribosomes, in this case yeast ribosomes. Each 
peak was found to contain active toxin. FIG 3.1.3. Lanes 4, 5 
and 6, representing fractions 4, 8 and 12 respectively, each 
display the characteristic rRNA fragment released following 
aniline cleavage of modified rRNA. This is an indication of 
the presence of biologically active SLT lA. The fragment sizes 
are directly comparable to that seen in lane 2 following 
modification of yeast rRNA by ricin A subunit. 
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FIG 3.1.2 High performance liquid chromatography (HPLC) 
elution profile. 
Crude Shiga-like toxin containing extract was applied to an 
Ultropac ISK DEAE - 5PW (LKB) HPLC column and eluted using a 
linear gradient of KCl (SOmM - O.SM) in 1 x Endo buffer (25mM 
Iris HCl pH7.6, 25mM KCl, 5mM MgC1 2 ). 24 x 3ml fractions were 
collected. 
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FIG 3.1.3 Examination of high performance liquid 
chromatography (nPLC) fractions for RNA N-glycosidase activity. 
10ul of the 3ml fractions 4, 8 and 12 (FIG 3.1.2) collected 
following purification of crude periplasmic extract by high 
performance liquid chromatography using an Ultropac TSK DEAE -
5PW HPLC column (LKB), was incubated with 30ug yeast ribosomes 
. 0 for 20m1n at 30C (2.11.1(i». In order to reduce non-specific 
degradation of ribosomal RNA (rRNA) vanadyl ribonucleoside 
complex (VRC) was also included at this stage (2mM final 
concentration). Prior to incubation with the ribosomes, each of 
the fractions had been preincubated with 2-mercaptoethanol to a 
final concentration of 6mM to ensure maximum activity of any 
SLT I present. The resultant rRNA was then extracted (2.4.1) 
and subjected to aniline cleavage (2.5.1). The resultant rRNA 
was then fractionated and visualised (2.6.1). 
Lane 2 = positive control: rRNA resulting from incubation with 
recombinant ricin A subunit (rRA). 
Lanes 4, 5 and 6: rRNA following incubation with HPLC fractions 
4, 8 and 12 respectively. 
+ indicates treatment of extracted rRNA with aniline reagent. 
indicates non treatment of extracted rRNA with aniline 
reagent. 
~indicates the characteristic fragment released following 
aniline cleavage of toxin-modified rRNA. 
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FIG 3.1.4 Analysis of high performance liquid chromatography 
(HPLC) fractions by SDS polyacrylamide gel electrophoresis (SDS 
PAGE) • 
The elution profile for high performance liquid chromatography 
(HPLC) purification of Shiga-like toxin I (SLT I) using an 
Ultropac TSK DEAE - 5PW HPLC column (LKB) exhibited three 
distinct peaks FIG 3.1.2. The relevant fractions were analysed 
by SDS polyacrylamide gel electrophoresis (SDS PAGE) (2.10.3) 
in comparison to pre column, crude SLT I containing polymyxin B 
per iplasmic extrac t (Pe tric et al. 1981) using a 15% 
polyacrylamide gel. The resolved proteins were visualised by 
coomassie blue staining of the gel (2.10.3(i». 
Lane I = crude SLT I containing pre column proteins. 
Lanes 2 - 4 represent fractions 4,8, and 12 (FIG 3.1.2) 
respectively. 
MW = molecular weight markers. 
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Analysis of the active fractions 4, 8 and 12 by SDS 
polyacrylamide gel electrophoresis (SDS PAGE) FIG 3.1.4 
however, revealed that in each of the fractions there remained 
a high degree of contamination with other proteins. Thus active 
fractions 4, 8 and 12 were pooled and applied to the Sephadex 
Gl00 - 120 (Sigma) column mentioned previously and eluted as 
above. No active toxin could be detected and at this stage it 
was decided that purification of SLT I would follow the 
successful protocol described by Ryd ~ al. (1989) to purify ST 
(2.12). 
Ryd et al. (1989) reported the purification of ST by a simple 
and rapid method exploiting the high specificity binding of the 
SLT I B subunit (SLT IB) to globotriose ( Gb3)' a trisaccharide 
possessing the important terminal disaccharide Ga~1-4Galj31. 
Coupling of the trisaccharide to a gel matrix, Fractogel TSK 
AF-Amino 32-63um, allowed single step purification of ST with 
87% recovery of biologically active material. Elution of the 
holotoxin from the gel matrix required the use of a strong 
denaturant, 6M guanidine RCl pH6.7 in order to overcome the 
tight binding of ST to the gel matrix. 
Successful purification of SLT I from E.coli 026:Rll was 
achieved as described by Ryd et a1. (1989) with only slight 
modification (2.12). 2 x 10L cul tures of E. coli 026: Hl1 were 
grown in a Braun Biostat E 10L glass fermenter for 18 - 20 
hours, at 3fc, with aeration of SL/min (no pR control) under 
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Category 11 containment at Public Health Laboratory Service 
(PHLS), Centre for Applied Microbiology Research (CAMR), Porton 
Down, Salisbury. As described by Ryd et aI. (1989) in the 
produc tion of ST, E. coli 026: Hll was grown in iron-depleted 
syncase media described by O'Brien et al. (1982). The iron 
concentration of the medium prior to inoculation was found to 
be 0.32 parts per million (ppm). 
The total yield from 20L of culture was 120g of wet cell paste. 
Typically 4g of cell pas te was resuspended in 20ml PBS and 
sonicated (10 x 20sec) using a MSE Soniprep 150 sonicator, 
• amplitude 22. The whole cell sonicate was then centrifuged (4C, 
10,000 x g, 45min). 
A 60% ammonium sulphate precipitation step was added as a pre-
affinity column step to eliminate non salt precipitable 
material which previously led to blockage of the mini-column. 
This additional step was found to effectively eliminate the 
viscous nature of the cell sonicate allowing it to pass through 
the column matrix more freely and extending the number of times 
that it could be used to purify SLT 1. Therefore the resultant 
supernatant was subjected to ammonium sulphate precipitation 
o (60% saturation) for 1 hour at 4C with stirring (Petric et al. 
1987) at this stage of the purification. The precipitate was 
p 
removed by centrifugation (4C, 10,000 x g, 10min) and 
resuspended in 20ml PBS pH7. 2 and dialysed overnight against 
o 
PBS pH7.2 at 4C. This was then filter sterilised as described 
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by Ryd et al. (1989) prior to being applied to the Gb3-
Fractogel column matrix which had been equilibrated with PBS 
pH7.2. The purification was carried out at 4C. 
Proteins which had failed to bind were removed from the matrix 
by washing with approximately 40 column volumes, ie 40ml of PBS 
pH7.2 Bound products were eluted using 6M guanidine HCl pH6.7. 
Six 1ml fractions were collected. The resultant elution profile 
is shown in FIG 3.1.5. As each fraction was collected it was 
dialysed immediately against 3L PBS pH7.2 which was replaced at 
intervals of 1, 3 and 12 hours. 
FIG 3.1.6 shows the purification scheme used to purify of SLT 
I. 
SDS PAGE analysis of each stage in the purification of SLT I 
(FIG 3.1.7), compares the crude whole cell sonicate (lane 1), 
60% ammonium sulphate precipitated proteins (lane 2) and 
affinity purified SLT I (lane 3). In lane 3, a protein band of 
approximately 32KDa (presumably SLT I A sUbunit) and a single 
band running just below the dye front are clearly visible, the 
latter of which are assumed to represent the SLT I B subunits. 
In addition two faint bands are evident. The first, at 
approximately 27 28KDa, indica tes the exis tence of 
proteolytically cleaved and reduced SLT lA, since it may be 
seen to be of the same size as the SLT I A1 fragment (27 _ 
28KDa). The second faint band, approximately 22 - 23KDa in size 
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FIG 3.1.5 Absorbance profile showing the elution of affinity 
bound material from a 1ml globotriosylceramide ( Gb3) 
Fractogel column. 
20mls of a 60% ammonium sulphate precipitated preparation of 
026:H11 whole cell sonicate proteins (typically from 4g cell 
paste) was applied to the lml Gb3 - Fractogel column (Biocarb). 
Proteins which failed to bind to the matrix were washed from 
the column using 40 column volumes ie 40ml PBS. Bound proteins 
were eluted using 6M guanidine Het pH6.7 as described by Ryd et 
al. (1989). Six 1ml fractions were eluted and dialysed 
immediately against PBS pH7.2. 
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FIG 3.1.6 Purification scheme used in the production of 
biochemically pure Shiga-like toxin I (SLT I). 
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Escherichia coli serotype 026:H1l 
grown in iron-depleted syncase ~edia (O'Brien et al. (1982» 
2 x 10L, 18 - 20 hours, 3rt, with aerati0fl5L7min 
Braun Biostat E 10L glass fermenter 
(PUBLIC HEALTH LABORATORY SERVICE, PORTON DOWN) 
+ 
total yield = l20g cell paste 
+ 4g cell paste re suspended in 20mls PBS pH7.2 
Sonication 10 x 20sec, amplitude 22 
MSE Soniprep 150 sonicator 
.+ 
centrifugation (qC, 10,000 x g, 45min) 
supernatant (15ml) 6~%~NH4)2S04 precipitation 
1 hour, qC with stirring 
centrifugation (~C~lO,OOO x g, lOmin) 
+ precipitate resuspended in 20ml PBS pH7.2 
dialysis overnight against PBS pH7.2 «(C) 
Filter sterilisation (~45Um Millipore filter) 
application to lml Gb3-;!:ctOgel column (Biocarb) 
equilibrated with PBS pH7.2 «(C) 
+ unbound proteins washed from column 
40 column volumes PBS pH7.2 
affinity bound~roteins eluted 
6M guanidine HCI pH6.7 «(C) 
+ 6 x lml fractions collected 
dialysed IMMEDIATELY against PBS pH7.2 (~C, 18 hours) 
+ 1. Bio-Rad determination of protein concentration 
2. SDS PAGE analysis 
3. Determination of biological activity (aniline assay) 
+ yield = 25ug SLT Ilg cell paste 
------------------------
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FIG 3.1.7 Purification of Shiga-like toxin I (SLT I). 
Production and purification of SLT I from SLT I-only producing 
E.coli strain 026:H11 was achieved using a slightly modified 
method of Ryd et al. (1989). Analysis of the elution products 
following overnight dialysis (2.12) in comparison to whole cell 
sonicate and 60% ammonium sulphate precipitation products was 
by SDS polyacrylamide gel electrophoresis (SDS PAGE) on a 15% 
gel (2.10.3) followed by Coomassie staining (2.10.3(iii». 
1: E.coli 026:H11 whole cell sonicate. 
2: 60% ammonium sulphate precipitated proteins. 
3: Affinity purified Shiga-like toxin I - Gb3 column fraction. 
MW: molecular weight markers. 
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may be a degradation product of SLT lA resul ting from non 
specific cleavage by small amounts of contaminating proteases. 
The resultant purified product was shown to be biologically 
active by its ability to depurinate susceptible eukaryotic 
ribosomes, in this 
3.1.8 shows the 
case rabbit reticulocyte ribosomes. 
resultant fractionated rRNA. 
FIG 
The 
characterisitic rRNA fragment released following aniline 
cleavage of the SLT lA modified rRNA is clearly distinguishable 
(lane 2) and directly comparable in size to that resulting from 
depurination of rabbit reticulocyte rRNA by ricin A subunit. 
Bio-Rad analysis (2.10.1) of toxin yield typically indicated a 
yield of 2Sug SLT I / g cell paste. Typically 19 of cell paste 
is derived from a culture of approximately 160mls E.coli 
026:H11 grown in iron-depleted syncase media (O'Srien et al. 
1982) under the conditions described. 
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FIG 3.1.8 Examination of the activity of pure Shiga-like toxin 
I A subunit on rabbit reticulocyte ribosomes. 
O.4ug of affinity purified Shiga-like toxin I (SLT I) was 
incubated with 30ug rabbit reticulocyte ribosomes for 20min at 
30C (2.11.1(i». In order to ensure maximum possible RNA N-
glycosidase activity of the toxin prior to incubation with the 
ribosomes the toxin was preincubated with 2-mercaptoethanol to 
a final concentration of 6mM. Following incubation with toxin 
the ribosomal RNA (rRNA) was extracted (2.4.1) and subjected to 
aniline cleavage (2.5.1). Fractiona tion and visualisation of 
the rRNA was then carried out (2.6.1). 
Lane 1 = positive control: rRNA extracted from rabbit 
reticulocyte ribosomes incubated with recombinant ricin A 
subunit. 
Lane 2 shows rRNA following incubation with pure SLT I. 
+ indicates treatment of extracted rRNA with aniline reagent. 
indicates non treatment of extracted rRNA with aniline 
reagent. 
~ indicates the characteristic fragment released following 
aniline cleavage of toxin-modified rRNA. 
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Conclusion Chapter 1 
After many unsuccessful attempts to purify SLT I to homogeneity 
by a variety of different methods, the slightly modified method 
developed by Ryd et al. (1989) finally proved to be a 
successful means of production and purification of SLT I. 
Highly pure toxin results from this purification strategy, the 
yield from the starting wet cell paste is however, relatively 
low (0.0025%). 
At first glance this method of purification appears to be 
relatively simple and straight forward. However, the first 
problem to be encountered is that of the iron-depleted syncase 
media described by O'Brien et al. (1982). Production of the 
media is extremely time consuming and laborious, since not only 
does it consist of numerous 'ingredients' but also the 
requirement for iron depletion prior to sterilisation. 
The considerable cost of purchasing the Gb3-Fractogel column 
matrix (Biocarb) presents the second problem, as does its size 
of 1ml. It was found that prior to the addition of an ammonium 
sulphate precipitation step to the purification procedure, the 
viscous nature of the whole cell sonicate supernation resulted 
in 'clogging' of the column. This severely reduced the number 
of times the column could be used. Even after addition of the 
ammonium sulphate precipi ta tion step to the procedure, as a 
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direct result of its small size the column still became 
'clogged' with material after only limited usage. 
The low toxin yield (0.0025%) compounded the problem of the 
limited life span of the lml column matrix. The requirement for 
toxin in the present study, as will be seen in subsequent 
chapters, was not extensive. However, a constant supply of 
biochemically pure SLT I was needed. Extended use of the column 
matrix was therefore a necessity. For this reason careful 
regeneration of the column matrix was carried out after each 
purification. 
Ultimately pure toxin was generated in sufficient amounts to 
fulfill the requirements of the present study. 
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A comparison of the biological activities of Shiga-like toxin I 
and ricin. 
Introduction 
The RNA N-glycosidase activity of ricin A subunit (RA) has been 
investigated extensively. By contrast, current knowledge of the 
RNA N-glycosidase activity of Shiga-like toxin I (SLT I) has, 
in the main, been derived from investigation into the RNA N-
glycosidase activity of Shiga toxin (ST). For example, Olsnes 
et al. (1981) and Reisbig ~ al. (1981) reported the inhibition 
of protein synthesis in rabbit reticulocyte lysate cell free 
translation systems by ST, whilst Endo et al. (1988) examined 
the mechanism by which Shiga toxin (ST) and SLT 11 were capable 
of modifying rat liver ribosomes. The latter study identified 
the specific site of modification by ST and SLT 11 to be 
adenine residue 4324 (A4324) of the 28S ribosomal RNA (rRNA) of 
rat liver ribosomes as had also been found to be the case with 
RA modification of rat liver ribosomes (Endo £! al. 1987). 
Since ST and SLT I were considered to be identical (Strockbine 
et al. 1988) it was assumed that SLT I would possess a 
biological activity identical to that of ST. Thus most studies 
compare the RNA N-glycosidase activities of ST and ricin. 
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To date few direct comparisons have been made between the RNA 
N-glycosidase activities of ricin and SLT I. In this chapter a 
direct comparison between the biological activities of SLT I 
and ricin is made. Where appropriate, comments are made on the 
comparable activities of SLT I and ST. 
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SECTION 3.2.1 Comparison of the cytotoxicity of Shiga-like 
toxin I with that of ricin on Vero cells. 
Introduction 
Both ricin and Shiga-like toxin I (SLT I) cause an irreversible 
inhibition of protein synthesis in eukaryotic cells, a process 
which leads to eventual cell death. 
With regard to Shiga toxin (ST) and thus SLT I, it has been 
found that some cell lines are resistant to the effects of the 
toxin. These include human melanoma cells, chinese hamster 
ovary cells (CHO) and foetal hamster kidney cells (BHK) (Olsnes 
and Eik1id, 1980). 125 1 labelled ST allowed Eiklid and Olsnes 
(1980) to examine whether or not toxin actually bound to these 
insensitive cell lines. Their findings were, that toxin bound 
to some but not all of the insensitive cell lines. They 
concluded that the existence of the cellular receptor is 
necessary but not sufficient for ST to be able to cause death 
of that cell line. More recently however, on identification of 
the glycolipid receptor for ST, Lindberg et al. (1987) observed 
that cells naturally resistant to ST were those which did not 
possess glycolipids with the terminal disaccharide, Gal~1-4Ga~ 
required for the binding of ST. 
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The cytosolic target for action of ST and SLT I has since been 
identified as being the ribosome, as is the case with ricin and 
thus the requirement for internalisation has also been 
realised. 
In addition to identifying certain cell lines as being 
insensitive to ST, Olsnes and Eiklid (1980) found both Vero and 
HeLa S3 cell lines to be sensitive to ST. Whereas no cytotoxic 
effect could be detected with CHO and BHK cell lines at toxin 
concentrations of up to 10ug/ml, 50% cell death of HeLa S3 
cells was achieved with toxin concentrations of only 0.1ng/ml. 
Later investigationsby Sandvig and Brown (1987) into the ionic 
requirements for the entry of ST into cells revealed that the 
sensitivity of Vero and HeLa cells to ST was dependent upon the 
presence of certain ions. For instance, in the presence of C0 2+ 
which blocks calcium transport across the cell membrane, both 
Vero and HeLa cells were found to be insensitive to ST. Thus it 
was suggested that entry of ST into the cytosol requires 
calcium transport. Incubation of Vero and HeLa cells in buffer 
containing high a concentration of K+ also resulted in 
insensi ti vi ty of the cells to ST. Under the same condi tions 
however, Vero cells were found to retain their sensitivity to 
ricin. Protection of Vero and HeLa cells by high K+ 
concentrations against ST is suggested to be as a consequence 
of a reduction in membrane potential, which in turn may affect 
not only the membrane itself, but also the interaction between 
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the membrane and the bound ligand. Blockage of Cl- transport by 
anions such as S04- and SCN- and also inhibitors of anion 
transport such as 4,4-diisothiocyano-stilbene-2,2-disulphonic 
acid were found to protect both Vero and HeLa cells against ST, 
whilst the entry of ricin into the cytosol is unaffected by the 
f Cl - S04-. F h bid· ST presence 0 or rom t ese 0 servat ons regar 1ng 
and ricin in addition to those regarding other toxins, Sandvig 
a 
and Brown (1987) co¥uded tha t despi te sharing many common 
properties the toxins studied appear to employ different 
mechanisms to cross the cell membrane and to enter the cytosol. 
Sandvig and Brown (1987) identified a1ID50 value for ST on Vero 
cells of 0.6ng/ml. 
Olsnes et al. (1981), again examining the cytotoxic effect of 
ST on HeLa S3 cells, identified a requirement of only 50 - 100 
molecules of ST to be added per cell for 50% cell death to 
occur overnight. This was compared to a figure of 1000 
molecules of ricin or abrin bound per cell required in order to 
achieve 50% cell death overnight (Sandvig ~ al. 1978). By 
comparison of the number of receptor sites per HeLa cell for ST 
and ricin (106 and 3 x 107 (Sandvig ~ al. 1976) respectively) 
it is suggested that the significant difference in the number 
of molecules required must be related to a difference in 
association constant Ka between the toxins and their receptors. 
The Ka values of ST and ricin for their receptors are 1010M-1 
and 2 x 107M-1 (Sandvig et al. 1978) respectively. However, 
there are now known to exist many other facto rs which may 
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account for the 10 fold difference in the number of ST and 
ricin molecules required to cause 50% cell death overnight 
observed by Olsnes et al. (1981). 
In order to reach their intracellular target - the ribosome, 
both ST and ricin must bind to their respective ,slJ1"'c.e. 
receptors and be effectively endocytosed. Ricin is capable of 
binding opportunistically to a number of different galactose-
terminating glycolipids and glycoproteins (Sandvig et al. 
1991). In many cases such binding may not lead to adsorptive 
endocytosis of the ricin molecule. The binding of ST to GaloQ-
4Gal ~ -terminating glycolipids however, is highly specific 
(Cohen et al. 1987, Lindberg ~ al. 1987, Lingwood ~ al. 
1987). Therefore it is likely that in each case the highly 
specific binding of ST to a receptor molecule will lead to 
receptor mediated endocytosis. Recent studies by (Stein ~ al. 
1992) of the crystal structure of the SLT I B subunit pentamer 
suggest that each pentamer has five potential receptor binding 
sites. This may account for the high binding affinity of the 
SLT IB subunit for its cellular receptor globotriosylceramide 
The entire process of binding, uptake and translocation is 
probably very complex. For this reason it is unlikely that the 
observed differences in the cytotoxici ty of ricin and ST of 
Olsnes ~ al. (1981) are simply as a result of a difference in 
122 
the binding affinities of the toxins for their respective 
receptors. 
O'Brien and LaVeck (1983) and Kongmuang et al. (1988) have 
examined the cytotoxic effect of SLT I. In the latter a 
comparison has been made between the cytotoxic effect of SLT I 
on Vero cells in both its nicked (ie proteo1ytica11y cleaved 
SLT lA ) and unnicked forms. A resultant 100% cytotoxic dose 
(CDIOO) value of 0.lng/m1 SLT I for both nicked and unnicked 
toxin led Kongmuang ~ al. (1988) to suggest that nicking did 
not alter the cytotoxic nature of SLT I as had also been found 
to be the case with ST (Olsnes et al. 1981). Studies on binding 
of nicked and unnicked SLT I also suggests that nicking of the 
toxin has no effect on the time taken to bind to susceptible 
cells (Kongmuang ~ al. 1988). 
Again it may be seen that much of that which is known about the 
activity, in this case cytotoxicity, of SLT I has been deduced 
from studies with ST. Here a direct examination of the 
cytotoxic effect of SLT I on Vero cells is undertaken and the 
result compared to that of ricin on Vero cells. 
Results and Discussion 
Using the procedure described (2.11.2), the cytotoxic nature of 
SLT I on Vero cells was examined. Vero cells were incubated 
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(2.11.2) with 0 - 100ng/ml pure SLT I for 24 hours. FIG 3.2.1 
shows the result of this incubation on the protein synthesis of 
intoxicated Vero cells by measuring the incorporation of 35 S_ 
Methionine into cell protein. The results shown are 
representative of results obtained from repeating the 
experiment four times. 
The resultant plot (FIG 3.2.1) allowed the 50% cytotoxic dose 
(IC SO ) value ie the concentration required for 50% inhibition 
of protein synthesis, to be determined for the action of SLT I 
on Vero cells, a value which was then compared directly to the 
IC 50 value for the action of ricin on Vero cells. 
The IC SO value for SLT I on Vero cells was found to be 
O.lng/ml, a value which is 10 fold lower than that of ricin on 
Vero cells (IC SO = I - 3ng/ml) (O'Hare et al. 1987,1990, 
Yoshida et al. 1991). 
As previously discussed, there are a number of factors which 
may account for the apparent difference in cytotoxicity of SLT 
I compared wi th those published for ricin. These include the 
cellular distribution of receptors, differences in binding 
affinities, plus the relative efficiencies of endocytosis and 
membrane translocation. 
The advantage afforded by the high specifici ty binding of ST 
and therefore 8LT I, to glycolipids possessing the terminal 
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FIG 3.2.1 Examination of the cytotoxic effect of Shiga-like 
toxin I (SLT I) on Vero cells. 
Concentrations of SLT I from 0 - 100ng/ml were incubated in 
quadruplicate with 1.2 - 1.5 x 104 cells per well for 24 hours. 
The addition of 1uCi 35S-methionine to each well following this 
incubation period allowed a measure of protein synthesis in 
order to indicate the extent of cell killing at each 
concentration of toxin. This was achieved by measuring the 
incorporation of isotope into cell protein in comparison to 
that of non toxin treated controls. Hence the 50% cytotoxic 
dose (IC50) value could be determined for SLT I on Vero cells. 
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disaccharide Gal~1-4Gal~ resulting in efficient endocytosis 
of the ST / SLT I has been discussed in comparison to the 
opportunistic binding of ricin to many different galactose-
terminating molecules, not all of which may result in 
endocytosis of the toxin. The events following endocytosis 
remain unclear in both cases. 
With regard to ST / SLT I there is evidence of its accumulation 
within the endoplasmic reticulum (ER) following endocytosis 
(Sandvig et al. (1992) • This sugges tS tha t ST is ei ther 
transported by glycolipids to the ER, or that as is thought to 
be the case with ricin, routing of the toxin to the ER occurs 
as a resul t of receptor exchange by the toxin in the trans-
Golgi network (TGN) and interaction with proteins containing a 
KDEL-like sequence. 
Reduction, processing and translocation of ST / SLT I and ricin 
remains an area of uncertainty which may represent a major rate 
limiting step in the cytotoxicity of the toxins. 
Finally, the observed difference in cytotoxici ty of ricin and 
SLT I may be a reflection of a difference in the catalytic 
activities of the toxins; a question which is addressed in 
SECTION 3.2.4. 
It may be seen that there are many factors, any number of which 
may account for the difference in cytotoxicity of SLT I on Vero 
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cells observed in this present study (IC SO = O.lng/ml) in 
comparison to that of ricin (IC SO = 1 - 3ng/ml (O'Hare et al. 
1987, 1990, Yoshida ~ al. 1991). In addition it is important 
to note that differences in cytotoxici ty between SLT I (this 
study) and those published for ricin may have arisen as a 
result of slight variations in the experimental methods used. 
The IC SO values obtained for the action of ricin on Vero cells 
(O'Hare et al. 1987, 1990, Yoshida et al. 1991) of 1 - 3ng/ml 
are the same as results obtained in our laboratory (C Pitcher, 
personal communication) using exactly the same method as 
described in the present study to determine the concentration 
of SLT I which results in SO% inhibition of protein synthesis 
of Vero cells. 
The ICSO value of O.lng/ml for the action of SLT I on Vero 
cells determined in the present study is the same as the 100% 
cytotoxic dose value reported by Kongmuang et al. 
(1988) for the action of SLT I in both its nicked 
(proteolytically cleaved SLT I A subunit) and unnicked forms on 
Vero cells. O.lng/ml was also the concentration of ST required 
to cause 50% cell death of HeLa S3 cells reported by Olsnes et 
al. (1981). With regard to the cytotoxic nature of ST on Vero 
cells both Eiklid and Olsnes (1980) and Sandvig and Brown 
(1987) report 1DSO values of 0.6ng/ml. The IC SO value of 
O.lng/ml reported in the present study for the action of SLT I 
on Vero cells is therefore, directly comparable to those values 
de termined for the cytotoxici ty of ST. In order to compare 
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directly the cytotoxic effect of ST and SLT I on Vero cells 
however, it would be necessary to carry ou t the cytotoxici ty 
assays simultaneously, under the same conditions and using the 
same materials and methods. 
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SECTION 3.2.2 Comparison of the RNA N-glycosidase activities 
of Shiga-like toxin I A subunit (SLT lA) and ricin A subunit 
(RA) on ribosomes from different sources. 
Introduction 
The sensitivity of ribosomes from a number of different 
eukaryotic sources to modification by ricin A subunit (RA) has 
been widely examined as have the factors affecting such 
sensitivity. However, it has been found that information 
regarding the susceptibilities of ribosomes to modification by 
Shiga-like toxin A subunit (SLT lA) has mainly been derived 
from knowledge of the activity of Shiga toxin A subunit (STA) 
and Shiga-like toxin 11 A subunit (SLT IIA). 
Endo et al. (1988) demonstrated the modification of rat liver 
ribosomes by ST and SLT 11. The work of Saxena et al. (1989) 
revealed modification of the ribosomes of Xenopus oocytes by 
ST, RA and SLT 11. From these results it was assumed that since 
ST and SLT I were almost identical in sequence and 
immmunologically, SLT I would also modify rat liver ribosomes 
and those of Xenopus oocytes. 
The RNA N-glycosidase activity of RA has been more closely 
studied than that of ST and SLT 11. Following identification of 
the site of depurination of rat liver 28S ribosomal RNA (rRNA) 
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by RA (Endo et 1. 1987), other workers examined the 
sensi ti vi ty of rabbi t re ticulocyte, yeast (Saccharomyces 
cerevisiae) and wheatgerm ribosomes to modification by RA 
(Osborn, 1990) by employing the aniline cleavage of modified 
ribosomal RNA (rRNA) assay first described by Endo .!:.! al. 
(1987). Stirpe ~ al. (1988) also employed this assay in order 
to compare the RNA N-glycosidase activity of a variety of 
ribosome inactivating proteins (RIPs) such as tritin, momordin 
and saporin on yeast and rabbi t reticulocyte ribosomes wi th 
that of ricin. Additional studies to examine the precise site 
of depurination by the above mentioned RIPs lead Stirpe et al. 
(1988) to suggest that it is likely that all RIPs, both type I 
and 11 inactivate ribosomes by 'the same mechanism and with 
exactly the same specificity'. 
Results shown here directly examine the RNA N-glycosidase 
activi ty of SLT lA on ribosomes from different sources and 
show a direct comparison with the RNA N-g1ycosidase activity of 
RA. 
Results and discussion 
The aniline assay developed by Endo et al. (1987) was employed 
in this study to determine the sensitivity of ribosomes 
isolated from different sources to modification by SLT lA. The 
assay works on the basis that release of the specific adenine 
residue from the large subunit (LSU) rRNA as a result of RNA N-
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glycosidase activity by a RIP, also results in an increased 
susceptibility of the phosphodiester backbone of the modified 
rRNA to attack by nucleophiles. Thus subjection of RIP-modified 
rRNA to aniline-catalysed hydrolysis results in the 
preferential release of a characteristic fragment from the 3' 
end of the LSU rRNA which may be visualised following 
resolution by denaturing gel electrophoresis (2.6.1). 
Recombinant RA (rRA) was the source of ricin A subunit used in 
this experiment to compare the RNA N-glycosidase activities of 
RA and SLT lA on ribosomes from a variety of sources. It 
differs from the native RA in the possession of a methionine 
residue at its N terminus and, unlike the native RA, it is not 
glycosylated. 
It was found in the course of this study, tha t a loss of 
activity of SLT I was observed on incubation with preparations 
of ribosomes which did not contain any form of reductant. Thus 
SLT I holotoxin used in these experiments was pretreated with 
2-mercaptoethanol to a final concentration of 6mM in order to 
ensure an ac tivi ty equivalen t to tha t found in the reducing 
environment of the cytosol. 
Although SLT I does not contain any interchain disulphide bonds 
linking the A and B subunits, it does possess a single 
intrachain disulphide bond which links the A1 and A2 peptides 
of SLT lA. It is presumed that on cellular translocation of SLT 
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FIG 3.2.2 Comparison of the activities of Shiga-like toxin I A 
subunit and ricin A subunit on ribosomes from different 
sources. 
In each case 30ug of ribosomes was incubated (30C, 20min) 
(2.11.1(i» with 1ng recombinant ricin A subunit (rRA) and 
O.4ug Shiga-like toxin I (SLT I), the latter of which had been 
pretreated with 2-mercaptoethanol to a final concentration of 
6mM in order to ensure optimal activity and maximal reduction 
of the Shiga like toxin A subunit (SLT lA). The ribosomal RNA 
(rRNA) was then extracted (2.4.1) and subjected to aniline 
cleavage (2.5.1). It was then fractionated by denaturing gel 
electrophoresis and the resultant gel stained with ethidium 
bromide to visualise the fractionated rRNA (2.6.1). 
A: tobacco leaf ribosomes 
B: Escherichia coli ribosomes 
C: Saccharomyces cerevisiae (yeast) ribosomes 
D: wheatgerm ribosomes 
E: rabbit liver ribosomes 
F: rabbit reticulocyte ribosomes 
Lane 1: non aniline treated rRNA (-). 
Lane 2: rRA modified rRNA. 
Lane 3: SLT lA modified rRNA. 
+ indicates treatment of rRNA with aniline reagent. 
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Source of Ribosome Depurinated by: 
RICIN A SLT lA 
TOBACCO + + 
R.coli 
- -
YEAST + + 
WHEATGRRM + + 
RABBIT LIVER + + 
RETICULOCYTE + + 
FIG 3.2.3 SUDlDlary of the activity of Shiga-like toxin I A 
subunit (SLT lA) on ribosomes fro. different sources compared 
to ricin A subunit (RA) activity_ 
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lA the intrachain disulphide bond is reduced. Reduction of this 
bond therefore, allows experimentation in vitro to be more 
closely representative of that which is proposed to take place 
in vivo. 
FIG 3.2.2 shows the results of aniline cleavage of the rRNA 
isolated from a variety of different ribosomes following their 
incubation with SLT lA and rRA. These results are summarised in 
FIG 3.2.3. 
Release of a characteristic fragment following aniline cleavage 
of the modified rRNA may be seen in lanes 2 and 3 of A 
(tobacco), C (yeast), D (wheatgerm), E (rabbit liver) and F 
(reticulocyte). Fragments released in each case are identical 
in size to those released from rRA-modified rRNA indicating 
that modification of the rRNA by SLT lA appears to be the same 
as that modified by RA. Such results suggest that SLT lA 
exhibits the same substrate specificities as does RA. These 
results show that in common with RA, SLT lA modifies rabbit 
reticulocyte ribosomes, tobacco ribosomes, S.cerevisiae (yeast) 
ribosomes and wheatgerm ribosomes. It is necessary to highlight 
here the apparent differences between for example, wheatgerm 
ribosomes and the yeast ribosomes with regard to the size of 
the fragment released following aniline cleavage of the rRNA. 
Such diffences are as a direct result of the variation in size 
of the LSU rRNA. Rat liver ribosomes (not shown here) for 
example, have a 28S LSU rRNA; following depurination by RA and 
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aniline cleavage a fragment of 390 nucleotides is released 
from the 3' end of the rRNA (Endo et al. 1987). In contrast, 
the yeast LSU rRNA is a 26S molecule and releases only a 368 
nucleotide fragment following depurination by RA and aniline 
cleavage. 
Also in common with RA (Hedblom et al. 1976, Stirpe and Hughes, 
1989) is the apparent inability of SLT lA to modify Escherichia 
coli ribosomes. The insensitivity of E.coli ribosomes to 
modification by SLT lA, it could be argued, would be expected 
since SLT I is an E.coli produced protein and activity could in 
this case result in death of the producer strain. It is 
possible therefore, that the insensitivity of E.coli ribosomes 
to the RNA N-glycosidase activity of SLT lA is a protection 
mechanism. The apparent insensitivity of E.co1i ribosomes to 
SLT lA is of particular relevance to this study since as is 
seen later it facilitates in vivo expression of recombinant SLT 
lA subunits (rSLT IAs). 
E.coli ribosomes are not however, resistant to all RIPs. 
Recently Hart1ey et a1. (1991) have demonstrated the 
sensitivity of E.co1i ribosomes to type I RIPs such as dianthin 
30 and 32 and pokeweed antiviral protein (PAP) and PAP-S; RIPs 
which by definition (ie type I RIPs), consist of an enzymatic A 
subunit alone. 
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The results presented here show eukaryotic ribosomes including 
mammalian ribosomes and plant ribosomes to be sensitive to 
modification not only by RA but also by SLT lA. E.coli 
ribosomes are however, insensitive to both. This suggests that 
SLT lA and RA are comparable with regard to their subs tra te 
specificities. Detailed kinetic analysis of SLT lA-catalysed 
depurination of wheatgerm ribosomes is presented in SECTION 
3.2.4. 
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SECTION 3.2.3 Identification of the precise site of 
depurination of yeast ribosomes by Shiga-like toxin I (SLT I). 
Introduction 
By direct sequencing of modified RNA, Endo et al. (1987, 1988) 
had successfully identified the exact site of depurination of 
rat liver 28S ribosomal RNA (rRNA) by ricin, Shiga toxin (ST) 
and Shiga-like toxin 11 (SLT 11) as being adenine residue 4324 
(A4324). Depurination of rat liver rRNA by SLT I was also 
assumed to occur a t the same si te since ST and SLT I are 
regarded as being 
1988). 
essentially identical (Strockbine et al. 
Osborn (1990), having initially demonstrated the modification 
of 26S rRNA isolated from Saccharomyces cerevisiae ribosomes by 
ricin A subunit (RA) went on to identify the exact site of 
depurination. Modification of the 26S rRNA was found to occur 
at adenine residue 3024 (A3024)' a site analogous to A4324 in 
rat liver 28S rRNA within a highly conserved loop structure 368 
nucleotides from the 3' end of the S.cerevisiae 26S rRNA. By 
direct sequencing of modified rRNA in order to identify the 
missing base, Stirpe et al. (1988) also found A3024 of 
S. cerevisiae 26S rRNA to be the si te of depurina tion of a 
number of other ribosome inactivating proteins (RIPs). 
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Previously it had only been assumed that SLT I modification of 
the rRNA of susceptible ribosomes was identical to that of ST 
and hence ricin (Endo ~ al. 1988). It was decided therefore, 
that the precise site of depurination of S.cerevisiae 26S rRNA 
by SLT I would be investigated and compared directly to that 
modified by ricin A subunit (RA) as identified by Osborn 
(1990). 
In identification of the RA modified site in S.cerevisiae 26S 
rRNA, Osborn (1990) developed a method which combined the use 
of primer extension and dideoxysequencing of the modified rRNA. 
This me thod, which proved much less time consuming than the 
direct rRNA sequencing method employed by Endo ~ al. (1987, 
1988) and Stirpe et al. (1988)), was the method chosen for use 
in the present study. 
The method employs reverse transcriptase in the production of 
cDNA from the modified S. cerevisiae 268 rRNA and is based on 
the observa tion tha t reverse transcriptase is unable to read 
certain chemically modified bases in an RNA template 
(Hagenbuchle et al. 1978, Youvan and Hearst, 1979). The 
inability to read modified bases results in the reverse 
transcriptase pausing or terminating which in turn results in 
the appearance of a single-length DNA band. This band 
corresponds to the length of the cDNA from the 5' end of the 
primer to the nucleotide immediately preceding the modified 
base. Osborn (1990) worked upon the basis that primer extension 
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of a RA modified rRNA template would result in the appearance 
of a band distinct to those resulting from extension of 
unmodified rRNA. 
Results and discussion 
Already in this study (SECTION 3.2.2), the ribosomes of 
S.cerevisiae have been shown to be susceptible to modification 
by SLT I. 
Primer extension of SLT I / rRA modified S.cerevisiae 26S rRNA. 
The 32p 5' end labelled 17 oligomer primer FIG 3.2.4 was kindly 
donated by R Osborn (Warwick) and is complementary to a region 
of the S.cerevisiae 26S rRNA approximately 70 nucleotides 3' to 
the putative site of depurination by SLT I and RA. The 
positions to which the primer anneals on the S.cerevisiae 26S 
rRNA are given as numbers below the 5' and 3' ends of the 
primer. 
The sequencing gel FIG 3.2.5 shows the products of primer 
extension following reverse transcription of unmodified 
S.cerevisiae 26S rRNA in the presence of the dideoxynuc1eoside 
triphosphates as indicated by tracks G, A, C and T. Track 3 
also shows the result of primer extension of unmodified 
S.cerevisiae 26S rRNA, whilst track 1 SLT lA subunit modified 
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FIG 3.2.4 Yeast primer used to determine the site of 
depurination by Shiga-like toxin I A subunit (SLT lA) in yeast 
ribosomal RNA. Kindly donated by R Osborn (Warwick). 
5' j 
CATAATCCAGCGGATGG 
3089 
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FIG 3.2.5 Sequencing gel showing the products of primer 
extension of Shiga-like toxin I A subunit (SLT lA) and ricin A 
subunit modified yeast ribosomal RNA. 
60ug yeast ribosomes were incubated with 0.4ug Shiga-like toxin 
I, with lng recombinant ricin A subunit (rRA) or with neither 
of these at 30~ for 60min. The yeast ribosomal RNA (rRNA) was 
then extracted (2.4.1) and used as the template~primer 
ex tension by reverse transcriptase as descr i bed (2.5.9). The 
products of primer extension are seen here following 
fractionation on a 8% polyacrylamide gel and visualisation by 
autoradiography (2.10.3(iii)). 
e,A,e,T denote the sequencing reactions carried out on 
unmodified yeast rRNA template in the presence of the 
dideoxynucleotide indicated at a concentration of 25uM. 
1: SLT lA modified and aniline cleaved yeast rRNA template. 
2: RA modified and aniline cleaved yeast rRNA template. 
3: unmodified yeast rRNA template. 
'" ,. denotes primer extension termination site. 
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rRNA and track 2 RA modified rRNA. Bands seen to be present 
from primer extension from unmodified rRNA template are as a 
result of the pausing or termination of the reverse 
transcriptase. However, in both the SLT lA subunit and RA 
modified rRNA tracks a major band may be seen to correspond to 
residue G3025 of the S.cerevisiae 26S rRNA sequence. This band, 
which is not seen to be present when unmodified 26S rRNA was 
used as the template for primer extension (track 3), represents 
a major termination site for the reverse transcriptase. Osborn 
(1990) also observed such a major termination site in primer 
extension of rRA modified S.cerevisiae 26S rRNA. From this he 
inferred that the site of depurination is one base 5' to the 
observed major termination site, ie the base susceptible to RA 
modification in S.cerevisiae 26S rRNA to be adenine residue 
3024. 
In this study it can be seen that the major termination site 
for reverse transcriptase in the SLT lA subunit-modified 
S.cerevisiae 26S rRNA corresponds exactly to that of the RA 
modified 26S rRNA. It may be concluded therefore, that the site 
of depurination is the same in both instances. For both toxins 
termination appears to occur at RNA residue G3025 • Primer 
extension is complementary to the 3' end of the rRNA, the site 
of depurination is, therefore adenine residue 3024, ie one 
base 5' to the site of termination seen here. This site occurs 
within the highly conserved 5' GAGAGG 3' loop structure of the 
26S rRNA. 
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Thus, as was originally inferred by Endo et ale (1988) from 
studies of the depurination of rat liver ribosomes by ST, SLT 
11 and ricin, SLT I (with regard to yeast ribosomal rRNA at 
least) also modifies the rRNA at precisely the same site as 
does ricin ie in this case A3024 of S.cerevisiae 26S rRNA. It 
is now highly likely that the analogous adenine residue 
occurring within the highly conserved GAGAGG rRNA loop is the 
likely target site of modification by ricin and all other known 
RIPs with catalytic site homologies. However, this would 
exclude RIPs such as ~ sarcin. Unlike RA catalysed hydrolysis 
of a single N-glycosidic bond of adenine residue 4324,~sarcin 
hydrolyses a single phosphodies ter bond in 28S rRNA between 
guanine residue 4325 and adenine residue 4326. In addi tion 
sarcin shares no homology with the ricin A subunit-like family 
of enzymes. 
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SECTION 3.2.4 Kinetic comparison of Shiga-like toxin I A 
subunit (SLT IA)-catalysed depurination with that of ricin A 
subunit (RA). 
Introduction 
As previously discussed, direct comparison between the 
activities of Shiga-like toxin I A subunit (SLT lA) and ricin A 
subunit (RA) has been limited. The following experiments 
attempt to compare kineticall~ SLT lA catalysed depurination of 
salt washed wheatgerm ribosomes with the findings of Osborn 
(1990) for RA. 
Studies by Osborn (1990) revealed a differential sensi ti vi ty 
between wheatgerm ribosomes and rabbit reticulocyte ribosomes 
to RA-catalysed depurination of approximately 1000 fold which 
was found not to be attributable to supernatant factors. In 
order to study the activity of RA on wheatgerm ribosomes more 
closely, Osborn (1990) carried out kinetic experiments using 
sal t washed ribosomes in order to elimina te bound elonga tion 
factors, which may lead to aberrant results. Thus it was hoped 
that in this way any observed differences in sensitivity could 
be attributed to either differences in binding affinity of RA 
for wheatgerm ribosomal RNA (rRNA) and rabbit rRNA or in the 
rate of catalysis. 
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The kinetic experiments carried out allowed the binding 
affinity of the enzyme (RA) for its substrate (wheatgerm rRNA) 
to be determined. The Michaelis - Menton equation for first 
order kinetics predicts that if the rate of dissociation (k2) 
of the enzyme substrate complex is greater than the rate of 
product formation (k3) then the Km value derived is a measure 
of the binding affinity of the enzyme for its substrate. By 
comparison of the dissociation constant (kd) for RA and rat 
liver ribosomes of 2uM (Hedblom et al. 1976) with the Km value 
of 2.6uM for the same reaction (Endo and Tsurugi, 1988), Osborn 
(1990) reasoned that Km and kcat values obtained from 
examination of RA-catalysed depurination of wheatgerm rRNA 
would be effective indicators of whether differences in 
sensi tivi ty of ribosomes to RA were binding or catalytic in 
nature. 
In the examination of SLT lA-catalysed depurination of 
wheatgerm rRNA, it was also assumed that the Km value derived 
would be a direct measure of the binding affinity of the enzyme 
(SLT lA) for its substrate (rRNA) as was the case with RA. 
Endo and Tsurugi (1988) had previous ly measured the rate of 
depurination of rat liver ribosomes by RA by calculating the 
amount of the characteristic 390 base fragment released 
following aniline cleavage of the depurinated ribosomal RNA 
(rRNA). In this study, radioactively labelled ribosomes had 
been used and the amount of aniline fragment released measured 
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from radioactive counts. The percentage depurination was 
calculated by expression of this figure as a ratio to the s.8S 
rRNA. 
Osborn (1990) also used the aniline assay as used by Endo and 
Tsurugi (1988) to measure the extent of depurination of 
wheatgerm ribosomes by RA. The amount of aniline released 
fragment and s.8S rRNA however, was determined direc tly from 
ethidium bromide stained gels on the assumption that labelling 
of the rRNA by ethidium bromide is directly proportional to the 
length of the RNA fragments. 
A Molecular Dynamics computing densi tometer was employed to 
scan negatives of rRNA gels and its volume integration option 
used to generate meaningful data. This data could then used to 
calculate the relative amounts of each rRNA fragment. Osborn 
(1990) was able to derive an equation to calculate the 
percentage depurination from the data generated from scanning 
of the RNA gel. Derivation of the equation required that the 
lengths of wheat SS and S.8S rRNA (120 and 164 nucleotides 
respectively) and the approximate length of the aniline 
fragment released from the 3' end of wheat 2sS rRNA following 
depurination (366 nucleotides) be known. 
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Equation 1: 
RELATIVE AMOUNT ANILINE FRAGMENT x 164 x 100 = % depurination 
RELATIVE AMOUNT 5.8S rRNA 366 
The above equation eliminates variations which may arise as a 
result of the differences in loading of RNA in the tracks, by 
expressing the aniline fragment relative to the 5.8S rRNA which 
is present in equimolar amounts to the 25S rRNA (Rubin, 1973). 
It was decided that application of the kinetic experiments as 
described by Osborn (1990) and also used successfully by 
Chaddock (1991) in studies on RA mutants, would provide a 
valuable insight into the depurination of ribosomes by SLT lA. 
In addition, use of salt washed wheatgerm ribosomes would 
provide a direct comparison between RA-catalysed depurination 
of wheatgerm ribosomes (Osborn, 1990) and SLT-IA catalysed 
depurination. 
Results and Discussion 
The initial substrate (ribosome) and enzyme (SLT lA) 
concentrations used to investigate the kinetics of SLT lA 
catalysed depurination of salt washed wheatgerm ribosomes were 
based upon those described by Osborn (1990). Salt washed 
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whea tgerm ribosomes were prepared as described (2.3 (ii» and 
used in the kinetic experiments in concentrations ranging from 
0.24uM to 1.43uM. For the following experiments it is assumed 
that wheatgerm ribosomes have a molecular weight of 4.2 x 106 
the same as that published for yeast ribosomes (Wool, 1979). 
As previously described, prior to incubation of SLT I holotoxin 
with ribosomes the holotoxin was pretreated with 
2-mercaptoethanol to a final concentration of 6mM to 
accommodate for the lack of a reducing agent such as 
2-mercaptoethanol in the preparation of the salt washed 
wheatgerm ribosomes. FIG 3.2.6 demonstrates the in vitro 
activity of SLT lA on salt washed wheatgerm ribosomes (lane 1) 
in comparison to that of RA (lane 2). 
With regard to quantifying SLT lA concentrations, the holotoxin 
was regarded as having a molecular weight of approximately 
69.5KDa. It was assumed that for any given concentration of 
holotoxin the 32KDa SLT I A subuni t and the SLT I B subuni t 
pentamer (5 x 7.5KDa .,. 37.5KDa) each comprised approximately 
46% and 54% of that concentration. Thus the concentration of 
SLT lA subunit in each case was determined by calculating 46% 
of the given concentration of SLT I holotoxin. SLT lA 
concentrations in the range of 0.015uM - O.luM were used in 
the following kinetic experiments. 
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FIG 3.2.6 Investigation of the activity of Shiga-like toxin I 
A subunit on wheatgerm ribosomes in comparison to that of ricin 
A subunit. 
O.4ug of pure Shiga-like toxin I (SLT I) was incubated with 
30ug wheatgerm ribosomes for 20min at 30C (2.11.1(i». The 
resultant ribosomal RNA (rRNA) was then extracted (2.4.1) and 
subjected to aniline cleavage (2.5.1). Fractionation and 
visualisation of the resultant rRNA was then carried out 
(2.6.1). 
Lane 1 shows wheatgerm rRNA following incubation with pure SLT 
I. 
Lane 2 shows wheatgerm rRNA following incubation with 
recombinant ricin A subunit (rRA). 
+ indicates treatment of rRNA with aniline reagent. 
- indicates that following incubation with SLT I and extraction 
the rRNA was not subjected to aniline cleavage. 
~ indicates the characteristic fragment released following 
aniline cleavage of toxin-modified rRNA. 
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Sal t washed wheatgerm ribosomes at a concentration of 1.27uM 
(160ug in a final reaction volume of 30ul) were incubated with 
a range of concentrations of SLT lA (O.015uM - O.luM) over a 
time course. This allowed the concentration of SLT lA which 
would give a linear rate of depurination and the time span over 
which this would remain linear to be determined. FIG 3.2.7 
shows the percentage depurination with time when [ribosomes] -
1.27uM and [SLT lA] = O.033uM. It may be seen that the rate of 
depurination remains approximately linear for the first 10min. 
The initial rate of depurination was also examined at different 
concentrations of SLT lA - O.015uM, O.033uM, O.05uM, O.067uM 
with a constant ribosome concentration of 1.27uM (160ug in a 
final volume 30ul). Aliquots were removed at two time points in 
order to allow a value for the initial rate of depurination to 
be determined. The resultant plot (FIG 3.2.8) shows the initial 
rate of depurination to remain approximately linear with regard 
to the concentration of SLT lA. It was not possible to examine 
the initial rate of depurination at higher SLT lA 
concentrations than O.067uM due to the low concentration of the 
SLT I holotoxin preparation. The SLT lA concentration chosen 
for use in the experiments to determine Km and kcat was 
O.033uM. 
A range of concentrations of salt washed wheatgerm ribosomes 
from O.35uM (45ug in a final reaction volume 30ul) to 1.43uM 
(180ug in a final reaction volume 30ul) were incubated with 
O.033uM SLT lA for 10min. Aliquots were removed from the 
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FIG 3.2.7 Time course for depurination of wheatgerm ribosomes 
by Shiga-like toxin I A subunit. 
160ug of salt washed wheatgerm ribosomes in a final reaction 
volume of 30ul (final concentration 1.27uM), were incubated at 
30°C for 20min wi th Shiga-like toxin I A subuni t to a final 
concentration of O.033uM (2.11.1(i». From the total reaction 
volume of 30ul aliquots of 3ul were removed at various time 
points and the ribosomal RNA (rRNA) extracted (2.4.1). This was 
then subjected to aniline cleavage (2.5.1) and fractionated by 
denaturing gel electrophoresis (2.6.1). Scanning of the rRNA 
using a Molecular Dynamics computing densitometer and the 
applica tion of EQUATION 1 to the da ta genera ted, allowed the 
percentage depurination in each case to be determined. 
This experiment was carried out in excess of six times. The 
resultant plot was achieved at least three times! 
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FIG 3.2.8 Examination of the effect of Shiga-like toxin I A 
subunit concentration on the initial rate of depurination. 
160ug of sal t washed wheatgerm ribosomes in a final reaction 
volume of 30ul (final concentra tion 1.2 7uM), were incuba ted 
with a range of concentrations of Shiga-like toxin I A subunit 
(SLT lA) from 0.015 - O.067uM (2.11.1(i». At intervals of 5 
and 10min aliquots of 3ul were removed from the reaction (30u1 
total volume) and the ribosomal RNA (rRNA) extracted (2.4.1). 
This was treated with aniline reagent (2.5.1) and fractionated 
by denaturing gel electrophoresis (2.6.1). Based on the 
assumption that the reaction rate remained linear over the 
first 10min of the reaction, the initial rate of depurination 
for each concentration of SLT lA was calculated from the 
percentage depurination at the two time points. 
This experiment was carried out a total of three times. The 
results are representative of data generated from the scanning 
of two gels. 
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reaction at two time points, Smin and 10min, in order to allow 
a value for the initial rate of depurination to be calculated 
for each reaction. The rRNA was then extracted, subjected to 
treatment with aniline, fractionated by denaturing gel 
electrophoresis and the resultant gel carefully stained with 
ethidium bromide. Scanning of the negative photograph of the 
gel and application of EQUATION 1 to the data obtained from the 
scanning allowed the percentage depurination at each time point 
to be determined. The initial rate of depurination for each 
[SLT lA] was then determined by application of these values to 
the following: 
sum % depurination (2 time points) - average % depurination 
2 
average % depurination - % depurination / min 
time (min) 
% depurination x ribosome concentration (uM) 
100 x time (min) 
INITIAL RATE DEPURINATION (uM/min) 
In order to produce meaningful experimental data by scanning 
with the densitometer, great care had to be taken in both gel 
preparation and in its staining with ethidium bromide in order 
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to visualise the resolved RNA. With regard to the latter, 
staining and destaining had to be carefully monitored, since it 
was found that diffusion of RNA bands occurred relatively 
quickly. Such diffusion resulted in an inability to distinguish 
between the 5 and 5. 8S rRNA bands. Thus, the genera tion of 
meaningful data by scanning the gel was impaired. 
Use of a computer programme 'Enzkin 9' allowed determina tion 
of Km and Vmax from the experimental data via a number of 
different methods. Statistically, the Cornish - Bowden plot 
provides the best method of analysis since median values and 
not mean values of Km and Vmax are generated. Thus, unlike the 
use of the Lineweaver - Burke plot, the analysis is virtually 
unaffected by one or two aberrant values. FIG 3.2.9 shows the 
plots obtained. FIG 3.2.10 displays the values of Km and Vmax 
0.978uM and 0.128umol/ min respectively obtained by Cornish -
Bowden analysis in comparison to that derived by Osborn (1990) 
for RA-catalysed depurina tion of salt washed whea tgerm 
ribosomes. 
The Km and Vmax values for the depurination of salt washed 
wheatgerm ribosomes by SLT lA are of a similar order to those 
values derived by Osborn (1990) for depurination of salt washed 
wheatgerm ribosomes by RA. The slightly lower Km value for 
depurination by SLT lA (Km = 0.978uM) indicates a higher 
affinity of SLT lA for its substrate than that of RA (K = 
m 
2.1uM). From the Vmax value the turnover number (kcat ) may be 
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FIG 3.2.9 Determination of ~ and Vmax for the depurination of 
wheatgerm ribosomes by Shiga-like toxin I A subunit using 
Cornish - Bowden and Lineweaver - Burke plots. 
Salt washed wheatgerm ribosomes in concentrations ranging from 
O.35uM - 1.43uM (45 - 180ug in a final reaction volume of 30ul) 
o 
were incubated at 30C (2.11.1(i» with O.033uM Shiga-like toxin 
I A subunit (SLT lA). Aliquots, each of 15ug were removed from 
the reaction at 5 and 10min and the ribosomal RNA (rRNA) 
extracted (2.4.1). This was then subjected to aniline cleavage 
(2.5.1) and fractionated by denaturing gel electrophoresis 
(2.6.1). Scanning of the resultant rRNA gel allowed the 
percen tage depurina t ion for each time point to be calcula ted 
using EQUATION 1. From this the ini tial ra te of depurina tion 
for each ribosome concentration was determined as described in 
the text. The resultant data was applied to Lineweaver - Burke 
and Cornish - Bowden analysis in order to calculate values of 
The resultant plots were generated from a single experiment. 
1: Cornish - Bowden plot 
2: Lineweaver - Burke plot 
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.4 
Vmax = 0.128 umol/min 
Km = 0.978 uM 
Vmax = 0.105 umo1/min 
Km = 0.826 uM 
ItA SLT lA 
Vmax (umol/min) 0.06* 0.128 
~ (uM) 2.1* 0.98 
Kcat (/min) 1.1* 3.9 
* (Osborn, 1990) 
FIG 3.2.10 Summary of the K.. Vmax and kcat values derived for 
Shiga-like toxin I A subunit (SLT lA) catalysed depurination of 
sal t washed whea tgerm ribosomes compared to those of ricin A 
subunit. 
163 
calculated giving a value of 3.9 min- 1 , a value almost four 
times greater than the value of 1.1 min-1 for RA catalysed 
depurination of wheatgerm ribosomes as determined by Osborn 
(1990). Kinetic analysis of RA-catalysed depurination of yeast 
(Saccharomyces cerevisiae) ribosomes by Chaddock (1991) 
revealed a binding affinity of RA for yeast rRNA (Km - 1.48uM) 
of a similar order to those of SLT lA (the present study) and 
RA (Osborn, 1990) for wheatgerm rRNA. However, a much greater 
turn over number (kcat = 195min-1 ) for depurination of yeast 
ribosomes by RA (Chaddock, 1991) was observed in this case 
which may serve to explain the differential sensi tivi ty of 
yeast and wheatgerm ribosomes to depurination by RA. 
The results of this investigation into the kinetics of the 
depurination of salt washed wheatgerm ribosomes by SLT lA 
suggest that the increased affinity (Km) and a maximum velocity 
value (Vmax ) for SLT lA, which is almost double that of RA-
catalysed depurination, are reflected by a turnover number 
almost four times as great as that for determined by Osborn 
(1990) for RA. Slight differences in SLT lA and RA-catalysed 
depurination of wheatgerm ribosomes are suggested by the 
findings of the present study. It is important to note however, 
that although the same protocols were followed to investigate 
SLT lA-catalysed depurination of wheatgerm ribosomes as had 
been used by Osborn (1990) to investigate RA-catalysed 
depurination of wheatgerm ribosomes, the complex nature of the 
experiments may also introduce a small degree of error. In 
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addition, it is also important to note that the salt washed 
wheatgerm ribosome substrate used may vary slightly in quality 
as a result of small differences in methods of preparation. 
Due to limited resources ie SLT l, the final experiment to 
generate data for the Cornish - Bowden analysis was carried out 
a total of three times. However, as a resul t of the complex 
nature of the kinetic assay, of the three resultant gels only 
one was suitable for scanning. Km and Vmax values presented 
here for SLT lA-catalysed depurination of salt washed wheatgerm 
ribosomes were therefore obtained from a single analysis. Due 
to the complex nature of the kinetic analysis, it is felt that 
differences (as revealed in this study) in the depurination of 
wheatgerm ribosomes by SLT lA (the present study) and RA 
(Osborn 1990) may in fact be attributable to experimental error 
and may therefore, be negligible. 
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Conclusion - Chapter 2 
The results presented in this chapter provide a direct 
comparison between a number of biological activities of ricin 
and Shiga -like toxin I (SLT I), both of which are Type 2 
ribosome inactivating proteins (RIPs) with a capacity to 
irreversibly inactivate eukaryotic ribosomes. The biological 
activities of ricin have been studied extensively and it is 
considered the proto-type member of the Type 2 RIPs. However, 
al though SLT I has previously been compared to ricin, direct 
comparison between the two has been limited. 
A direct comparison of the cytotoxicities, substrate 
specificities, precise site of depurination and the kinetics of 
depurination of salt washed wheatgerm ribosomes between SLT I 
and ricin is presented here. Sugar or receptor binding has not 
been analysed. 
In comparison, the 50% cytotoxic dose value (ICSO) of O.lng/ml 
for the action of SLT I on Vero cells (SECTION 3.2.1) is seen 
to be approximately 10 fold less than that displayed by ricin 
(1 - 3ng/ml) (O'Hare ~ al. 1987, 1990, Yoshida et al. 1991). 
Results obtained by Olsnes et al. (1981) for the cytotoxic 
action of Shiga toxin (ST) on HeLa cells also report a 
reduction in the number of ST molecules required to cause 50% 
cell death compared with that of ricin. This is suggested to be 
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attributable to a greater binding affinity of ST for its 
cellular receptor than that of ricin for its. More recent 
studies however, present evidence to sugges t that the 
differences in cytotoxicity of ricin and ST / SLT I may be 
attributable to any number of steps in the complex processes of 
binding, uptake and translocation of toxin. For example, ricin 
binds opportunistically to cell-borne glycolipids and 
glycoproteins terminating in galactose (Sandvig et al. 1991). 
Such opportunistic binding may not lead to endocytosis of the 
ricin molecule. In contrast, the binding of ST and SLT I to 
glycolipids terminating in GalCXl-4Gal~ is highly specific 
(Cohen et al. 1987, Lindberg et al. 1987, Lingwood ~ al. 
1987). It is likely therefore, that in each case binding will 
lead to endocytosis of the ST I SLT I molecule. The existence 
of five potential receptor binding sites on the ST I SLT I B 
subunit pentamer observed from the crystal structure of the SLT 
I B subunit pentamer (Stein et al. 1992) may also contribute to 
the high specificity, tight binding of ST I SLT I to its cell-
borne receptor. 
There are of course other possibilities to explain the 
increased cytotoxicity of SLT I as compared to ricin. In both 
cases the processes following endocytosis remain unclear. 
Following absorptive endocytosis routing of ricin to the 
endoplasmic reticulum (ER) is thought to occur as a result of 
receptor exchange by the toxin in the trans-Golgi network (TGN) 
and interaction with proteins with KDEL-like sequences. Sandvig 
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et al. (1992) present evidence for the accumulation of ST in 
the ER following receptor mediated endocytosis (RME). The 
mechanism by which it reaches the ER is not known. However, it 
is suggested that as with ricin routing may occur via receptor 
exchange within the TGN or by interaction with proteins 
possessing KDEL-like sequences. A further suggestion is that 
transport of ST to the ER is media ted by glycolipids. As is 
evident, the process of intracellular routing may be complex. 
Other factors which may contribute to the observed differences 
in cytotoxicity of ricin and SLT I, are those of 
processing, membrane translocation and differences in catalytic 
activity of the two toxins. The results of detailed kinetic 
analysis of the depurination of salt washed wheatgerm ribosomes 
by SLT lA (SECTION 3.2.4) may shed some light upon this matter. 
Results in this section reveal a turnover number (kcat ) 
approximately four times that of ricin A subunit (RA) catalysed 
depurination of wheatgerm ribosomes as determined by Osborn 
(1990) (3.9min-1 (SLT lA) and 1.1min-1 (RA)). This may be 
attributed to a maximum velocity value (Vmax = 0.128umol / min) 
double that obtained for RA (0.06umol / min, Osborn, 1990) in 
addi tion to an increased binding affini ty of SLT lA for its 
substrate (Km = 0.978uM (SLT lA) compared to 2.1uM (RA -
Osborn, 1990». Thus it may be the case that the in vitro 
comparison of SLT lA and RA catalysed-depurination is reflected 
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in vivo, resul ting in a reduction in the amount of SLT I 
required to give 50% cell death in Vero cells. 
A comparison of the activities of SLT lA and RA on eukaryotic 
ribosomes isolated from different sources (SECTION 3.2.2) 
demonstrates that of the ribosomes examined, SLT lA has the 
same substate specificity as does RA. Whilst both RA and SLT lA 
may be seen to modify the ribosomal RNA (rRNA) of yeast, 
wheatgerm, rabbit reticulocyte, rabbit liver and tobacco leaf 
ribosomes, neither is able to modify the rRNA of Escherichia 
coli ribosomes. This is in contrast to recently characterised 
RIPs, dianthin 30, 32 and pokeweed antiviral proteins which can 
depurinate E.coli ribosomes (Hartley ~ al. (1991). 
In addition to exhibiting the same substrate specificities as 
RA, examina tion of the precise si te of depurina tion of yeast 
(Saccharomyces cerevisiae) ribosomes (SECTION 3.2.3) by SLT lA 
reveals that exactly the same adenine residue is removed 
(A3024) as is removed by RA (Osborn, 1990). 
To conclude, it would appear from investiga tions carried out 
here, that in essence the biological activity of SLT I is 
almost identical to that of ricin. 
In addition, results presented in this study allow the activity 
of SLT I to be compared with published observations regarding 
the activity of ST. 
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With regard to RNA N-glycosidase activity of ST, Olsnes et al. 
(1981) and Reisbig et al. (1981) have reported the inhibition 
--
of protein synthesis in rabbit reticulocyte cell free systems 
by ST. Resul ts from the present study (SECTION 3.2.2) also 
demonstrate the modification of rabbit reticulocyte ribosomes 
by SLT I. Comparison of the activities of ST and ricin by Endo 
et al. (1988) and Saxena ~ al. (1989) suggests that the two 
have the same substrate specificities. This was also the 
finding of the present study (SECTION 3.2.2) regarding the RNA 
subs tra te specifici ties of SLT lA and RA. It would appear, 
therefore, tha t ST / SLT I and ricin all exhibi t the same 
substrate specificities and enzymatic activities. 
This suggestion is further substantiated by Endo ~ al. (1988) 
who demonstrated that modification of rat liver ribosomes by 
ST occurred a t the same si te as tha t of ricin ie adenine 
residue 4324 of the 28S ribosomal RNA (rRNA). Results presented 
by this study (SECTION 3.2.3), reveal that the precise site of 
depurination by SLT I in yeast ribosomes is adenine residue 
3024. This is the same si te a t which RA has been shown to 
modify yeast 26S rRNA (Osborn, 1990). Since studies reveal that 
ST depurinates rat liver ribosomes at exactly the same site as 
does ricin (Endo ~ al. (1988), and that SLT I depurinates 
yeast rRNA at exactly the same site as does ricin (the present 
study) it would appear tha t ST and SLT I modify the rRNA of 
susceptible eukaryotic ribosomes by depurination at the same 
adenine residue. 
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Examination of the cytotoxic effect of SLT I on Vero cells 
revealed a requirement of 0.lng/m1 SLT I to resul t in 50% 
inhibi tion of cell protein synthesis. This was also the 100% 
cytotoxic dose value for SLT I on Vero cells reported by 
Kongmuang et al. (1988) and by Olsnes and Eiklid (1980) for the 
cytotoxic effect of ST on HeLa S3 cells. For the cytotoxic 
effect of ST on Vero cells both Eiklid and Olsnes (1980) and 
Sandvig and Brown (1987) report an ID50 value of 0.6ng/ml. It 
may be seen that results obtained in the present study 
regarding the cytotoxic activity of SLT I on Vero cells, is 
comparable to those obtained by other groups. In order to draw 
a direct comparison between the observed cytotoxicity of SLT I 
(this study) and SI (Sandvig and Brown, 1987) on Vero cells, it 
would be necessary to carry out the assays simultaneously 
using exactly the same materials and methods in each instance. 
Recent kinetic studies of RA-catalysed depurination of 
eukaryotic ribosomes has revealed Km values ranging from 0.1 -
2.6uM and k cat values ranging from 201 - 1500min-
1 (Endo and 
Isurugi, 1988, Osborn, 1990, Chaddock, 1991 and Ready et al. 
1991) depending on the source of ribosomes used and the assay 
conditions. In contrast, there has been little kinetic analysis 
of the depurination of eukaryotic ribosomes by ST / SLT I / SLT 
II. Reisbig ~ al. (1981) do however, report a turn over 40 
ribosomes per minute for the action of the ST Al fragment on 
reticulocyte ribosomes. SI Al fragment used in this study was 
generated by pre-nicking of ST A subunit with trypsin followed 
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by reduction. Resul ts presented in the present study for SLT 
lA-catalysed depurination of salt washed wheatgerm ribosomes 
give a k cat value of 3.9min-
l
• In this study SLT I holotoxin 
was pretreated with 2-mercaptoethanol (final concentration 6mM) 
in order to examine acti vi ty of the holotoxin in a 
physiological environment, similar to the reducing conditions 
of the cytosol. In order to compare directly the kinetics of 
SLT I / ST-catalysed depurination of eukaryotic ribosomes the 
same assay conditions and same source of ribosomes must be used 
since there may be a marked difference in sensitivity of 
reticulocyte and wheatgerm ribosomes to depurination by SLT lA 
/ ST A. With regard to this Osborn (1990) reported the 
differential sensitivity of reticulocyte and wheatgerm 
ribosomes to depurination by RA (reticulocyte ribosomes were 
1000 times more sensitive than were wheatgerm ribosomes). 
Results presented here do however, suggest that as proposed by 
S trockbine et al. (1988), ST and SLT I are "', the 
same. 
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CHAPTER 3 
SECTION 3.3 Production of recombinant Shiga-like toxin I A 
subunits. 
Introduction 
It has been proposed and in some cases demonstrated, that 
bacterial toxins such as cholera toxin (CT) (Gill, 1976), 
Escherichia coli heat labile toxin (LT) (Spicer and Noble, 
1982, Yamamoto et al. 1987), Pseudomonas exotoxin A (PE) (Jinno 
~ al. 1989, Hadhus and Collier, 1989, Ogata !!.!!. 1990) and 
diphtheria toxin (DT) , have a requirement for proteolytic 
processing in order to generate an enzymatic fragment with 
enhanced activity. This has also been suggested to be the case 
with Shiga toxin (ST) and Shiga-like toxin I (SLT I). 
Olsnes et al. (1981) examined differences in the cytotoxic 
effects of nicked-reduced, nicked-unreduced and unnicked SI 
and reported there to be no difference in cytotoxicity for HeLa 
S3 cells. In order to examine the effect of nicking and 
reduction on SI activity the toxin was treated with trypsin and 
reducing agents such as 5% 2-mercaptoethanol. 
Kon8muang et al. (1988) report there to be no difference in the 
cytotoxicity of nicked and unnicked SLT I on Vero cells. Again, 
these effects were studied by incubation of toxin with trypsin 
in order to generate nicked SLT I. 
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Reisbig et al. (1981) used a variety of different chemical 
treatments including urea, sodium dodecyl sulphate (SDS), 
dithiothreitol (DTT), 2-mercaptoethanol and trypsin in order to 
compare the activity of isolated ST Ai fragment (27.5KOa) to 
that of the untreated, intact whole ST A subunit (32KOa). Their 
findings were that the A1 fragment alone was six times more 
efficient in the inactivation of rabbit reticulocyte ribosomes 
than was the unnicked A subunit and three times more active 
than trypsin / OTT / urea treated holotoxin. The increase in 
activity following such treatment they attribute to the 
splitting off of the A2 peptide from the ST A subunit. This in 
turn results, they suggest, in the achievement of full activity 
of the A1 fragment of ST. 
It is evident from such studies that the Ai and A2 peptides 
have been generated via rather non specific chemical means. It 
was therefore decided that any role of the A2 peptide in 
activity of the SLT I A subunit would be examined in this 
present study by the construction of recombinant SLT I A 
subunits (rSLT IAs). This would then allow any differences in 
enzymatic activity of the whole SLT I A subunit and the A1 
peptide to be examined both in vivo and in vitro without a 
prequisite for non specific chemical and enzymatic treatments 
of the proteins under examination. 
Examination of the primary sequence of bacterial toxins such as 
PE (Jinno ~ al. 1989, Madhus and Collier, 1989, Ogata et al. 
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1990) revealed that, the region of the protein predicted to 
undergo proteolytic cleavage to generate a fragment with 
enhanced enzyma tic ac ti vi ty was arginine-rich and bounded by 
cysteine residues capable of forming a disulphide bridge (FIG 
1.7.2). 
Calderwood et a1. (1987) proposed that this may also be the 
case with the SLT I A subunit. It was suggested that cysteine 
(eys) residues 242 and 261 bounded a region which, on 
proteolytic cleavage, would generate two peptides. The sizes 
of these fragments would correspond to those observed 
following careful digestion of SLT I A subunit with trypsin and 
resolution under reducing conditions by SDS polyacrylamide gel 
electrophoresis (PAGE). FIG 3.3.1 demonstrates the necessity 
not only for treatment of SLT lA with trypsin for production of 
the separate SLT IA1 and SLT IA2 peptides but also the 
requiremen t for reduc tion (lane 1). Nei ther alone resul ts in 
separation of the two peptides (lanes 2 and 3). 
Two arginine (Arg) residues exist within this proposed cleavage 
site (Arg248 and Arg251 ). Spicer and Noble (1982) proposed that 
proteolytic cleavage of the A subunit of LT to generate A1 and 
A2 polypeptides occurred after Arg188. In add! tion, Jinno et 
al. (1989) and Ogata ~ a1. (1990), found that mutagenesis of 
Arg residues 276 and 279, (residues within domain 11 of PE) to 
glycine (Gly) greatly reduced the cytotoxicity of the toxin 
even though normal cell binding and enzymatic capabilities were 
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FIG 3.3.1 The effect of treating Shiga-like toxin I A subunit 
(SLT lA) with trypsin and reducing agent. 
In each case 10ug purified Shiga-like toxin was subjected to 
different combinations of treatment with L-l-tosylamido-2-
phenylethyl chloromethyl ketone treated-trypsin (Sigrna) 
(50ug/ml final concentration (2.10.2) and SDS polyacrylamide 
gel electrophoresis (SDS PAGE) (2.10.3) under both reducing and 
non reducing conditions. Reducing conditions were achieved by 
the addi tion of 2-mercaptoe thanol to the sample buffer to a 
final concentration of 0.7SM. Treatment with trypsin was by 
i nc u ba t ion at 31c for 1 Srn i n ( 2 . 10 • 2 ). The re suI tan t prod u c t s 
were analysed by SDS PAGE (non reducing and reducing 
conditions) on a 15% gel followed by Coomassie staining 
(2.10.3(iii». 
1 : SLT I treated with trypsin and 2-mercaptoethanol (reducing). 
2: SLT I treated with 2-mercaptoethanol alone (reducing) • 
3: SLT I treated with trypsin alone (non reducing). 
4: SLT I untreated (non reducing). 
MW: molecular weight markers. 
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MW12 34 
KDa 
31·0 
B 
177 
evident. Again the Arg rich region within domain 11 of PE is 
bounded by Cys residues capable of forming a disulphide bond. 
Ogata ~ al. (1990) followed the processing of PE in mammalian 
cells and were able to conclude from their studies that native 
PE undergoes proteolytic cleavage within domain 11 close to Arg 
residue 279. Reduction of this nicked product generated an 
enzymatically active 37KDa fragment which could then enter the 
cytosol and act upon its intracellular target. Proteolytic 
cleavage of the domain 11 mutant, Gly276, they found, did not 
take place; hence the reduction in cytotoxicity of the 
molecule. 
It was on the basis of the above evidence for proteolytic 
cleavage of PE and LT within an Arg rich region bounded by Cys 
residues, tha t Arg residues 248 and 251 were identified as 
potential sites for cleavage in SLT I A subunit. It was decided 
that for the purpose of studying the role of the A2 peptide in 
both the RNA N-glycosidase activity of SLT lA and the cellular 
uptake of the holotoxin these residues would be the targets for 
site directed mutagenesis in order to generate recombinant SLT 
I A fragments. 
Recent work by Jobling and Holmes (1992) examined the 
interaction between the A2 peptide of cholera toxin (CT) and 
its pentamer of B subunits. By constructing fusion proteins of 
bacterial alkaline phosphatase, maltose-binding protein and 
beta-lactamase, each possessing a C terminal CT A2 peptide, it 
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was found that each of the fusion proteins were capable of 
associating with CT B subunits to form holotoxin-like chimeric 
molecules. In addition, the recent work of Streatfield et al. 
(1992) suggests a role for C terminal of E.coli heat labile 
toxin (LT) A subunit in promoting the oligomerisation of the B 
subunit pentamer of the toxin. On deletion of the last 14 C 
terminal residues of the LT A subunit (LTA) (-14), a 
significant reduction in assembly of the B subunit pentamer 
was observed. Deletion of only the last 4 amino acid residues 
of LTA (-4) however, resulted in assembly of an A2-BS complex 
but with apparent reduced stability. These observations led to 
the suggestion that residues -14 to -4 of LTA are in some way 
involved in the promotion of B subunit oligomerisation, whilst 
the las t 4 residues behave as an 'anchor' in stabilising the 
interaction between the A and B subunits during holotoxin 
assembly. 
To date the role of the SLT IA2 peptide in association of the 
SLT IB pentamer with the SLT lA subunit remains unclear. Thus, 
in addition to facilitating study of any contribution of the 
SLT IA2 peptide in the RNA N-glycosidase activity and cell 
entry properties of the SLT I A subunit, it was decided that 
the recombinant SLT I A subunits constructed should also allow 
examination of the non covalent interaction between the SLT IA2 
peptide and the Shiga like toxin I B subunit (SLT IB) pentamer. 
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The following recombinant SLT I A subunits were generated: 
(a) a truncated SLT lA comprising the Al fragment alone 
(b) a full length SLT lA rendered insusceptible to proteolytic 
processing. 
A fragment of SLT lA A2 alone was not successfully produced. 
FIG 3.3.2 shows the recombinant SLT I A subunits generated. 
Generation of the truncated SLT lA comprising the Al fragment 
alone was achieved by conversion of serine (Ser) residue 247 
and Arg 248 to STOP codons by si te directed mutagenesis 
(2.5.8) using Oligonucleotide Al (FIG 3.3.3). 
The full length, 'protease insensitive' SLT lA was generated by 
conversion of the Arg residues at the proposed site of 
proteolytic cleavage ie Arg 248 and Arg25I to alanine (Ala) and 
glycine (Gly) respectively (FIGS 3.3.2 and 3.3.4). Both the 
size and the charge of the replacement residues were carefully 
considered in order to minimise any conformational changes in 
the subunit which may result in changes in its activity. 
Schlossman et al. (1989), in the mutagenesis of ricin A 
subunit (RA), reported a considerable difference in the 
activity of two mutants under examination. Replacement of 
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I 7j ~I 
WILD TYPE SLT lA SUBUNIT 
I A, I 
TRUNCATED SLT lA SUBUNIT At ALONE 
AG 
I Al 
I 
I A2 I 
FULL LENGTH SLT lA StrnUNIT - 'PROTEASE INSENSITIVE 
, 
R = Arginine 
A = Alanine 
G = Glycine 
FIG 3.3.2 Recombinant Shiga-like toxin A subunits (rSLT IAs) 
designed to alloy the role of the A2 peptide in SLT lA 
RNA N-gtycosidase activity to be deterained. 
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OLIGONUCLEOTIDE Al 
• • 5' CAT CAT CAT GCA TAG TGA GTT GCC AGA 3' 
OLIGONUCLEOTIDE AIA2 
.. . 
5' CAT GCA TCG GCA GTT GCC GGA ATG GCA 3' 
OLIGONUCLEOTIDE SEQ 
1042 1060 
5' ACA AGA CTC TGT TCG TGT A 3' 
1042 - 1060 indicates the region within SLT lA to which 
sequencing primer OLIGONUCLEOTIDE SEQ is homologous • 
• = misma tch 
Fig 3.3.3 Oligonucleotides used in the production of 
recombinant Shiga-like toxin A subunits. 
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Protease Sensitive 
Linker Region 
Al 
CHHHAS RVARMASDEFPSM~ 
242 : 1: + 261 
:k G 
I 
I 
j \ 
STOP STOP 
FIG 3.3.4 The proposed Shiga-lite toxin I A subunit (SLT lA) 
protease sensitive region. 
The amino acid sequence for this region is detailed with the 
cysteine residues thought to form a disulphide bridge at this 
region denoted c. 
Arginine residues (R) and their conversions in this study to 
alanine (A) and glycine (G) by site directed mutagenesis are 
indicated by ~ ~ 
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glutamic acid (Glu) residue 177 (at the proposed active site 
cleft of RA) with first Ala resulted in a 20 fold decrease in 
activity whilst replacement with aspartic acid (Asp) gave a 
reduction in activity of 80 fold. The latter substitution, they 
suggest, may result in a conformational change in the active 
site cleft as a result of the electrostatic interaction between 
the charged side chain of the Asp residue and an existing 
residue, Arg180 • This, they suggest, may account for the 
greater decrease in RA activity with substitution of a 
conservative Asp than is evident with the substitution of 
Glu 177 with an uncharged Ala residue. 
Ala and Gly were the residues chosen to replace Arg residues 
248 and 251 in SLT IA in this study, since both are relatively 
small in size and neither possesses a charged side chain. 
Alanine residues are frequently used in protein engineering to 
introduce changes which are structurally non perturbing 
(Ashenazi !! al. 1990, Kasturi et al. 1992). 
The full length, 'protease insensitive' SLT lA was generated by 
site directed mutagenesis (2.5.8) using Oligonucleotide A1A2 
(FIG 3.3.3). 
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Cloning steps involved in generation of the recombinant Shiga-
like toxin I A subunits • 
Plasmid pSC25 (FIG 3.3.5) expressing the whole SLT I A subunit 
under lac promotion was kindly provided by Dr S Calderwood 
(Boston USA). 
(a) Cloning steps involved 
recombinant, truncated SLT lA 
in the generation 
(rSLT lAI "(AI alone)}. 
of the 
A 976 base pair (bp) Pst I I ~ I fragment was excised from 
pSC25 by restriction of the DNA (2.5.3) with the above 
mentioned endonucleases. This was then ligated (2.5.5) into the 
cloning site of bacteriophage M13mp18X (FIG 3.3.6) which had 
been restricted (2.5.3) and gel purified (2.4.4) as a Pst I I 
Sma I fragment. In this way a forced orientation cloning was 
achieved, eliminating the need for screening of successful 
recombinants. In addition, following successful mutation of the 
SLT lA DNA, it could be excised as Pst I / Eco RI fragment (Eco 
RI in this instance being a site in the HI3 DNA) and 
substituted back into pSC25 for in vivo expression in E.coli. 
Following ligation, the DNA was used to transform E.coli strain 
JMlOl (2.7.3). Successful transformants were identified and 
single-stranded (ss) M13mp18X / SLT lA DNA prepared (2.4.2 
(iv» in readiness for site directed mutagenesis (SDM). SDM 
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FIG 3.3.5 Plasmid pSC25. 
pSC25 
(3800q,) 
Eco RI JJ50 
Ssp I 974 
Nru I 
Xmnl818 
III 
Kindly donated by Dr S Calderwood (Boston, USA). The plasmid 
contains the DNA for the entire Shiga-like toxin I A subunit 
(SLT lA) under transcriptional control of the lacZ promoter 
{Hovde ~~. (1988). 
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Hinc 11 
Accl 
EcoRI Sst I Ken I BamHI Xhol Sail Pst I Sph I Hind III 
ACGAATTCGAGCTCGGTACCCGGGGATCCTCTAGCCTCGAGGCTAGAGTGGACCTGCAGGCATGCAAGCTTG 
Smol 
Xmol 
FIG 3.3.6 Bacteriophage Ml3mp18X cloning site. 
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(2.5.8) was carried out using Oligonucleotide Al (FIG 3.3.3) to 
instigate the required mutations. Putative mutants were then 
screened for possession of the desired mutations by dideoxy 
sequencing of the ss MI3 I SLT lA DNA (2.5.8) using 
Oligonucleotide SEQ (FIG 3.3.3) complementary to bases 1042 to 
1060 in the SLT lA DNA • This allows the sequence across the 
mutant region to be determined. FIG 3.3.7 shows the resultant 
dideoxy sequencing of a recombinant SLT lA wi th the correct 
nucleotide subs ti tut ions required to genera te 
IAI (AI alone). 
truncated SLT 
(b) Cloning steps involved in the generation of a recombinant, 
full length, 'protease insensitive' SLT IA1A2. 
A l150bp Pst I I Eco RI fragment was excised from pSC25 (FIG 
3.3.5) by restriction of the DNA (2.5.3). Again this was 
ligated (2.5.5) into the cloning site of bacteriophage M13mp18X 
(FIG 3.3.6), which in this case had been restricted (2.5.3) as 
a Pst I I Eco RI fragment and gel purified (2.4.4). Once again 
forced orientation cloning of the SLT lA fragment ruled out the 
necessity for screening of successful recombinants. Following 
mutagenesis this fragment could also be easily excised and 
substituted back into pSC25 for in vivo expression studies. 
Following ligation of the SLT lA fragment with M13mp18X steps 
taken were as described in (a) above. However, in this case SDM 
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FIG 3.3.7 Dideoxysequencing of putative recombinant Shiga-like 
toxin A subunit (rSLT IAs) mutants. 
In each case lpmol single stranded (ss) bacteriophage Ml3 / SLT 
lA DNA was used as template to which O.5pmol primer (OLIGO SEQ 
FIG 3.3.3) was annealed as described (2.5.8(i». Dideoxy 
sequencing of the DNA was then carried out using Sequenase™ as 
detailed (2.5.8(i». The products of dideoxy sequencing of the 
M13 / SLT lA putative mutants were fractionated on an 6% 
polyacrylamide gel (2.6.3) and visualised by autoradiography 
(2.10.3(iii». 
G,T,A,C denote the dideoxynucleotide relating to each 
termination reaction. 
WT: rSLT lA (wild type). 
rSLT IAl (truncated SLT I - Al alone). 
rSLT IAlA2 (full length SLT IAlA2 
insensitive'). 
::: indicates region of mutation. 
'protease 
----- indicates nucleotides separating sequences targetted for 
site directed mutagenesis. 
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WT Al AlA;. 
GTAC GTAC GTAC 
.. 
A T Al ALONE 
C G C G A --·_·-A G A WILD TYPE 
GC G AI/A2 
NON CLEAVABLE 
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(2.5.8) was achieved using Oligonucleotide A1A2 (FIG 3.3.3). 
Screening of putative mutants was again achieved by dideoxy 
sequencing of the ss M13 / SLT lA DNA (2.5.8) using 
Oligonucleotide SEQ (FIG 3.3.3). The resultant dideoxy 
sequencing is seen in FIG 3.3.7 showing the nucleotide 
substitutions (compared to the wild type SLT lA) required to 
successfully produce a recombinant, full length, 'protease 
insensitive' SLT IA1A2' 
In order to proc~ with expression of the recombinant SLT IAs 
in both in vitro and in vivo systems, it was first necessary to 
prepare replicative forms (RF) of the M13 I SLT lA DNA 
(2.4.2 (ii i) ) in each case. The requi red recombi nant 5LT lA 
fragments could then be excised from the M13 / SLT lA 
constructs (FIG 3.3.8). 
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FIG 3.3.8 Recombinant Shiga-like toxin I A subunit (rSLT lA) 
DNA fragments excised from H13mp18X following site directed 
mutagenesis. 
Base pairs (bp X 10-2) 
-
-0 
~ 9 1 ~ ~ 1 ~ ~ ? ~ ? 1.0 1,1 11 
SLT lA 
:JC .-
Pst I Pvu 11 Hind III Xmn I Nru I Ssp I Eco RI 
SLT 1A1A2 
I ::Tl,--
Pst I Pvu 11 Hind III Xmn I Ssp I Eco RI 
SlT IAl 
::rc- .. )-\ 
Pst I Pvu JI Hind III Xmn I Kpnl EcoRI 
__ .M 13 mp laX DNA 
SECTION 3.3.1 In vi tro expression of recombinant Shiga -like 
toxin I A subunits. 
Introduction 
Following the successful generation of recombinant Shiga-like 
toxin I A subunits (rSLT IAs) it was necessary to employ an 
expression system which would permit the sizing of the 
recombinant SLT lA protein products. In addition a system was 
required which would allow the relative sensitivity to 
proteolytic cleavage of the recombinant, full length, 'protease 
insensitive' SLT IAIA2 to be determined by comparison to that 
of the wild type SLT lA subunit. The RNA N-glycosidase activity 
of the recombinant SLT IAs was also an important aspect to be 
examined. 
It was therefore, decided that in vi tro expression of the 
recombinant SLT lAs would be employed in an initial attempt to 
address these questions. 
Results and Discussion 
Plasmid pGEM2 (FIG 3.3.9) was chosen as a suitable vector for 
in vitro expression of the rSLT IAs, since it provided suitable 
cloning si tes for expression of the rSLT lAs under 
transcriptional control of the T7 promoter. In addition, this 
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pGEM2 
( 2869bp) 
2627 
Ssp 11975 
~H~~~~~~~~--~E~ 
70 1 
FIG 3.3.9 In vitro expression vector pGKH2. 
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B - Bco RI 
Sa - Sac I 
Av =- Ava I 
S. ,. Saa I 
B ,. Ba. HI 
X -XDa'1 
S =- Sar I 
A - Ace I 
Hi - 'iiIiic II 
P = Pat I 
H ., iITiid III 
particular vector had previously been used successfully by 
several members of our laboratory. 
Steps involved in the generation of pGEM2 I SLT lA (wild type) 
(pGEM2WT) J pGEM2 I truncated SLT IAl (A l alone (pGEM2Al ) and 
pGEM2 / full length J 'protease insensi ti ve' 5LT IAl A2 
(pGEH2A1A2)· 
In order for the in vitro activities of the rSLT IAs to be 
compared directly J cons truction of vector pGEM2 carrying the 
wild type SLT lA subunit (pGEM2WT) was necessary in addition to 
the construction of pGEM2 vectors carrying the recombinant SLT 
lA subunits. 
(a) Construction of pGEM2At _ 
A fragment of approximately 990bp was excised (2.5.3) from the 
H13mp18X I SLT IAl RF DNA (FIG 3.3.8) as a Pst I I Eco RI 
fragment thus releasing the mutant SLT IAl subunit. This was 
then ligated (2.5.5) into pGEM2 (FIG 3.3.9) which had also been 
res t r i c t e d ( 2 • 5 • 3 ) us in g Ps t I I E coR I and gel pu r if i e d 
(2.4.4). The resultant pGEM2 I SLT IAl DNA was used to 
transform E.coli strain JMlOl (2.7.2). Forced orientation 
cloning of the 5LT lAl fragment into pGEM2 eliminated the 
necessity for screening to determine fragment orientation. They 
were, however, screened for possession of the mutation required 
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for generation of the SLT lA subunit Al alone by dideoxy 
sequencing of the plasmid DNA (2.5.8 (ii». Large scale 
preparation (2.4.2(ii» of pGEM2A1 (FIG 3.3.10) was then 
carried out in order to yield purified plasmid DNA. 
Cb) Construction of pGEM2WT and pGKM2A1A2 _ 
An lI50bp Pst I / Eco RI fragment was excised (2.5.3) from 
plasmid pSC25 (FIG 3.3.5) and ligated (2.5.5) into pGEM2 (FIG 
3.3.9) exactly as described in construction of pGEM2A1 in order 
to generate pGEM2WT (FIG 3.3.11). 
Generation of pGEM2AIA2 (FIG 3.3.12) also involved the excision 
(2.5.3) of an 1150bp Pst I / EcoRI fragment which was then 
ligated (2.5.5» into Pst I / !£2 RI restricted (2.5.3) and 
gel purified (2.4.4) pGEM2 (FIG 3.3.9), however, in this case 
the source of the 1150bp fragment was M13mpI8X I SLT IAIA2 RF 
DNA (FIG 3.3.8) which carried the correct mutation for 
generation of the full length, 'protease insensitive' SLT 1AIA2 
subunit. 
Transformation of the ligated DNA in E.coli strain JM101 
(2.7.3) anti dideoxy sequencing of resultant plasmid DNA 
(2.5.8(ii» in order to determine possession of the required 
rSLT lA DNA fragment followed by large scale preparation of the 
plasmid DNA was as described for construction of pGEM2A1 • 
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pGEM2A1 
(3821bp) 
Hind III Pstl 
FIG 3.3.10 Plasmid pGKM2Al. 
992 
Xmn 1818 
ind III 
Construction of pGEM2Al allowed in vitro expression of the 
truncated Shiga-like toxin I A subunit (SLT IAI - Al alone). A 
Pst I I Eco RI fragment of approximately 990 base pairs 
encoding the recombinant SLT IAI was ligated (2.5.5) with 
similarly restricted pGEM2 (FIG 3.3.9). The SLT IAl was 
transcribed under control of the pGEM2 T7 promoter. 
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pGEM2WT 
( 3979t:p) 
FIG 3.3.11 Plasmid pGKM2WT. 
Pstl 
o 
EcoRI 1150 
I 
Nrul 
Xmn I 818 
Construction of pGEM2WT allowed in vitro expression of the wild 
type Shiga-like toxin I A subunit (SLT lA) thus providing an 
experimental comparison between the wild type and recombinant 
SLT lA subunits. A Pst I I Eco RI fragment of approximately 
1150 base pairs encoding the wild type SLT lA was ligated 
(2.5.5) with similarly restricted pGEM2 (FIG 3.3.9). The SLT lA 
wild type was transcribed under control of the pGEM2 T7 
promoter. 
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pGEM2A)A2 
(3979bp) 
Hind III Pstl 
FIG 3.3.12 Plasmid pGKM2A1A2. 
Xmn I 818 
Construction of pGEM2A1A2 allowed in vitro expression of the 
full length protease insensitive Shiga-like toxin I A subunit 
(SLT IAIA2). A ~ I / Eco RI fragment of approximately 1150 
base pairs encoding the recombinant SLT IA1A2 was ligated 
(2.5.5) with similarly restricted pGEM2 (FIG 3.3.9). The SLT 
IAIAZ was transcribed under control of the pGEM2 T7 promoter. 
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Prior to in vitro transcription (2.8.1) of the pGEM2 / rSLT lAs 
DNA, linearisation of the DNA was first necessary. This was 
achieved in all cases by restriction of the plasmid DNA (2.5.3) 
with Eco RI, a restriction endonuclease which cuts at a single 
site in all of the pGEM2 I rSLT lAs generated in this study. 
Following restriction, the DNA was extracted and precipitated 
(2.4.3) and its concentration determined spectrophotometrically 
(2.4.5). In each case 2ug of DNA was used in the transcription 
reaction (2.8.1). 
In vitro translation of recombinant SLT lA transcripts. 
(a) Wheatgerm translation. 
Translation of the recombinant 5LT lA transcripts in a 
wheatgerm translation system allowed the sizes and sensitivity 
to proteolytic cleavage of the rSLT IAs to be examined. 
Following in vitro transcription (2.8.1) of the pGEM2 I rSLT 
IAs each resultant transcript was subjected to in vitro 
translation in a wheatgerm system (2.8.2(i». Resolution of the 
resultant 35S-~ethionine labelled translation products by SDS 
PAGE (2.10.3) on a 15% polyacrylamide gel (reducing conditions) 
followed by their visualisation by autoradiography 
(2.10.3(iii» revealed (FIG 3.3.13) (by comparison with 
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FIG 3.3.13 Sizing of recombinant Shiga-like toxin I A subunits 
(rSLT lAs) by translation in a vheatger. cell free syste •• 
Q lug of each rSLT lA mRNA transcript was translated inAwheatgerm 
cell free system as described (2.8.2(i». Translation products 
were then resolved using a 15% polyacrylamide gel (2.10.3) 
(reducing conditions) and visualised by autoradiography 
(2.10.3(iii». 
1: rSLT lA (wild type) translation product. 
2: rSLT IAl (truncated SLT I - Al alone) translation product. 
3: rSLT IAIA2 (full length SLT IAIA2 - 'protease insensitive') 
translation product. 
MW: molecular weight markers. 
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standard molecular weight (MW) markers) that they were indeed 
the sizes expected for rSLT lA (wild type) (32KDa) (lane 1), 
full length, 'protease insensitive' rSLT IAIA2 (32KDa) (lane 3) 
and truncated rSLT IA1 (AI alone) (27-28KDa) (lane 2). 
In addition to bands of sizes corresponding to those expected 
for each of the rSLT lAs generated ie 32KDa and 27 - 28KDa, a 
smaller translation product is evident in each case. The bands 
seen in lanes 1 and 3 appear to be the same size 
approximately 20KDa; whilst that in lane 2 appears to be 4 - 5 
KDa smaller. This size difference would appear to reflect the 
size difference between the rSLT IAl (AI alone) and rSLT lA 
(wi Id type) and rSLT IA1 A2 (' protease insensi t i ve ') ie 4 -
5KDa. It is suggested that the additional bands may have arisen 
as a result initiation of translation at an internal initiation 
codon. Alternatively they may be C terminal proteolytic 
fragment s genera ted as a resul t of non specific cleavage by 
serine proteases present in wheatgerm lysate. 
In order to determine the sensitivity of the recombinant SLT lA 
translation products, each was incubated with different 
concentrations of trypsin (2.10.2) prior to 
resolution by SDS PAGE (2.10.3) on a 15% polyacrylamide gel 
under reducing conditions. Again the radioactively labelled 
wheatgerm translation products were visualised by 
autoradiography (2.10.3(iii». FIGS 3.3.14 and 3.3.15 show the 
result of incubation of the recombinant SLT lA translation 
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FIG 3.3.14 Examination of the sensitivity to trypsin of 
recombinant Shiga-like toxin I A subunits (rSLT IAs) following 
wheatgerm lysate in vitro translation. 
lug mRNA transcript in each case was translated in wheatgerm 
cell free system as described (2.8.2(i». The resultant 
translation products in each case were then incubated with L-l-
tosylamido-2-phenylethyl chloromethyl ketone treated-trypsin 
(Sigma) (2.10.2) to a final concentration of 20ug/ml or 30ug/ml 
37C for l5min. Products were resolved using a 15% 
polyacrylamide gel (2.10.3) (reducing conditions) and 
visualised by autoradiography (2.l0.3(iii». 
In each case: 
1: non trypsin treated translation product. 
2: 20ug/ml (final concentration) trypsin added. 
3: 30ug/ml (final concentration) trypsin added. 
WT: rSLT lA (wild type). 
AI: rSLT lAI (truncated SLT I - Al alone). 
A1A2 : rSLT 1A1A2 (full length SLT 1AIA2 
insensitive'). 
MW: molecular weight markers. 
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FIG 3.3.15 Examination of the sensitivity of recombinant 
Shiga -like toxin I A subunits (rSLT IAs) to a range of 
concentrations of trypsin following wheatger. lysate in vitro 
translation. 
lug mRNA transcript in each case was translated in wheatgerm 
cell free system as described (2.8.2(i». The translation 
products in each case were then incubated with a range of 
concen trat ions (0 50ug Iml) of 1-!-tosylamido-2-phenylethyl 
chloromethyl ketone treated-trypsin (Sigma) (2.10.2) for 15min. 
Products were resolved using a 15% polyacrylamide gel (2.10.3) 
(reducing condi tions) and visualised by autoradiography 
(2.10.3(iii». 
Lanes 1 - 6 show the result of incubation of the rSLT lA (wild 
type) with 50, 40, 30, 20, 10, Oug/ml trypsin. 
Lane 7 shows the truncated rSLT lA! (AI alone). 
Lanes 8 - 12 show the result of incubation of the full length 
rSLT 1AIA2 ('protease insensitive') with 0, 10, 20, 30, 40 and 
50ug/ml trypsin. 
A1A2 = Full length SLT lA = 32KDa 
Al = 5LT IAl fragment alone = 27KDa 
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products with concentrations of trypsin in a range from 0 -
SOug/ml (FIG 3.3.15) and 0 - 30ug/ml (FIG 3.3.14). 
It may be seen from FIG 3.3.14 that the size of the translation 
product identified as rSLT lAl (Al alone) (27-28KDa) is 
unchanged as a result of incubation with trypsin (lanes 2 and 
3, Al). This resul t sugges ts the successful construction of 
rSLT lAl (Al alone) since it is of the expected size (27-28KDa) 
and unaffected by treatment with a protease such as trypsin. 
Incubation of the rSLT lA (wild type) (32KDa) with trypsin sees 
a reduction in size to that of the truncated Al alone (27-
28KDa) at approximately 30ug/ml trypsin (FIG 3.3.14 lane 3, WT 
and FIG 3.3.15 lane 3). A faint band of this size (27 - 28KDa) 
is also evident however, in lane 1 WT of FIG 3.3.14 - non 
trypsin treated rSLT lA (wild type) translation product. The 
existence of a faint band corresponding to the size of rSLT IAl 
(A1 alone) may again be as a resul t of cleavage of rSLT lA 
(wild type) by serine proteases present in wheatgerm lysate. At 
30ug/ml tryps in (FIG 3.3.14 lane 3WT and higher FIG 3.3.15 
lanes 3 - 1) the 27 - 28KDa (A1 sized band) predominates. This 
indicates that rSLT lA (wild type) is undergoing proteolytic 
cleavage predominately at the proposed cleavage site. 
With regard to the full length rSLT IA1A2 ('protease 
insensitive') (32KDa) a faint Al alone sized band (27 - 28KDa) 
is also evident in non trypsin treated rSLT IA1A2 ('protease 
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insensitive') (FIG 3.3.14 lane 1 AIA2 and FIG 3.3.15 lane 8). 
The intensity of this band is not however, seen to increase in 
intensity at following treatment of the translation product 
with trypsin. At higher trypsin concentrations (40 - 50ug/ml) 
(FIG 3.3.15 lanes 12 and 13) however, an intermediate sized 
fragment approximately 2 3KDa smaller than rSLT IA1A2 
('protease insensitive') (32KDa) is visible. This intermediate 
tY'!At~ 
which is also to be seen following"rSLT I (wild type) with 
30ug/ml trypsin (FIG 3.3.14 lane 3 WT) may have arisen as a 
resul t of proteolytic cleavage of the rSLT IA1 A2 (' protease 
insensitive') and rSLT lA (wild type) at a different arginine 
rich site less sensitive to cleavage by protease. It is 
possible that arginine residues 266 and 268 outside the 
disulphide bonded peptide of SLT lA may represent such a site. 
Cleavage close to these residues would result in a reduction in 
size of the rSLT IA1A2 similar to that seen in lanes 11 and 12 
of FIG 3.3.15. Results seen here do, however, suggest that the 
full length, rSLT IA1A2 ('protease insensitive') construct is 
indeed less sensitive to proteolytic cleavage within the 
proposed cleavage site than is the wild type SLT lA subunit. 
In the present study trypsin is used in vitro to mimic the 
proposed in ~ proteolytic processing of SLT lA by a specific 
intracellular (endosomal) protease. However, it may be 
difficult to mimic these intracellular events precisely using 
relatively crude in vitro methods. For example, native SLT lA 
produced in vivo possesses a disulphide loop between cysteine 
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residues 242 and 261, which is likely to be correctly surface-
exposed to the specific intracellular protease responsible for 
proteolytic processing in vivo. It is unlikely during in vitro 
production of the rSLT IAs in a wheatgerm system, that this 
loop is formed. Results presented here do however, provide an 
indication of preferential cleavage at the proposed sites 
within the rSLT IAs generated. In the absence of microsequence 
data however this cannot be stated unambiguously. 
(b) Reticulocyte lysate translation. 
In vitro translation of the recombinant SLT lA transcripts in a 
reticulocyte lysate system allows the question of RNA N-
glycosidase activity to be addressed. Activity may be examined 
in two ways using this system: 
(i) Examination of the ribosomal RNA (rRNA) following 
translation (2.11.1(ii». rRNA from reticulocyte ribosomes 
endogenous to the reticulocyte lysate translation reaction 
(2.8.2(ii» may be extracted (2.4.1) following translation of a 
potentially toxic transcript and subjected to aniline cleavage 
(2.5.1). Resolution of the resultant rRNA (2.6.1) then reveals 
a characteristic fragment of approximately 390 bases if the 
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translation product did indeed possess RNA N-glycosidase 
activity. 
(ii) Ability of the endogenous ribosomes to translate a second 
messagenger RNA (mRNA) encoding a non-toxic product following 
translation of a transcript encoding a toxic product 
(2.11.1(iii». In other words, an attempt to synthesize a 
second translation product is made. This is not, however, 
possible if the endogenous reticulocyte ribosomes have been 
irreversibly inactivated by the RNA N-glycosidase activity of 
the first translation product. The results of the double 
translation may be examined by SDS PAGE (2.10.3) followed by 
autoradiography (2.10.3(iii». 
It is important to include a control transcript in both 
approaches in order to firmly establish that any depurination 
of the ribosomal RNA (rRNA) is as a direct result of 
translation of a product with RNA N-glycosidase activity. Thus 
in approach (ii), the inability to translate a second 
transcript may be determined as being a direct result of 
translation of the first transcript leading to depurination of 
the reticulocyte ribosomes. Lysozyme was chosen as the control 
transcript. It is a translation product which is not capable of 
inac ti va ting the re ticulocyte ribosomes. In addi tion it 
provides a second trans la tion product (14KDa) which may be 
easily distinguished by SDS PAGE (2.10.3) and autoradiography 
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(2.10.3(iii)) from the initial translation products, the rSLT 
IAs, which range in size from 27-32KDa. 
In vitro transcription and translation of the plasmid pTK2Lys 
(Drummond et al. 1985) resulted in the non toxic control 
translation product lysozyme. 
FIG 3.3.16 shows the extracted and aniline treated rRNA of the 
reticulocyte ribosomes following translation of the rSLT lA 
transcripts. 
The appearance of the characteristic 390 base rRNA fragment 
released following aniline cleavage of depurinated rRNA (lanes 
1, 2 and 3) indicates that all three of the rSLT IAs 
constructed possess RNA N-glycosidase activity. 
FIG 3.3.17 demons trates the inabili ty of reticulocyte 
ribosomes to translate a second transcript ie pTK2Lys after 
having first translated the rSLT lA transcripts. The pTK2Lys 
translation product, lysozyme (14KDa) (L) is clearly visible in 
lanes 1 and 2, the latter of which is the result of translation 
of the pTK2Lys transcipt alone. The translation products seen 
in lane 1 are as a result of translation of yeast preproalpha 
factor mRNA - a non toxic product (0() of 18.6KDa (May et al. 
1989) followed by translation of the pTK2Lys mRNA. The 
reduction in the amount of the second translation product, 
lysozyme would suggest a reduction in efficiency of the 
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FIG 3.3.16 Extraction and aniline cleavage of rabbit 
reticulocyte ribosomal RNA following in vitro translation of 
recombinant Shiga-like toxin I A transcripts. 
lug of each recombinant Shiga-like toxin I A subunit (rSLT lA) 
transcript was translated in vi tro using rabbi t reticulocyte 
lysate (non nuclease treated) (Promega) (2.11.1(ii». The 
ribosomal RNA (rRNA) was then extracted (2.4.1) and subjected 
to aniline cleavage (2.5.1). The resultant rRNA was then 
fractionated by gel electrophoresis and visualised by staining 
the gel with ethidium bromide (2.6.1). 
Lane 1: reticulocyte rRNA resulting from translation of rSLT lA 
(wild type). 
Lane 2: re ticulocyte rRNA resul ting from transla tion of rSLT 
IAl (AI alone). 
Lane 3: reticulocyte rRNA resulting from translation of rSLT 
1AIA2 ('protease insensitive'). 
Lane 4: non aniline treated extracted reticulocyte rRNA. 
+ indicates treatment of rRNA with aniline reagent . 
.... indicates the characteristic fragment released following 
aniline cleavage of toxin-modified rRNA. 
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FIG 3.3.17 Examination of the ability of reticulocyte 
ribosomes to translate a second transcript folloving 
translation of recollbinant Shiga - like toxin I A subunlt 
transcripts. 
lug of each recombinant Shiga-like toxin I A subunit (rSLT lA) 
transcript was transla ted in vi tro using rabbi t re ticulocyte 
o lysate (Promega) (Z.11.1(iii» for 1 hour at 30C. lug of a 
second transcript encoding a non toxic transcript, in this case 
lysozyme (approx 14KDa) (Drummond et ~. 1985) was then added 
o 
and incubated for a further 1 hour at 37C. lug of messenger RNA 
(mRNA) encoding yeast preproalpha factor (May et al. 1989) a 
further non toxic product, was used as a control primary 
translation. The translation products were resolved by SDS 
polyacrylamide gel electrophoresis (SDS PAGE) (Z.10.3) 
(reducing conditions) using a 15% polyacrylamide gel and 
visualised by autoradiography (2.10.3(ii1). 
Lane 1: Yeast preproalpha factor + lysozyme 
Lane 2: Lysozyme alone 
Lane 3: rSLT lA1AZ ('protease insensitive') + lysozyme 
Lane 4: rSLT lA1 (AI alone) + lysozyme 
Lane 5: rSLT lA (wild type) + lysozyme 
AIA2 = full length SLT lA = 3ZKDa. 
Al = truncated SLT lA (AI alone) = 27KDa. 
L: lysozyme 
cx: yeast preproalpha factor 
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reticulocyte system in translation of a second mRNA. It is 
possible that this may be as a result of depletion of energy 
or amino acids following efficient translation of the first 
mRNA. In both lanes 1 and 2 a band indicating a translation 
product of approximately 31KDa may be seen, although this is 
much less evident in lane 1. The origin of this band is 
unknown. 
In lanes 3, 4 and 5 the rSLT lA translation products are 
clearly visible. There is a disinct lack of the second 
translation product, lysozyme (L). Again, as with the results 
seen in FIG 3.3.16, this would appear to suggest that the rSLT 
IAs constructed in this study all possess RNA N-g1ycosidase 
activity. 
A band corresponding to the size of rSLT IA1 (AI alone) - 27 
28KDa is again to be seen in lanes 5 rSLT lA (wild type) and 3 
(rSLT IAlA2 ('protease insensitive'» of FIG 3.3.17 as was also 
the case in FIG 3.3.14 (lanes 3 WT and 3 Al AZ). Again this 
suggests cleavage of the rSLT IAs by serine pro teases present 
in reticulocyte lysate. The Al size band in lane 3 (FIG 3.3.17) 
in lane 5. is much less evident than the corresponding band 
This adds to the suggestion that the rSLT IA1A2 ('protease 
proteolytic 
(wild type). 
insensitive') 
cleavage in 
has a reduced 
comparison to 
susceptibility 
that of rSLT lA 
to 
Alternatively the smaller rSLT lA bands seen may represent 
products of internal initiation of translation. 
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Interestingly, the various rSLT lA forms can be visualised in a 
re ticulocyte 1ysa te trans1a tion. This contras ts wi th ricin A 
subunit (RA) which can rarely be seen when RNA is translated in 
this system. It is possible that this indicates a greater 
senstivity of reticulocyte ribosomes to RA than to SLT lA. 
It may be concluded from the above results therefore, that all 
of the recombinant SLT lA constructs exhibit RNA N-glycosidase 
activity. The assays described however, do not allow any 
accurate quantification of enzymatic activities. 
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SECTION 3.3.2 In vivo expression of the recombinant Shiga-like 
toxin I A subunits. 
Introduction 
In vivo expression of the recombinant Shiga-like toxin I A 
subunits (rSLT IAs) in Escherichia coli ultimately allowed the 
activities of the constructs to be examined in more detail. In 
vivo expression was also conducive to larger scale production 
of the rSLT IAs, a process which would eventually allow 
production of purified rSLT lA containing ho10toxins. In this 
way the effect of the SLT lA A2 peptide on the cytotoxic nature 
of the holotoxin could be addressed by comparing the 
cytotoxicities of recombinant, full length SLT IA1A2 ('protease 
insensitive')- and the recombinant, truncated SLT IA1 ( A1 
alone)-containing holotoxins with that of the recombinant, wild 
type SLT lA-containing holotoxin. 
Results and Discussion 
Using plasmid pSC25 (FIG 3.3.5) Hovde .!! a1. (1988), excised 
the SLT lA DNA as a Pst I / Eco RI fragment, carried out the 
required mutagenesis for their study and substituted the 
mutated Pst I / Eco RI fragment back into pSC25 for in vivo 
expression in E.co1i. Expression was achieved using the 
inducible lac promoter. Since Hovde et a1. (1988) had 
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recombinant SLT lA in this way, it was decided that a similar 
strategy would also be employed for the in vivo expression of 
the rSLT IAs generated in the present study. 
Generation of the pSC25 derivative plasmids. 
(a) Construction of pSC25A1 (FIG 3.3.18). 
A fragment of 990bp was excised (2.5.3) from the 
M13mp18X / SLT IA1 RF DNA (FIG 3.3.8) as a Pst I / Eco RI 
fragment thus releasing the mutant SLT IA1 subunit. This was 
then ligated (2.5.5) into pSC25 (FIG 3.3.5) which had also been 
restricted (2.5.3) using Pst I / Eco RI and gel purified 
(2.4.4). The resultant pSC25 / rSLT lA! DNA was used to 
transform E.coli strain JM101 (2.7.2). The requirement for 
screening of transformants to de termine fragment orienta tion 
had been eliminated by forced orientation cloning of the rSLT 
lA! fragment into pSC25, they were, however, screened for 
possession of the mutation required for generation of the SLT 
lA subuni t Al alone by dideoxy sequencing of the plasmid DNA 
(2.5.8(ii». Large scale preparation (2.4.2(ii» of pSC25A1 
(FIG 3.3.18) was then carried out in order to yield purified 
plasmid DNA. 
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pSC25Al 
(3752 bP) 
FIG 3.3.18 Plasmid pSC25Al • 
Derived from plasmid pSC25 (FIG 3.3.5) which was kindly donated 
by Or S Calderwood (Boston, USA). The plasmid contains the DNA 
for the recombinant, truncated, Shiga-like toxin I A subunit 
(rSLT IA1 (AI alone» under transcriptional control of the lacZ 
promoter (Hovde ~ al. (1988). In order to generate pSC25A1 a 
Pst I / Eco RI fragment of approximately 990 base pairs 
encoding the rSLT lAI (AI alone) DNA was ligated (2.5.5) with 
similarly restricted pSC25 (FIG 3.3.5). 
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(b) Construction of pSC25A1A2 (FIG 3.3.19). 
Genera tion of pSC25A1 A2 (FIG 3.3.19 ) involved the excision 
(2.5.3) of an 1150bp Pst I / Eco RI fragment from the M13mp18X 
/ SLT IAl A2 RF DNA (FIG 3.3.18) which carried the correc t 
mutation for generation of the full length, protease 
insensitive rSLT IAIA2. This was then ligated (2.5.5» into 
~ I / Eco RI restricted (2.5.3) and gel purified (2.4.4) 
pSC25 (FIG 3.3.5). 
Transformation of the ligated DNA in E.coli strain JMIOl 
(2.7.3) and dideoxy sequencing of resultant plasmid DNA 
(2.5.8 (ii» in order to de termine possess ion of the required 
rSLT lA DNA fragment followed by large scale preparation of the 
plasmid DNA was as described for construction of pSC25A1 • 
Each of the pSC25 derivatives {pSC25Al {FIG 3.3.18)and 
pSC25AI A2 (FIG 3.3.19) plus pSC25 (FIG 3.3.5) expressing the 
wild type SLT lA were used to transform E.coli strain JM101 
(2.7.2) in readiness for expression in vivo (2.9). IPTG induced 
expression of pSC25 (FIG 3.3.5) , pSC2SA1 (FIG 3.3.18) and 
pSC25A1A2 (FIG 3.3.19) was carried out exactly as described 
by Hovde ~ al. (1988) in expression of SLT lA glutamic acid 
(Glu) 167 mutant ( Asp l67). 
222 
~C25A A2 (3800~) 
Sph' 
FIG 3.3.19 Plasmid pSC25A1AZ-
Eco RI 1150 
I 
Derived from plasmid pSC25 (FIG 3.3.5) which was kindly donated 
by Dr S Calderwood (Boston, USA). The plasmid contains the DNA 
for the recombinant, full length, 'protease insensitive' Shiga-
like toxin I A subunit {rSLT IA1AZ (protease insensitive») 
under transcriptional control of the lacZ promoter (Hovde et 
al. (1988). In order to genera te pSC25A1 AZ a Ps t I / Eco RI 
fragment of approximately 1150 base pairs encoding the rStT lA 
(protease insensitive) DNA was ligated (2.5.5) with similarly 
restricted pSC25 (FIG 3.3.5). 
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The SLT lA and SLT lB subunits each possess a signal peptide 
which causes them to be transported to the periplasm where 
assembly of the holotoxin takes place as is the case wi th 
E.coli heat labile toxin (LT). Hovde et al. (1988) prepared a 
periplasmic extract of recombinant SLT lA by incubation of the 
re suI tant cell pelle t wi th polymyxin B (Griffin and Gemski, 
1983 ). Osmotic release of the contents of periplasm (2.9.1) 
was however, the method chosen for preparation of periplasmic 
extracts in this particular study. 
Successful expression of rSLT lA (wild type), rSLT lAl (AI 
alone) and rSLT IAl A2 (' protease insensi ti ve') was determined 
by assay of the respective periplasmic extracts for RNA N-
glycosidase activity. This was determined by incubation of a 
small amount of each periplasmic extract with yeast ribosomes 
(2.11.1) with the addition of vanadyl ribonuclease complex 
(VRC) to a final concentra tion of 2mM, in order to inhibi t 
random degradation of the ribosomal RNA (rRNA) by ribonucleases 
indigenous to the periplasmic extracts. 
FIG 3.3.20 shows the resultant yeast rRNA following its 
extaction (2.4.1), treatment with aniline reagent (2.5.1) and 
resolution by denaturing gel electrophoresis (2.6.1). The 
presence of the characteristic fragment released by aniline 
cleavage of depurinated rRNA (lanes 2, 3 and 4) indicates the 
successful in vivo expression of biologically active rSLT IAs 
224 
FIG 3.3.20 Examination of in vivo produced recombinant Shiga-
like toxin I A subunits for RNA N-glycosidase activity. 
10ul of each recombinant Shiga-like toxin I A subuni t (rSLT 
lA) -containing per iplasmic extract was incuba ted wi th 30ug 
yeast ribosomes for 20min at 30°C (2.11.1(i». In order to 
reduce non specific degradation of ribosomal RNA (rRNA) vanadyl 
ribonucleoside complex (VRC) was also included at this stage 
(2mM final concentration). Prior to incubation with the 
ribosomes each of the extracts was preincubated with 2-
mercaptoethanol to a final concentration of 6mM to ensure 
maximum activity of any SLT lA present. The resultant rRNA was 
then extracted (2.4.1) and subjected to aniline cleavage 
(2.5.1) • The resul tant rRNA was then fract iona ted and 
visualised (2.6.1). 
Lane 1 = positive control: rRNA resulting from incubation with 
pure 5LT I. 
Lanes 2, 3 and 4: rRNA following incubation with rSLT lA (wild 
type), rSLT lA1 (AI alone) and rSLT lA1 A2 ( 'protease 
insensitive') respectively. 
+ indicates treatment of rRNA with aniline reagent. 
indicates non treatment of extracted rRNA with aniline 
reagent. 
~indicates the characteristic fragment released following 
aniline cleavage of toxin-modified rRNA. 
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since the same fragment is also seen to occur (lane 1) 
following modication of the rRNA by pure SLT I. 
It was noticed during the culturing of E.coli JM101 expressing 
each of the rSLT IAs that those expressing the rSLT IA1 (AI 
alone) appeared to grow more slowly in comparison to those 
expressing rSLT lA (wild type) and rSLT IA1A2 (protease 
insensitive). Slow growth of E.coli had also been observed by 
others in expression of Type I ribosome inactivating proteins 
such as those which are now known to be capable of inactivating 
E.coli ribosomes eg dianthins 30 and 32 and pokeweed antiviral 
proteins (Hartley ~ al. 1991). Thus we might propose tha t a 
possible role for the SLT lA A2 peptide might be to protect 
homologous ribosomes from depurination during production of 
this E. col i-produced toxin. In order to examine this 
possibili ty, the RNA N-glycosidase acti vi ty of rSLT lAl (AI 
alone) on E.coli ribosomes was examined. 
rSLT IA1 (AI alone)-containing periplasmic extract was 
incubated with E.coli ribosomes (2.11.1) plus VRC (in order to 
eliminate unwanted ribonuclease degradation of the rRNA) the 
rRNA extracted (2.4.1) treated with aniline reagent (2.5.1) and 
examined by gel electrophoresis (2.6.1). FIG 3.3.21 shows the 
resultant RNA gel comparing non aniline treated E.coli rRNA, 
E. coli rRNA following incubation wi th pure SLT I and aniline 
treatment (lane 1) and E.coli rRNA following incubation with 
rSLT lAl (AI alone). No characteristic aniline-released 
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FIG 3.3.21 Investigation of the activity of recombinant. 
truncated Shiga - like toxin I A subunit (A1 alone) on 
Escherichia coli ribosomes. 
10ul of periplasmic extract (2.9.1) containing recombinant, 
truncated Shiga-like toxin I A subunit (rSLT IA1 (AI alone) 
previously shown to exhibi t RNA N-gIycosidase ac ti vi ty (FIG 
3.3.20), was incubated with 30ug Escherichia coli ribosomes for 
20min at 30·C (2.11.1 (i». This followed preincuba tion of the 
extract with 2-mercaptoethanol to a final concentration of 6mM 
to ensure maximum activity of any SLT I present. The resultant 
ribosomal RNA (rRNA) was then extracted (2.4.1) and subjected 
to aniline cleavage (2.5.1). Fractionation and visualisation of 
the resultant rRNA was then carried out (2.6.1). 
Lane 1 shows E.coli rRNA following incubation with pure SLT I. 
Lane 2 shows E.coli rRNA following incubation with rSLT lA1 (AI 
alone). 
+ indicates treatment of rRNA with aniline reagent. 
- indicates that following incubation with toxin and extraction 
the rRNA was not subjected to aniline cleavage. 
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fragment is visible indicating that, as is the case with pure 
SLT lA, (Chapter 2 SECTION 3.2.2), rSLT IAl (At alone) is 
inactive on E.coli ribosomes. 
Although successful expression of biologically active r5LT IAs 
was achieved, it was found that expression of r5LT IA1 (Al 
alone) was either at very low levels only or that it was 
retrievable only at very low levels. The latter of which may be 
attributable to a reduction in stability of the recombinant 
protein often associated with truncated proteins. Attempts were 
made to increase the level of expression of rSLT IAI (AI) by 
cloning the r5LT IAI (At) DNA into the high level expression 
vector pKK223.3 (Pharmacia). This vector has been used 
successfully by several members of our laboratory. In order to 
achieve such cloning it was necessary via polymerase chain 
reaction (peR) to generate a r5LT IAI (Al) DNA fragment 
possessing suitable restriction sites. A suitable fragment was 
generated, however successful ligation (2.5.5) with the 
pKK223.3 vector was never achieved. Unfortunately time did not 
permit further attempts to reclone or resolve the PCR problems 
encountered. 
It was decided that studies into the role of the 5LT lA2 
peptide in both the RNA N-glycosidase activity of 5LT lA and 
its association with the SLT IB pentamer could be suitably 
examined using the two remaining r5LT lAs constructed. Thus 
attention, as will be seen in subsequent chapters, was focus sed 
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upon the expression, purification and ultimately the 
cytotoxicies and in vitro activities of rSLT lA (wild type) 
and rSLT lA1A2 ('protease insensitive') in order to elucidate 
the consequences of an in tac t, non cleavable A2 peptide on 
enzymatic activity and cytotoxicity. 
231 
Conclusion - Chapter 3 
Recombinant Shiga-like toxin I A subunits (rSLT IAs) have been 
constructed for the purpose of studying any involvement of the 
A2 peptide in the RNA N-glycosidase activity and cytotoxicity 
of of the SLT I. Results presented here serve to demonstrate 
the successful production of rSLT IAs, which are of expected 
size and which possess RNA N-glycosidase activity following 
expression in both in vitro and in vivo systems. In addition, 
the requirement for a recombinant SLT lA subunit with reduced 
sensitivity to proteolytic cleavage has also been met. 
Unfortunately the expression level of rSLT lA (Al ) alone) in 
.coli was too low to permit further analysis (data not shown). 
As will be seen in subsequent chapters, the development of a 
successful purification scheme serves to allow a closer, more 
quantitative examination of the cytotoxicity of the 'non 
cleavable' rSLT lAlA2 ('p'rotease insensitive') when 
reassociated with Shiga-like toxin I B subunit (SLT IB). This 
also allows the enzymatic activity of an unnickable SLT lA 
subunit (rSLT IAlA2 ('protease insensitive'» to be examined 
and compared with a wild type SLT lA subunit. 
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SECTION 3.4.1 Purification of the Shiga-like toxin I B 8ubunit 
(SLT IB). 
Introduction 
Several unsuccessful attempts to raise antisera to gel eluted 
SLT lA subunit in both rabbits and rats made it necessary to 
search for an alternative method by which recombinant Shiga-
like toxin r A subunits (rSLT rAs) could be purified to 
homogeneity. The original strategy had proposed purification of 
the rSLT IAs via anti SLT lA affini ty chroma tography. Once 
purified their relative RNA N-glycosidase activities could be 
determined and, by reassociation with purified Shiga-like toxin 
I B subunit (SLT IB), their relative cytotoxicities could also 
be determined. 
Weinstein et al. (1989), in production of hybrid Shiga toxin 
(ST) / SLT I / SLT 11 molecules, had successfully coexpressed A 
and B subunits each encoded by separate compatible plasmids 
wi th individual selective markers. Coexpression resul ted in a 
cytotoxic product. The relevant plasmids - pDLlVl01 (Weinstein 
et al. 1989) encoding SLT lA and pJN26 (Newland et al. 1985) 
encoding SLT lB, were kindly provided by Dr C. Schmitt 
(Bethesda HD). The intention was to substitute rSLT IAs into 
pDLW101 and to coexpress them with SLT lB in order to produce a 
mutant holotoxin. This could then be purified to homogenei ty 
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exploiting the highly specific binding of SLT IB to globotriose 
(Gb 3 ) via the method decribed by Ryd et al. (1989) in 
purification of the naturally occuring ho1otoxin. However, 
logistics prevented this approach, since coexpression would 
have required Category III containment; a facility which could 
not reliably be provided. 
Several groups (Ito et al. 1988, Donohue-Rolfe !:l al. 1989), 
had reported the successful reassociation of ST / SLT 1 / SLT 
11 A subunits with ST I SLT I I SLT 11 B subunits by mixing of 
the separate subunits together, reSUlting in the production of 
a cytotoxic product. In addition Takeda et al. (1981) had 
successfully demonstrated the association in vitro of the 
separated A and B subunits of cholera toxin (CT) and 
Escherichia coli heat labile toxin (LT) to generate 
biologically active, hybrid toxins. Again this was achieved by 
a simple mixing together of the relevant subunits. 
Ito et al. (1988) had examined the formation of SLT I I SLT 11 
hybrid molecule. This was achieved by mixing together the 
required combination of propionic acid treated, high 
performance liquid chromatography (HPLC) separated A and B 
subunits and dialysing for 16 hours in order to remove the 
denaturant. Product cytotoxicity was determined using Vera 
cells. 
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Donohue-Rolfe et al. (1989) successfully reassociated ST 
subunits which had undergone denaturation and chromatographic 
separation. If both subunits were still in a denatured state 
they were mixed together and dialysed for 36 hours prior to 
testing for cytotoxic product. If, however, both subunits had 
been renatured, they were simply mixed together and assayed for 
cytotoxicity immediately. Both procedures gave a cytotoxic 
product. 
It was therefore decided that a similar approach would be taken 
in order to purify the rSLT IAs. In each case an excess of 
pure SLT IB would be mixed with perip1asm containing each of 
the expressed rSLT IAs in the hope that reassociation would 
take place. The reassociated mutant holotoxins would then be 
purified by exploitation of the binding affinity of SLT IB for 
the Gb3 molecule as described by Ryd ~ al. (1989). 
In order to achieve this, production and purification of SLT IB 
was first necessary. 
Results and Discussion 
Dr S Calderwood (Boston USA) kindly provided pSBC32 (Calderwood 
et al. 1990) (FIG 3.4.1), a vector capable of high level 
expression of SLT lB. 
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pS8C32 
I1 Nco I 
~TGt .. ·· 
Nco I/Sspl 
·----SlT lA DNA 
FIG 3.4.1 Plasmid pSBC32. 
Kindly donated by Dr S Calderwood (Boston, USA), pSBC32 encodes 
the Shiga like toxin I B subunit (SLT IB) under control of the 
trc promoter of pKK233.2 (Calderwood et al. 1990). 
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A cuI ture of E. coli JM105 carrying pSBC32 was grown up and 
expression induced with IPTG exactly as detailed by Calderwood 
et al. (1990). Preparation of a periplasmic extract was 
achieved by osmotic shock (2.9.1) as opposed to incubation of 
the culture with polymyxin B sulphate used by Calderwood. 
Osmotic shock preparation of periplasm reduced the production 
time of SLT IB by 24 hours. This resulted from there being no. 
requirement for the removal of the polymyxin B from the 
periplasm preparation prior to the purification. Such removal 
would normally require an overnight dialysis step. 
The periplasm preparation resulting from osmotic shock was 
applied to the Gb 3-Fractogel column (Biocarb) immediately and 
following washing of the column with phosphate buffered saline 
pH7.2 (PBS) the bound SLT IB was eluted using 6M guanidine HCl 
pH6.7 as described by Ryd et al. 1989 for elution of ST. 
Following overnight dialysis to remove guanidine HCI from the 
resul tant fractions, they were analysed by SDS polyacrylamide 
gel electrophoresis (SDS PAGE) against pure SLT I and 
periplasmic extracts (FIG 3.4.2). Fractions 1 and 2 (lanes 3 
and 4 respectively) may be seen to contain a band which 
migrates to the same point as the B subunit of the purified SLT 
I control (lane 1). 
Protein determination by the Bio-Rad (2.10.1) procedure 
revealed a SLT IB concentration of 2mg I ml which could 
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FIG 3.4.2 Purification of Shiga-like toxin I B subunit (SLT 
IB). 
A periplasmic extract of E.coli JM105 expressing plasmid pSBC32 
(FIG 3.4.1) encoding SLT IB, was prepared (2.9.1). This was 
applied to a globotriosylceramide (Gb3 ) column allowing a 
single step purification of SLT IB by exploitation of the high 
specificity binding of SLT IB to the Gb 3 molecule. Elution of 
the bound SLT IB was achieved wi th guanidine hydrochloride 
(2.12). The elution products were then analysed by SDS 
polyacrylamide gel electrophoresis (SDS PAGE) (2.10.3) on a 15% 
gel (reducing condi tions) in comparison wi th purified SLT I 
holotoxin and the pre-column periplasmic extracts. The resolved 
proteins were visualised by Coomassie staining (2~10.3(i» of 
the gel. 
1: Pure Shiga-like toxin I (approx. 4ug). 
2: E.coli JM105 + pSBC32 (FIG 3.4.1) periplasmic extract. 
3: Gb 3 column fraction 1. 
4: Gb 3 column fraction 2. 
Hll: molecular weight markers. 
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then be used in order to attempt purification of the 
recombinant SLT lA subunits. 
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SECTION 3.4.2 Reassociation of reco.binant wild type Shiga-
like toxin I A subunit and full length, 'protease insensitive' 
Shiga-like toxin I A subunit with Shiga-like toxin I B subunit. 
Introduction 
Reassociation of the recombinant, wild type Shiga-like toxin I 
A subunit (rSLT lA (wild type» and recombinant, full length, 
'protease insensitive' Shiga-like toxin I A subunit (rSLT IA1A2 
protease insensitive) with purified Shiga -like toxin I B 
subunit (SLT IB) was achieved using the simple but successful 
method described by Ito et al. (1988) and Donohue-Rolfe et al. 
-- --
(1989) of simply mixing the component subunits together and 
testing for product cytotoxicity. 
Results and Discussion 
In this study only the SLT IB subuni t prepara tion was of a 
known concentra tion as determined by Bio-Rad Assay (2.10.1) 
SECTION 3.4.1. In both rSLT lA (wild type) and rSLT IA1A2 
('protease insensitive') periplasm preparations (2.9.1) (each a 
lml preparation resulting from a lL culture), the concentration 
of rSLT lA (wild type) or rSLT IAIA2 (protease insensitive) 
respectively was unknown. 
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To SOOul of each periplasm extract was added an excess 
(approximately 200ug) of purified SLT lB subuni t plus phenyl 
methyl sulphonyl fluoride (PMSF) to a final concentration of 
lmM in order to inhibi t the action of contamina ting serine 
o proteases. The mixture was mixed overnight at 4C in order to 
promote reassociation of the SLT I subunits. 
The resultant mixture was then applied directly to the 1ml Gb 3-
Fractogel column (Biocarb) in order to allow purification of 
any reassocia ted product and free SLT lB. In each case the 
column was washed with phosphate buffered saline (PBS) pH7.2 in 
order to remove any unbound proteins and bound product was 
eluted using 6M guanidine HCL as described by Ryd et al. (1989) 
in purification of Shiga toxin (ST). 
Following overnight dialysis against PBS to remove guanidine 
Hel from the resultant fractions analysis was by SDS 
polyacrylamide gel electrophoresis (SDS PAGE) (2.10.3). FIG 
3.4.3 shows the resultant purified rSLT lA (wild type) 
containing holotoxin (lane 2) in comparison to purified SLT lB 
(lane 1), pure SLT I (lane 3) and periplasmic extracts 
containing rSLT lA (wild type) with added SLT lB (lane 4). 
FIG 3.4.4 shows the resultant purified reassociated rSLT IA1A2 
('protease insensi ti ve') containing holotoxin (lane 1) in 
comparison with pure SLT I (lane 2). 
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FIG 3.4.3 151 SDS polyacrylamide gel showing the stages in 
purification of the reassociated wild type recombinant Shiga-
like toxin I A subunit {rSLT lA (wild type) containing 
holotoxin. 
1ml of a periplasm preparation (2.9.1) containing an unknown 
concentration of wild type recombinant Shiga-like toxin I A 
subunit (rSLT lA (wild type», was mixed with approximately 
200ug of purified Shiga like toxin I B subunit (SLT IB) (2.13) 
with the addition of phenyl methyl sulphonyl fluoride (PMSF) to 
a concentration of 1mM. Following overnight mixing at 4C the 
mixture was applied to the globotriose (Gb3)-Fractogel column 
(Biocarb) used in the purification of SLT I (Chapter 1). Bound 
products were eluted using GM guanidine Hel pHG.7 as described 
by Ryd ~!!.l. (1989) in the purification of Shiga toxin (ST). 
Products were resolved using a 15% polyacrylamide gel and 
visualised by silver staining (2.10.3(i1». 
Lane 1 = purified SLT IB 
Lane 2 = purified reassociated rSLT lA (wild type) containing 
holotoxin 
Lane 3 = purified SLT I 
Lane 4 = periplasm proteins containing rSLT lA (wild type) 
Lane 5 = molecular weight markers 
A and B represent SLT lA and SLT IB respectively. 
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FIG 3.4.4 15% SDS polyacrylamide gel shoving purified 
reassociated full length, 'protease insensitive' recombinant 
Shiga - like toxin I A subunit (rSLT 1AlA2 ('protease 
insensitive'» containing holotoxin. 
An overnight mixing at 4C of lml of a periplasm preparation 
(2.9.1) containing an unknown concentration of full length, 
protease insensitive recombinant Shiga-like toxin I A subunit 
(rSLT IA1A2 (protease insensitive» with approximately 200ug of 
purified Shiga-like toxin I B subunit (SLT IB) (2.13) was 
followed by application of the mixture to the globotriose 
( Gb3)-Fractogel column (Biocarb) used in the purification of 
SLT I (Chapter 1). Eluted of affinity bound products was 
achieved using 6M guanidine HCl pH6.7 (Ryd et al. 1989). 
Resultant fractions were resolved using a 15% polyacrylamide 
gel and visualised by silver staining (2.10.3(ii». 
Lane 1 = purified reassociated rSLT IA1A2 ('protease 
insensitive') containing holotoxin 
Lane 2 = purified SLT I 
A and B represent SLT lA and SLT IB respectively. 
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In each case it may be seen that an excess of SLT IB subunit is 
present in each prepara tion. For this reason quanti ta tion of 
rSLT lA (wild type) or rSLT IAl AZ (' protease insensi ti ve' ) 
respectively was determined by densitometry in comparison to 
aliquots of SLT lA subunit of known amount. This was achieved 
by SDS polyacrylamide gel electrophoresis (SDS PAGE) (reducing 
conditions) of three equal aliquots of each rSLT lA-containing 
holotoxin and a range of known quantities of native SLT I (0.05 
0.3ug). The resultant gel was then silver stained 
(Z.10.3(ii», scanned using a Molecular Dynamics computing 
densitometer and analysed using the volume integration package. 
A 'sum above background' value was determined for each SLT lA 
and rSLT lA band. A standard curve for native SLT lA was then 
plo t ted (FIG 3.4.5). An average 'sum above background' value 
was obtained from the three readings obtained for each of the 
rSLT IAs. By comparison of this value to those of native SLT lA 
it was possible to determine the concentration of rSLT lA in 
each reassociated holotoxin. FIG 3.4.5 shows the standard curve 
derived for known amounts of SLT lA and the derivation of rSLT 
lA concentrations from this. 
It should be noted that in each case prior to purification of 
the reassociated holotoxins using the Gb 3-Fractogel column 
(Biocarb), the column was thoroughly 'cleansed' of any residual 
bound SLT I. This was achieved using 6M guanidine HCI pH6.7 and 
PBS. Prior to each purification of reassociated holotoxin, 7 -
8 lml guanidine HCI fractions were collected from the column 
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FIG 3.4.5 Determination of the concentration of each rSLT lA • 
In each case three equal aliquots of lOOul of rSLT IA-
containing holotoxin were resolved by SDS polyacrylamide gel 
electrophoresis (SDS PAGE) (2.10.3) (reducing conditions). In 
addition a range of known quantities (0.05 - 0.3ug) of native 
SLT lA were also subjected to SDS PAGE. The resultant gel was 
silver stained (2.10.3(ii», scanned and analysed using a 
Molecular Dynamics computing densitometer and its volume 
integration package. A 'sum above background' value was found 
for each SLT lA and rSLT IA gel band. Those values obtained for 
native SLT lA were then plotted against amount of SLT lA (ug) 
to generate a standard curve. An average value was determined 
from the 'sum above background' values determined for each rSLT 
IA. By comparison to the standard curve it was possible to 
determine the amount of rSLT lA in each lOOul aliquot of rSLT 
lA-containing holotoxin and hence the concentration. 
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and analysed for the presence of SLT I by (i) abili ty to 
depurinate yeast ribosomes (2.11.1(i» (FIGS 3.4.6A and 3.4.6B) 
and (ii) SDS PAGE (2.10.3) (FIG 3.4.7). 
FIGS 3.4.6A and 3.4.6B demonstrate the lack of any biological 
activity in 'clean' column fractions eluted prior to 
purification of reassociated rSLT lA (wild type) and rSLT IAIA2 
(protease insensi ti ve) containing holotoxins respec tively. In 
both cases there would appear to be no evidence of residual, 
biologically active SLT I in any of the eluted fractions as 
indicated by the lack of the characteristic aniline-released 
rRNA fragment (lanes 2 8 FIG 3.4.6A) (lanes 1 7 FIG 
3.4.6B). 
SDS PAGE analysis of 'clean' column fractions (FIG 3.4.7) prior 
to purification of reassociated rSLT lAIA2 ('protease 
insensitive') containing holotoxin also reveals a distinct lack 
of any residual SLT I (lanes 2 - 8) in comparison with purified 
rSLT lA (wild type) containing holotoxin (lane 1). 
The results of this 'cleaning' procedure serve to demonstrate 
that this method of column regeneration leaves no detectable 
residual SLT I bound to the column. Thus any purified product 
detected in the above purification of reassociated 
rSLT lA-containing holotoxin is just that. 
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FIG 3.4.6B Aniline assay to detect residual Shiga-like toxin I 
(SLT I) RNA N-glycosidase activity in Gb3-Fractogel column 
fractions following column regeneration prior to use in the 
purification of reassociated recombinant full length, protease 
insensitive Shiga-like toxin I A subunit containing holotoxin. 
10u1 of each lm1 fraction eluted from the globotriose (Gb3)-
Fractogel column (Biocarb) (using 6M guanidine HCl pH6.7) was 
incubated with 30ug yeast ribosomes at 30C for 20min (2.11(i». 
The ribosomal RNA (rRNA) was then extracted (2.4.1) and 
subjected to aniline cleavage (2.5.1). The resultant rRNA was 
then fractionated by gel electrophoresis and visualised by 
staining with ethidium bromide (2.6.1). 
Lanes 1 - 7 = rRNA following incubation of yeast ribosomes with 
Gb3-Fractogel column fractions 1 - 7. 
Lane 8 - positive control. Resultant rRNA following incubation 
of yeast ribosomes with pure SLT I. 
Lane 9 non aniline treated, SLT I modified yeast rRNA. 
+ indicates treatment of yeast rRNA with aniline reagent. 
~indicates characteristic fragment released following aniline 
treatment of depurinated rRNA. 
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FIG 3.4.6A Aniline assay to detect residual Shiga-like toxin I 
(SLT I) RNA N-glycosidase activity in Gb3-Fractogel column 
fractions following column regeneration prior to use in the 
purification of reassociated recombinant wild type Shiga-like 
toxin I A subunit containing holotoxin. 
10ul of each lml fraction eluted from the globotriose (Gb3)-
Fractogel column (Biocarb) (using GM guanidine HCl pH6.7) was 
incubated with 30ug yeast ribosomes at 30C for 20min (2.11(i». 
The ribosomal RNA (rRNA) was then extracted (2.4.1) and 
subjected to aniline cleavage (2.5.1). The resultant rRNA was 
then fractionated by gel electrophoresis and visualised by 
staining with ethidium bromide (2.6.1). 
Lane 1 = positive control. Resultant rRNA following incubation 
of yeast ribosomes with pure SLT I. 
Lanes 2 - 8 = rRNA following incubation of yeast ribosomes with 
Gb3-Fractogel column fractions 1 - 7. 
+ indicates treatment of yeast rRNA with aniline reagent. 
~indicates characteristic fragment released following aniline 
treatment of depurinated rRNA. 
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FIG 3.4.7 SDS polyacrylamide gel electrophoresis (SDS PAGE) 
analysis of Gb3-Fractogel column factions following 'cleaning'. 
Residual bound proteins were eluted from the globotriose (Gb 3)-
Fractogel column (Biocarb) using 6M guanidine Hel pH6.7. Seven 
lml fractions were collected and dialysed overnight against 
phosphate buffered saline (PBS) pH7.2. SOOul of each fraction 
was analysed by SDS polyacrylamide gel electrophoresis (SDS 
PAGE) (2.10.3) on a 15% polyacrylamide gel in comparison wi th 
reassociated recombinant wild type Shiga-like toxin I A subunit 
(rSLT lA (wild type» containing holotoxin. Resolved proteins 
were visualised by silver staining of the gel (2.10.3(ii». 
Lane 1 shows reassociated rSLT lA (wild type) containing 
holotoxin 
respectively. 
A and B indicating SLT lA and B subunits 
Lanes 2 - 8 = column fractions 1 - 7. 
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Conclusion - Chapter 4 
The successful reassociation of the rSLT lAs with purified SLT 
lB demonstrated here facilitated the subsequent purification of 
the rSLT IAs. In addition, the generation of rSLT lA-containing 
holotoxins also allows examination of the cytotoxic nature of a 
'protease insensitive' SLT lA subunit in comparison to that of 
the wild type SLT lA subunit. 
The generation of rSLT lA containing holotoxins may be seen to 
be a relatively simple procedure. However, although it may be 
seen to give relatively pure rSLT lA-containing holotoxins, 
yields in each case were very poor (lug / ml rSLT lA (wild 
type) and 2.4ug / ml rSLT lAlA2 ('protease insensitive') as 
determined by densitometry in comparison to SLT lA standards}. 
In particular, this presented certain limitations to the 
kinetic analysis (Chapter 5 SECTION 3.5.2), since it was 
possible only to examine a relatively small range of 
concentrations of rSLT lA in each case. Yields were however, 
sufficient to allow a limited examination of the relative 
biological activities of the rSLT IAs. 
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SECT ION 3.5.1 Comparing the cytotoxicities of reassociated 
holotoxin containing recombinant, wild type Shiga-like toxin I 
A subunit and recombinant, full length, 'protease insensitive' 
Shiga-like toxin I A subunit. 
Introduction 
As previously discussed, the work of Olsnes et al. (1981) on 
Shiga toxin (ST) and of Kongmuang ~ al. (1988) on Shiga-like 
toxin I (SLT I) has shown there to be no difference in 
cytotoxici ty of pre-nicked and unnicked ST and SLT I 
respectively. In order to carry out studies on the effects of 
nicking and reduction on the ST I SLT I A subunits however, the 
toxins were pretreated with trypsin. Studies by 01snes et al. 
(1981), also involved treatment of ST with reducing agents such 
as 5% Z-mercaptoethanol. 
One of the main aims of this study was to investigate the 
consequences of unnicked toxin in cellular uptake and enzymatic 
activity wi thout a requirement for chemical pretreatment of 
the proteins under investigation. 
In vi tro expression of the recombinant SLT lA subunits (rSLT 
IAs) generated in this study has shown the recombinant, full 
leng th, , pro tease insensi t i ve ' Shiga -1 ike toxin I A subuni t 
(rSLT IA1AZ ('protease insensitive'» to be of the same 
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expected size as the recombinant, wild type Shiga like toxin I 
A subuni t (rSLT lA (wild type» ie 32KDa (Chapter 3 SECTION 
3.3.2). An apparent reduction in the sensitivity of the rSLT 
IA1A2 ('protease insensitive') to cleavage by the protease 
trypsin has also been demonstrated (Chapter 3 SECTION 3.3.2). 
Successful reassociation of both the rSLT lA (wild type) and 
also the rSLT IA1A2 ('protease insensitive') with purified SLT 
IB subuni t (Chapter 4 SECTION 3.4.2) has provided a way in 
which the cytotoxic nature of the rSLT IA1A2 ('protease 
insensitive') may be compared to that of the rSLT lA (wild 
type) • It is hoped that the observed reduction in 
susceptibility to proteolytic cleavage of rSLT IAIA2 ('protease 
insensitive') in vitro may also be the case in vivo, ie it will 
remain as a full length, unprocessed SLT IA1A2 subunit 
comprising both the Al and the A2 in an unnicked state. 
Results and Discussion 
The cytotoxic nature of the reassociated, recombinant 
holotoxins was tested by incubation of Vero cells (2.11.2) with 
o - SOng/ml for 1, 3, 6 and 24 hours. FIG 3.5.1 shows the 
results of 3 and 6 hour incubations on the protein synthesis of 
intoxicated Vero cells by measuring the incorporation of 35 S_ 
~ethionine into cell protein. 
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FIG 3.5.1 Examination of the cytotoxic effect of reassociated, 
recombinant Shiga-like toxin I A subunit (rSLT IA)-containing 
holotoxins on Vera cells. 
o - SOng/ml of each recombinant Shiga-like toxin I A subunits 
(rSLT IAs) ie rSLT lA (wild type) and rSLT IA1 A2 (' protease 
insensitive') was incubated with 1.2 - 1.S x 104 cells in 
quadruplicate. Periods of cell intoxication of 3 and 6 hours 
were examined. The addition of 1uCi 3SS-methionine to each well 
allowed the cell viability to be determined via incorporation 
of isotope into cell protein. The SO% cytotoxic dose (ICSO) 
value was then determined for each of the rSLT IAs ie rSLT lA 
(wild type) and rSLT IA1A2 ('protease insensitive') on Vero 
cells at each incubation period. 
This experiment was carried out twice. 
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50% cytotoxic dose (IC50) values obtained following an 
incubation period of 6 hours may be seen to be the same for 
both rSLT lA (wild type)-containing holotoxin and for rSLT 
('protease insensitive')-containing ho1otoxin ie 
approxima te1y O.lng/ml as found previously wi th na t i ve SLT I 
holotoxin (Chapter 2 SECTION 3.2.1». This was also found to be 
the case following a 24 hour incubation period. However 
examination of the results following reduced periods of 
incubation with toxin give a very different perspective. 
In order to examine shorter periods of incubation of Vero cells 
with toxin, modification of the protocol described (2.11.2) was 
necessary. Cells were incubated with toxin as described 
(2.11.2) for 1, 3 and 6 hours. In each case the toxin was then 
washed off (2.11.2) and the intoxicated cells incubated with 
35S-~ethionine (2.11.2) for a reduced time of 30 min as opposed 
to 2 hours (2.11.2). The described protocol (2.11.2) was then 
followed. 
FIG 3.5 .1A shows the resul t of incubation of rSLT lA (wild 
type) and rSLT IA1 A2 ( 'pro tease ins ens i t i ve '. ) -cont aining 
holotoxins with Vero cells for 1 hour only. The cytotoxic 
effect in both cases is negligible. However, after an 
incubation time of 3 hours (FIG 3.5.1) a marked difference in 
the cytotoxic effect of the rSLT lA (wild type) and rSLT IA1A2 
('protease insensitive')-containing ho10toxins is visible. IC 50 
values for rSLT lA (wild type) and rSLT IA1A2 ('protease 
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FIG 3.S.1A Examination of the cytotoxic effect of 
reassociated, recombinant Shiga-like toxin I A subunit (rSLT 
IA)-containing holotoxins on Vero cells. 
Concentrations of 0 - SOng/ml of the recombinant Shiga-like 
toxin I A subunits (rSLT IAs) ie rSLT lA (wild type) and rSLT 
IA1A2 ('protease insensitive') were incubated in quadruplicate 
with 1.2 - 1.5 x 104 cells per well for a 1 hour period. The 
addi tion of luCi 35S-methionine to each well following this 
incubation period allowed the extent of cell killing to be 
determined in each case. This was achieved by measuring the 
incorporation of isotope into cell protein. 
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insensitive') 
reduction in 
are 0.lng/m1 
cytotoxicity 
and 
of 
0.8ng/m1 respectively. A 
rSLT IAlA2 ('protease 
insensitive') may be attributed to a number of factors. 
Jinno et al. (1989) and Ogata ~ al. (1990) in studies on the 
cellular processing of Pseudomonas exotoxin A (PE) reported the 
greatly reduced cytotoxicity of a PE mutant in which Arg 
residue 276 had been substituted by G1y; Arg residue 276 having 
been proposed as the processing site for an endosomal protease 
(Fryling et al. 1992). Pretreatment of the mutant molecule with 
trypsin restored cytoxici ty. Radiolabe11ing of the mutant PE 
molecule revealed tha t the molecule was not proteo1ytica11y 
cleaved by the intoxicated cell and did not therefore generate 
the translocation competent 37KDa PE fragment required for 
toxici ty. This, is not however the case wi th the rSLT lAl A2 
('protease insensitive') generated in this study. Results show 
tha t after a 6 hour incuba tion period (FIG 3.5.1) the rSLT 
lA1 A2 (' protease insensi ti ve') displayed the same degree of 
cytotoxicity as did the rSLT lA (wild type). Both gave an IC SO 
value of O.lng/ml. The rSLT IAlA2 (protease insensitive) did 
however, require a longer period of incubation in which to 
achieve this. Proteolytic cleavage would appear to be a rate 
limiting step in activity of the rSLT IAlA2 ('protease 
insensitive'). 
The observed lag may have arisen as a resu1 t of suboptimal 
processing of the mutant molecule at a location within the 
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molecule other than that at which proteolytic processing of SLT 
lA would normally take place. Such proteolytic cleavage may 
generate a fragment with reduced RNA N-glycosidase activity or 
one which is less efficiently translocated. It is speculated 
tha t some sort of nicking is required in this ins tance, in 
order to liberate Al from the A2-BS moiety which might impose a 
considerable barrier to membrane translocation and ribosome 
inactivation. Nicking, as occurs in PE and diphtheria toxin 
(DT), can occur intracellularly (Fryling et al. 1992) and 
probably precedes the reductive cleavage step which might occur 
else~Yhere in the cell to physically liberate Al for membrane 
translocation (Pelham et ~. 1992). 
It is possible however, that mutagenesis of Arg residues 248 
and 251 may be responsible, via their interactions with other 
residues, for conformational changes at the proposed active 
site of the SLT lA subunit resulting in a reduction in RNA N-
glycosidase activity. Thus it became important to examine the 
enzymatic activity of the isolated reduced rSLT IAIA2 
('protease insensitive') in comparison with that of the rSLT lA 
(wild type). 
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SECTION 3.5.2 Kinetic examination of the depurinating 
activities of reduced holotoxins containing recombinant, wild 
type Shiga-like toxin I A subunit and recombinant, full length, 
'protease insensitive' Shiga-like toxin I A subunit. 
Introduction 
Reassociation of recombinant wild type Shiga-like toxin I A 
subuni t (rSLT lA (wild type» and recombinant, full length, 
'protease insensitive' Shiga-like toxin I A subunit (rSLT IAlA2 
( 'protease insensi tive' » wi th Shiga -like toxin I B subuni t 
(SLT IB) and the subsequent purification of the resultant 
holotoxins (Chapter 4 SECTION 3.4.2) allowed their rela ti ve 
cytotoxicities on Vero cells to be determined (Chapter 5 
SECTION 3.5.1). As discussed in the previous section (SECTION 
3.5.1), examination of such cytotoxici ties revealed a marked 
reduction in the cytotoxic effect of the rSLT IAlA2 ('protease 
insensitive')-containing holotoxin following incubation with 
toxin for a period of 3 hours prior to radiolabelling. After a 
6 hour incuba tion period prior to radiolabeling however, the 
latter was seen to demonstrate the same cytotoxic effect as did 
the rSLT lA (wild type)-containing holotoxin. 
As discussed 
explanations 
in 
for 
the previous 
this; one 
section, 
being 
there may be several 
the possibility that 
mutagenesis of the SLT I A subunit (required in order to 
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generate the rSLT IA1A2) ('protease insensitive') may, via 
conformational changes to the subunit, have reduced its RNA N-
glycosidase activity. Thus it was decided that the enzymatic 
activities of rSLT lA (wild type) and the rSLT IA1A2 (protease 
insensitive) would be examined kinetically. 
Once again, as described in Chapter 2 SECTION 3.2.4 in the 
kinetic comparison of SLT lA-catalysed depurination of salt 
washed wheatgerm ribosomes with that of ricin A subunit, the 
protocol was based on that of Osborn (1990). 
Results and Discussion 
The experimental conditions described in SECTION 3.2.4 of this 
study examining the kinetics of SLT lA-catalysed depurination 
of salt washed wheatgerm ribosomes, provided a basis from which 
suitable enzyme and substrate concentrations could be 
determined. Again salt washed wheatgerm ribosomes were chosen 
as the substrate for the kinetic investigations since they may 
be produced in large, relatively undegraded quantities. 
Also in common with previous experiments in this study was the 
pretreatment of the reassociated recombinant holotoxins with 
2-mercaptoethanol to a final concentration of 6mM to ensure 
complete reduction analogous to the situation in the cytosol of 
a cell. 
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In this case the concentration of each rSLT lA was determined 
by SDS polyacrylamide gel electrophoresis (SDS PAGE) (2.10.3) 
of 3 equal aliquots of each reassociated rSLT lA holotoxin and 
a range of known amounts of native SLT I holotoxin. The 
resultant gel was then silver stained (2.10.3(ii» and scanned 
using a Holecular Dynamics computing densitometer and analysed 
using the volume integration package. The concentration of each 
rSLT lA ie rSLT lA (wild type) and rSLT IA1A2 (protease 
insensitive) was determined from a standard curve plotted from 
the data for the known amounts of native SLT lA (FIG 3.4.5, 
SECTION 3.4.2). 
(i) Recombinant SLT lA (wild type)-catalysed depurination of 
wheatgerm ribosomes. 
FIG 3.5.2 demonstrates the RNA N-g1ycosidase activity of rSLT 
lA (wild type) containing holotoxin on sal t washed whea tgerm 
ribosomes (lane 2) compared with that of pure SLT I (lane 1). 
1.27uM (160ug in a final reaction volume of 30ul) salt washed 
wheatgerm ribosomes was incubated with a range of 
concentrations of rSLT lA (wild type) 0.005uM - O.OluM in order 
to determine a concentration which would give a linear rate of 
depurination with regard to time. Due to the relatively dilute 
nature of the reassociated rSLT lA (wild type) holotoxin and 
the constraints of the reaction volume, the range of 
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FIG 3.5.2 Investigation of the activity of reassociated. 
recombinant, wild type Shiga-like toxin I A subunit-containing 
holotoxin on wheatgerm ribosomes. 
O.05ug of reassociated, recombinant, wild type Shiga-like toxin 
I A subunit (rSLT lA (wild type»-containing holotoxin 
previously shown to be cytotoxic to Vero cells (FIG 3.5.1) was 
incubated with 30ug wheatgerm ribosomes for 20min at 30G 
(2.11.1(i». This followed preincubation of the reassociated 
holotoxin with 2-mercaptoethanol to a final concentration of 
6mM to ensure optimal activity and maximal reduction of any SLT 
I present. The resultant ribosomal RNA (rRNA) was then 
extracted (2.4.1) and subjected to aniline cleavage (2.5.1). 
Fractionation and visualisation of the resultant rRNA was then 
carried out (2.6.1). 
Lane 1 = positive control: wheatgerm rRNA following incubation 
with pure SLT I. 
Lane 2 shows whea tgerm rRNA following incuba tion wi th 
reassociated rSLT lA (wild type) containing holotoxin. 
+ indicates treatment of rRNA with aniline reagent. 
- indicates that following incubation with toxin and extraction 
the rRNA was not subjected to aniline cleavage. 
~indicates the characteristic fragment released following 
aniline cleavage of toxin-modified rRNA. 
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concentrations of rSLT lA (wild type) which could be tested was 
limi ted. FIG 3.5.3 shows the percentage depurination against 
time when [rSLT lA (wild type)] = O.OluM and the [ribosome] = 
1.27uM. It would appear that at this enzyme concentration the 
rate of depurination remains approximately linear for 20min. 
As stated earlier, the initial rate of depurination with regard 
to [rSLT lA (wild type)] was investigated. As above, the 
substrate concentration was kept at 1.27uM (160ug ribosomes in 
a final reaction volume 30ul) and incubated with concentrations 
rSLT lA (wild type) of O.OOSuM, 0.0075uM and O.OluM. The 
results represented in FIG 3.5.4 shows the initial rate of 
depurination to be approximately linear with regard to [rSLT lA 
(wild type)]. A concentration of O.OluM rSLT lA (wild type) was 
used in the successive experiments to determine Km and kcat • 
Concentrations of wheatgerm ribosomes incubated with this 
concentration of SLT lA (wild type) ranged from 0.32uM - O.95uM 
(40 - l20ug ribosomes in a final reaction volume 30ul). In 
order to determine an average initial rate of depurination in 
each case, aliquots of the reaction mix were removed at 5min 
and lOmin. The rRNA was then extracted, treated with aniline 
and the resultant rRNA resolved by denaturing gel 
electrophoresis. Following visualisation of the gel by ethidium 
bromide staining the gel was photographed and the negative 
photograph analysed using a Molecular Dynamics computing 
densitometer. As described in SECTION 3.2.4 EQUATION 1 was 
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FIG 3.5.3 Time course for depurination of wheatgerm ribosomes 
by recombinant, wild type Shiga-like toxin I A subunit. 
160ug of salt washed wheatgerm ribosomes (final concentration 
1.27uM), were incubated at 3~C for 30min with recombinant, wild 
type Shiga-like toxin I A subunit (rSLT lA (wild type)) to a 
final concentration of O.OluM (2.11.1(i)) in a total volume of 
30ul. Aliquots of 3ul were removed at various time points and 
the ribosomal RNA (rRNA) extracted (2.4.1). This was then 
subjected to aniline cleavage (2.5.1) and fractionated by 
denaturing gel electrophoresis (2.6.1). Scanning of the rRNA 
using a Molecular Dynamics computing densitometer and the 
application of EQUATION 1 to the data generated, allowed the 
percentage depurination in each case to be determined. 
This experiment was carried out four times. Results are 
representative of two successful analyses. 
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FIG 3.5.4 Examination of the effect of recombinant, wild type 
Shiga-like toxin I A subunit concentration on the initial rate 
of depurination. 
160ug of salt washed wheatgerm ribosomes (final concentration 
1.27uM), were incubated with a range of concentrations of 
recombinant, wild type Shiga-like toxin I A subunit (rSLT lA 
(wild type» from 0.005 - O.OluM (2.11.1(i». At 5 and 10min 
intervals 3ul aliquots were removed from the reaction (total 
volume 30ul) and the ribosomal RNA (rRNA) extracted (2.4.1). 
This was treated with aniline reagent (2.5.1) and fractionated 
by gel electrophoresis (2.6.1). Based on the assumption tha t 
the reaction rate remained linear over the first 10min of the 
reaction, the initial rate of depurination for each 
concentration of rSLT lA (wild type) was calculated from the 
percentage depurination at the two time points using EQUATION 1 
and other equations as described in the text (SECTION 
3.5.2(i». 
This experiment was carried out twice. Results seen here are 
representative of data generated in both cases. 
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applied to the data obtained allowing determination of the 
ini tial ra te of depurina tion for each ribosome concentra tion 
using the following: 
sum % depurination (2 time points) = average % depurination 
2 
average % depurination = % depurination I min 
time (mins) 
• % depurination x ribosome concentration (uM) 
100 x time (mins) 
INITIAL RATE DEPURINATION 
Again, as in Chapter 2 SECTION 3.2.4, the computer programme 
'Enzkin 9' was employed in order to determine Km and kcat from 
the experimental data obtained. FIG 3.5.5 shows the resultant 
Lineweaver - Burke and Cornish - Bowden plots. The Cornish -
Bowden method is considered statistically to be the best method 
of analysis. As previously discussed, the Km and Vmax 
generated by this method are median and not mean values with 
the result that an aberrant value will not distort the findings 
of the analysis. 
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FIG 3.5.5 Determination of ~ and Vmax for the depurination of 
wheatgerm ribosomes by recombinant. wild type Shiga-like toxin 
I A subunit using Cornish - Bowden and Lineweaver - Burke 
plots. 
Salt washed wheatgerm ribosomes in concentrations ranging from 
o . 32 - 0 . 9 5 uM (40 - 120ug ribosomes in a final reaction 
volume of 30ul) were o incubated at 30C, (2.11.1(i» in a final 
volume of 30ul wi th 0.01 uM reduced, recombinan t, wild type 
Shiga-like toxin I A subunit (rSLT lA (wild type». Aliquots, 
each of 14ug were removed from the reaction at 5 and 10min and 
the ribosomal RNA (rRNA) extracted (2.4.1). This was then 
subjected to aniline cleavage (2.5.1) and fractionated by 
denaturing gel electrophoresis (2.6.1). Scanning of the 
resultant rRNA gel allowed the percentage depurination for each 
time point to be calculated and thus the initial rate of 
depurination for each ribosome concentration to be determined 
using EQUATION 1 and other equations as detailed in SECTION 
3.5.2 (i). The resultant data was applied to Lineweaver - Burke 
and Cornish - Bowden analysis in order to calculate values of 
Km and Vmax • 
The resultant plots were generated from a single experiment. 
1: Cornish - Bowden plot 
2: Lineweaver - Burke plot 
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Vmax = 0.462 x 10-1 uaol/_in 
Km = 0.844 uH 
1 
Vmax = 0.453 x 10-1 umol/_in 
Km = 0.829 uJ4 
4 
From the Vmax value (0.462 x 10-lumol/min) derived by Cornish-
Bowden analysis of the data, it is possible to calculate the 
turnover number (kcat ) for the reaction. This is found to be 
4.62 min-1 , which is similar to the kcat value of 3.9 min-1 
calculated in chapter 2 SECTION 3.2.4 for the depurination of 
salt washed wheatgerm ribosomes by native SLT lA. This serves 
to indica te tha t the recombinant wild type 5LT I A subuni t 
behaves in an almost identical way to the native SLT I A 
subuni t and therefore provides a valuable 'wild type' SLT lA 
control in examination of the depurination of salt washed 
wheatgerm ribosomes by rSLT lAIA2 ('protease insensitive'). 
Comparison of the Km values derived for rSLT lA (wild type) 
(O.844uM) and native 5LT lA (O.978uM), indicating the binding 
affinity of the SLT lA for its substrate, also suggests that 
the rSLT lA is indeed acting as a 'wild type' SLT lA subunit. 
The maximum velocity (Vmax ) for rSLT lA cata~ed depurination 
(0.462 x 10-lumol/min) is however, lower than that of native 
SLT lA (O.128umol/min) indicating a slight reduction in 
catalytic activity of rSLT lA (wild type) compared to that of 
native SLT lA. It is felt that as a result of the complex 
nature of the kinetic analysis these slight differences may be 
as a result of experimental error. Thus, rSLT lA may still be 
considered a valuable 'wild type' standard against which rSLT 
IA1AZ ('protease insensitive') can be compared. 
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(il) Recombinant SLT IAIA2 ('protease insensitive')-catalysed 
depurination of wheatgerm ribosomes. 
FIG 3.5.6 demonstrates the RNA N-glycosidase activity of rSLT 
lAIA2 ('protease insensitive')-containing holotoxin on salt 
washed wheatgerm ribosomes (lane 2) in comparison to that of 
pure SLT lA (lane 1). 
Wheatgerm ribosomes at a concentration of 1.27uM (l60ug in a 
final reaction volume of 30ul) were incubated with a range of 
concentrations of rSLT lAIA2 ('protease insensitive') from 
O.005uH O.02uM in order to determine a concentration of 
enzyme which would give a linear rate of depurination with 
regard to time. FIG 3.5.7 represents the results obtained when 
[substrate] = 1.27uM and [enzyme] = O.OluM. Depurination 
appears to proceed at an approximately linear rate for up to 
20min. 
The ini tial rate of depurina tion wi th regard to rSLT lAl A2 
('protease insensitive') concentration was again investigated. 
1.27uM (160ug in a final reaction volume 30u!) wheatgerm 
ribosomes were incubated with O.005uM, O.OluM and O.02uM rSLT 
lAI A2 (' protease insensi ti ve' ). FIG 3.5.8 shows the resul ts 
obtained. Again as in (i) above it would appear tha t there 
exists a linear rate of depurination with regard to enzyme 
concentration. For the following experiments to determine Km 
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FIG 3.5.6 Investigation of the activity of reassociated, 
recombinant, full length J 'protease insensi ti ve' Shiga -like 
toxin I A subunit-containing holotoxin on wheatgerm ribosomes. 
O.05ug of reassocia ted, recombinant, full leng th, 'protease 
insensi ti ve' Shiga - like toxin I A subuni t ( 'rSLT IA1 A2 
(protease insensitive'»-containing ho1otoxin, previously shown 
to be cytotoxic to Vero cells (FIG 3.5.1) was incuba ted wi th 
30ug wheatgerm ribosomes at 3~C for 20min (2.11.1(i». In order 
to ensure its maximal reduction, prior to incubation with 
ribosomes, the reassocia ted holotoxin was pre trea ted wi th 2-
mercaptoethanol to a final concentration of 6mM. Following 
incubation with the reassociated holotoxin, the wheatgerm 
ribosomal RNA (rRNA) was then extracted (2.4.1) and subjected 
to aniline cleavage (2.5.1). Fractionation and visualisation of 
the resultant rRNA was then carried out (2.6.1). 
Lane 1 = positive control: wheatgerm rRNA following incubation 
with pure SLT I. 
Lane 2 shows whea tgerm rRNA following incubation with 
reassociated rSLT IA1A2 ('protease insensitive')-containing 
holotoxin. 
+ indicates treatment of rRNA with aniline reagent. 
- indicates that following incubation with toxin and extraction 
the rRNA was not subjected to aniline cleavage. 
~indicates the characteristic fragment released following 
aniline cleavage of toxin-modified rRNA. 
282 
1 2 
+ + 
283 
FIG 3.5.7 Time course for depurination of wheatgerm ribosomes 
by recombinant, full length, 'protease insensitive' Shiga-like 
toxin I A subunit. 
160ug of salt washed wheatgerm ribosomes (final concentration 
o 
1.27uM), were incubated at 30C for 30min with recombinant, full 
length, 'protease insensitive' Shiga-like toxin I A subunit 
(rSLT IA1A2 ('protease insensitive')) to a final concentration 
of O.OluM (2.11.1(i)) in a total volume of 30u1. Aliquots of 
3ul were removed at various time points and the ribosomal RNA 
( r RNA) ex t r act e d ( 2 • 4 • 1 ). Th i s was the n sub j e c t e d t 0 ani 1 in e 
cleavage (2.5.1) and fractionated by denaturing gel 
electrophoresis (2.6.1). Scanning of the rRNA using a 
Molecular Dynamics computing densitometer and the application 
of EQUATION 1 to the data generated, allowed the percentage 
depurination in each case to be determined. 
This experiment was carried out three times. Results are 
representative of two successful analyses. 
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FIG 3.5.8 Examination of the effect of recombinant, full 
length, 'protease insensi ti ve' Shiga -like toxin I A subuni t 
concentration on the initial rate of depurination. 
160ug of salt washed wheatgerm ribosomes (final concentration 
1.27uM) were incubated with a range of concentrations of 
recombinant, full length, 'protease insens i ti ve ' Shiga - like 
toxin I A subunit (rSLT IAIA2 ('protease insensitive'» from 
0.005 0.02uM (2.l1.1(i». At 5 and 10min intervals 3u1 
aliquots were removed from the reaction (total volume 30ul) and 
the ribosomal RNA (rRNA) extracted (2.4.1). This was treated 
with aniline reagent (2.5.1) and fractionated by denaturing gel 
electrophoresis (2.6.1). Based on the assumption that the 
reaction rate remained linear over the first 10min of the 
reaction, the initial rate of depurination for each 
concentration of rSLT IAIA2 ('protease insensitive') was 
calculated from the percentage depurination at the two time 
points using EQUATION 1 and other equations descibed in the 
text (SECTION 3.5.2 (i). 
This experiment was carried out twice. Resu1 ts seen here are 
representative of data generated in both cases. 
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and kcat for the catalysed depurination of wheatgerm ribosomes 
a [rSLT IAIA2 ('protease insensitive')] of O.OluM was used. 
Concentrations of wheatgerm ribosomes incubated with O.OluM 
rSLT IAIA2 ('protease insensitive') ranged from O.16uM - O.95uM 
(20 - 120ug in a final reaction volume 30ul). As previously 
described in this section (i), aliquots were removed from the 
reaction after 5min and lOmin and the rRNA extracted, aniline 
treated and fractionated by denaturing gel, electrophoresis. 
The resultant gel was then analysed by scanning of a negative 
photograph of the ethidium bromide stained gel using a 
Holecular Dynamics computing densitometer and use of its volume 
integration programme. EQUATION 1 and other equations (SECTION 
3.5.1 (i» were applied to the data obtained in order to 
generate an initial rate of depurination value for each 
ribosome concnetration. Km and kcat values for the reaction 
were derived as above by use of the 'Enzkin 9' computer 
programme. 
FIG 3.5.9 shows both Lineweaver - Burke and Cornish - Bowden 
plots for the rSLT IAIA2 ('protease insensitive')-catalysed 
depurination of salt washed wheatgerm ribosomes. 
Calculation of the turnover number (kcat ) for the reaction from 
the maximum velocity value (Vmax ) derived by Cornish-Bowden 
analysis of the data (O.233umol/min) gives a figure of 23.3min-
1, which is approximately five times greater than the turnover 
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FIG 3.5.9 Determination of Km and Vmax for the depurination of 
wheatgerm ribosomes by recombinant, full length, 'protease 
insensi ti ve ' Shiga -like toxin I A subuni t using Cornish -
Bowden and Lineweaver - Burke plots. 
Salt washed wheatgerm ribosomes in concentrations ranging from 
0.16 - 0.95uM (20 - 120ug ribosomes in afina1 volume of 30u1) 
were incubated at 3d'C, (2.11.1(i)) in a final volume of 30u1 
with O.OluM recombinant, full length, 'protease insensitive' 
Shiga - like toxin I A subuni t (rSLT IAl A2 ( 'protease 
insensi ti ve' )). Aliquots, each of 10ug were removed from the 
reaction at 5 and lOmin and the ribosomal RNA (rRNA) extracted 
( 2 • 4 • 1 ). Th is was the n sub j e c t e d to ani 1 in e cl e a v age ( 2 • 5 • 1 ) 
and frac t Iona ted by denaturing gel elect rophore si s (2.6.1). 
Scanning of the resultant rRNA gel allowed the percentage 
depurination for each time point to be calculated and thus the 
initial rate of depurination for each ribosome concentration to 
be determined using EQUATION 1 and other equations as detailed 
in SECTION 3.5.2 (i). The resultant data was applied to 
Lineweaver - Burke and Cornish - Bowden analysis in order to 
calculate values of Km and Vmax • 
The resultant plots were generated from a single experiment. 
1: Lineweaver - Burke plot 
2: Cornish - Bowden plot 
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Vmax = 0.279 umo1/min 
Km = 5.89 uM 
8 
Vmax = 0.223 umol/min 
K.m = 4.67 uM 
4 
number derived for rSLT lA (wild type)-catalysed depurination 
of sal t washed whea tgerm ribosome s (4. 62min -1). The binding 
affinity of rSLT IA1A2 ('protease insensitive') for its 
substrate however, may be seen to be lower (Km = 4.67uM), than 
tha t of rSLT lA (wild type) (Km = O. 844uM) • The observed 
increase in maximum veloci ty of rSLT IAl AZ ('protease 
insensi tive' ) -ca talysed depurina tion of sal t washed wheatgerm 
ribosomes (0.Z33umol / min) compared to that of rSLT lA (wild 
type) (0.462 x 10-1 ) is of more significance, since it implies 
a slight increase in the catalytic activity of rSLT IAlA2 
('protease insensitive'). 
FIG 3.5.10 summarises the Km and Vmax values for rSLT lA (wild 
type) - and rSLT IA1 AZ ( 'protease insensi t i ve ' ) -ca talysed 
depurination of salt washed wheatgerm ribosomes. 
The experimental data obtained here would suggest that 
possession of the SLT lA2 peptide, as demonstrated by rSLT 
lA1A2 ('protease insensitive'), results in a slight decrease in 
the binding affinity with a possible compensatory increase in 
the catalytic activity of the SLT lA subunit; a result which 
is not reflected by comparison of the relative cytotoxicities 
of rSLT lA (wild type)- and rSLT lA1A2 ('protease 
insensitive')-containing holotoxins (SECTION 3.5.1). 
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rSLT 
rSLT 
lA (wild type) 
IA1 A2 ('protease insensitive') 
LB = Lineweaver-Burke 
CB = Cornish-Bowden 
Vmax (umol/min) 
0.453 x 10-1 
0.426 x 10-1 
0.279 
0.233 
Km (uM) 
0.829 (LB values) 
0.844 (CB values) 
5.890 (LB values) 
4.670 (CB values) 
FIG 3.5.10 Summary of the Vmax and Km values derived for the 
depurination of salt washed wheatgerm ribosomes by recombinant 
Shiga-like toxin I A subunits. 
292 
Conclusion - Chapter 5 
Results presented in SECTION 3.5.1 regarding the relative 
cytotoxicities of the rSLT IAs were found to be reproducible. 
As previously discussed, there are several explanations which 
may account for the observed reduction in cytotoxicity of rSLT 
IA1AZ ('protease insensitive')-containing holotoxin compared to 
tha t of rSLT lA (wild type )-containing toxin. These include 
slower proteolytic processing of rSLT lAl A2 ( 'protease 
insensitive') at suboptimal cleavage sites, total lack of 
processing of the rSLT lAl AZ ('protease insensitive')-
containing holotoxin and slower translocation of the molecule 
as a result of hindrance by the SLT lB subunit pentamer, which 
may remain associa ted wi th the unprocessed SLT lA subuni t. 
Since the entire process of binding, uptake, processing and 
translocation of toxins is thought to be a highly complex 
procedure, it is not possible, by simply carrying out a 
cytotoxicity assay, to determine which of these explains the 
observed lag in activity of rSLT lAlA2 ('protease 
insensitive'). 
Detailed kinetic analysis of rSLT lA-catalysed depurination of 
sal t washed wheatgerm ribosomes was carried out in order to 
eliminate reduced RNA N-glycosidase activity (caused by 
conformational changes induced during mutagenesis of SLT lA), 
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of rSLT IA1 A2 (' protease insensi ti ve') as an explana tion for 
observed lag in cytotoxicity. 
At first glance the kinetic analysis (SECTION 3.5.2), would 
appear to indicate a slight decrease in binding affinity of of 
rSLT IA1A2 ('protease insensitive') with a possible 
compensatory increase in catalytic activity compared to that of 
rSLT lA (wild type). This result is not however, reflected by 
the cytotoxicity assays carried out in SECTION 3.5.1. The 
latter results show a distinct lag in activity of the rSLT 
('protease insensitive')-containing holotoxin in 
comparison with that of rSLT lA (wild type)-containing 
holotoxin. The cytotoxic effect of rSLT IA1A2 ('protease 
insensitive')-containing holotoxin would appear from these 
results (SECTION 3.5.1) to be eight times less than that of 
rSLT lA (wild type)-containing holotoxin. 
Due to limitations of time, low yields of reassociated toxin 
and the breakdown of the densitometer, final experiments 
used to generate data for Lineweaver - Burke and Cornish -
Bowden analyses presented. in SECTION 3.5.2 were carried out 
only twice in the case of rSLT IAIA2 ('protease insensitive') 
and three times in the case of rSLT lA (wild type). As a result 
of the complex nature of the kinetic analysis in each case only 
one gel sui table for analysis was generated. Thus the Km and 
Vmax values for each rSLT lA were derived from a single 
experiment in each case. In addi tion, due to the complica ted 
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nature of the kinetic analysis, it is felt that the observed 
differences in catalytic activity of rSLT lA (wild type) and 
rSLT lAIA2 ('protease insensitive') may be within the realms of 
'experimental error'. Thus, it is felt that in order to 
substantiate the initial findings of the kinetic analyses and 
to correla te these resul ts wi th those regarding the rela ti ve 
cytotoxici ties of the rSLT lA-containing holotoxins, kinetic 
analysis of the rSLT lAs needs to be repeated. 
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SECTION 4 FINAL DISCUSSION - Chapters 3, 4 and 5 
Final discussion - chapters 3, 4 and 5. 
The aim of work carried out as described in chapters 3, 4 and 5 
has been to study the contribution of a non cleavable A2 
peptide in the biological activity (ie cytotoxicity and 
catalytic activity) of the Shiga-like toxin I A subunit (SLT I 
A). This has been facilitated by the construction of 
recombinant Shiga-like toxin I A subunits (rSLT lAs) (Chapter 
3) and by successful reassociation of rSLT lA (wild type) and 
rSLT lAlA2 ('protease insensitive') with purified Shiga-like 
toxin I B subunits. This allowed purification of the rSLT lAs 
(Chapter 4 SECTION 3.4.2) and ultimately comparison of their 
relative biological activities. 
Unfortunately, an inability to express the truncated rSLT lAI 
(AI alone) or A2 alone (data not shown) at sufficiently high 
levels in vivo, meant that investigation into the role played 
by the A2 peptide in associating with the Shiga-like toxin I B 
subunit pentamer was not possible in the time available. 
The relative cytotoxicities on Vero cells of rSLT lA (wild 
type) and rSLT IA1A2-containing holotoxins were examined 
(Chapter 5 SECTION 3.5.1). Following incubation periods of 
greater than 6 hours the cytotoxic effect of the wild type and 
the 'protease insensitive' -containing holotoxins were seen to 
be identical; revealing a 50% cytotoxic dose (lC 50 ) value of 
O.lng/ml in each case. This value agreed with that determined 
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for the cytotoxic effect of native SLT I on Vero cells (Chapter 
2 SECTION 3.2.1) and also the values derived by Kongmuang ~ 
al. (1988) for pre-nicked (proteolytically cleaved) and 
unnicked SLT I. In both, the study of the cytotoxic nature of 
native SLT I (the present study) and that carried out by 
Kongmuang et a1. (1988), Vero cells had been i ncuba ted wi th 
toxin for a period of 24 hours. This led to the conclusion by 
Kongmuang et al. (1988) tha t there was no difference in the 
cytotoxicities of nicked and unnicked SLT I as had also been 
the conclusion of Olsnes !:.! al. (1981) wi th regard to nicked 
and unnicked Shiga toxin (ST). Again cells, in this case HeLa 
S3' had been incubated with toxin for an 'overnight' period; ie 
a period in excess of 6 hours. 
A similar scenario was reported by Tsuji et al. (1984) in 
studies to compare the effect of nicked (proteolytically 
cleaved) and unnicked Escherichia coli heat labile toxin (LT) 
on chinese hamster ovary cells (CHO). Following an incubation 
period of 18 hours, examination of the CHO cells revealed that 
the activity of the unnnicked LT was almost identical to that 
of the nicked form. However, shorter incubation periods 
revealed a distinct lag in appearance of biological activity of 
the unnicked form of the toxin. 
The effect of shorter incubation times on the biological 
activity of rSLT 1AIA2 ('protease insensitive')-containing 
holotoxin was therefore examined. The cytotoxic effect 
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following 1 and 3 hour incubation periods was examined (FIGS 
3.S.1A and 3.5.1 respectively). After a period of only 1 hour 
the cytotoxic effect of both rSLT lA (wild type) and rSLT IA1AZ 
('protease insensitive' )-containing holotoxins was seen to be 
negligible. However, after 3 hours, a distinct 1ag was evident 
in the case of rSLT IA1AZ ('protease insensitive' )-containing 
ho1otoxin. ICSO values for rSLT lA (wild type) and rSLT IA1AZ 
('protease insensitive') were determined as being O.1ng/ml and 
O.8ng/ml respectively. Although an eight fold difference may 
not at first glance appear to be significant, this reflects a 
decrease in cytotoxicity of almost an order of magnitude below 
that of the extreme potency displayed by the wild type SLT lA. 
A similar difference in the potency of ricin A subunit, 
described as significant, was observed following the addition 
of -KDEL to its C terminus (Wales ~~. 1992). In this case 
there was a seven fold increase in potency of the molecule. 
Several suggestions were put forward at this stage to explain 
the observed 1ag in the biological act i vi ty of the protease 
insensi ti ve ie unnicked rSLT IA1 A2 , wi th regard to previous 
studies of other bacterial toxins, such as Pseudomonas exotoxin 
A (PE) and LT, also with a prerequisite for proteolytic 
processing. 
It was suggested that proteolytic processing of the rSLT IAIA2 
('protease insensitive') may be the rate limiting step, 
resu1 ting in the observable 1ag in cytotoxic potency. 
298 
Ultimately in the case of rSLT lA1A2 ('protease insensitive'), 
proteolytic processing may occur no tat the usual si te for 
proteolytic cleavage, generating the expected Al and A2 
peptides of 27KDa and 5KDa respectively, but at a site less 
accessible or favourable for cleavage. Such suboptimal 
processing may in turn result in production of a fragment of 
reduced transloca tion-compe tence and / or wi th lower RNA N-
glycosidase activity. 
The possibility of proteolytic cleavage of rSLT lA1A2 
('protease insensitive') at a site less susceptible to cleavage 
may be substantiated by results generated earlier in this study 
(Chapter 3 SECTION 3.3.1). 
In vitro examination of the sensitivity of the rSLT lAs 
constructed revealed the full length, 'protease insensitive' 
rSLT lA1 A2 to be less sensitive to proteolytic cleavage than 
the wild type rSLT lA, as required. However, at higher 
concentrations of trypsin (40 and SOug/ml) a reduction in size 
of the rSLT IA1 A2 (' protease insensitive') of 2 - 3KDa was 
evident. Thus, it may be the case that this situation is 
reflected in vivo. However, great care must be taken in 
extrapolating data from in vitro studies with trypsin and the 
proposed intracellular processing events. For a start, trypsin 
is not the likely intracellular processing enzyme, although a 
serine protease of some description does appear to be involved. 
Work by Fryling ~ al. (1992) on the intracellular processing 
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of PE suggests that the enzyme responsible for such processing 
is endosomal (in at least one cell line) with a low pH 
requirement. However, until the compartment-specific protease 
responsible is known, it is difficult to know how similar the 
protease behaves compared with trypsin. The lack of an optimal, 
surface-exposed arginine residue may be compensated 
intracellularly by cleavage elsewhere. The intracellular 
protease may however, select quite a different site to that 
selected by trypsin in vitro. If proteolytic processing of rSLT 
IA1A2 ('protease insensitive') occurs at a site other than that 
at which cleavage would normally occur, a fragment with reduced 
enzymatic activity may be generated. Alternatively, such a 
fragment may translocate less efficiently. Potential sites for 
cleavage by a serine protease, which would result in the 
observed size reduction of 2 - 3KDa in the size of rSLT IA1A2 
('protease insensitive') (32KDa) seen in vitro at high trypsin 
concentrations (FIG 3.3.15), occur after arginine residues 266 
and 268 of the Shiga like toxin I A subunit. 
As mentioned above, a reduced translocation efficiency may well 
explain the observed lag. Such reduction in translocation 
efficiency could be attributable to either total 
insusceptibility of the rSLT IA1A2 ('protease insensitive') to 
proteolytic processing resulting in an attempt to translocate a 
larger sized A fragment than usual, or the production of a 
fragment not ideally suited for the membrane transfer step. We 
have no idea which of the options is likely. When considering 
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the translocation step it is worth remembering that the SLT IB 
subunit pentamer is likely to remain associated with A2 
intracellularly (evidence for an exclusive A2-BS association 
comes from studies wi th comparable toxins of this design -
cholera toxin (eT) Jobling and Holmes (1992) and LT (Sixma et 
al. 1991, Streatfield et al. 1992). Membrane translocation of a 
- --
holotoxin would be extremely unlikely. It is known that 
alteration of the PE cell binding domain by mutagenesis of the 
translocation domain-arginine residues, produces a toxin of 
greatly reduced potency (Jinno et al. 1989). Likewise, ricin A 
subunit (RA) fused directly with staphylococcal protein A (PA) 
has no cytotoxic effect even though enzymic activity is evident 
(O'Hare et al. 1990). In the latter case however, when a 
cleavable linker (diphtheria toxin (OT) loop) is included 
between RA and PA, the fusion protein is cytotoxic (O'Hare et 
al. 1990). This has been interpreted as meaning a block in 
translocation in the 'protease insensitive' fusion rather than 
in cell binding, endocytosis or catalytic activity. With this 
in mind, it would seem that attachment of A2-Bs to A1 would 
permanently render 5LT I a poor cytotoxin. In contrast, the 
time lag in cytotoxicity suggests a rate limiting step, such as 
a slower rate of translocation - perhaps of an imperfectly 
processed A1 subunit, which nevertheless lacks most of A2 and 
all of the Bs pentamer. 
Earlier evidence (Olsnes et al. 1981, Kongmuang et al. 1988)of 
pre-nicked versus unnicked ST / SLT I being of similar potency 
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is now thrown into doubt. In both cases these earlier 
experiments involved long periods of incubation wi th toxin. 
Under these circumstances any rate limiting step may have been 
overlooked. Results in the present study demonstrated that 
after incubation periods of 6 hours plus, both rSLT lA (wild 
type) and rSLT IAIA2 ('protease insensitive') appeared to have 
similar cytotoxicities. In addition, we know from RA-PA fusions 
that pre-nicking with trypsin is not necessary (O'Hare !! al. 
1990). A so called unnicked toxin can apparently become nicked 
intracellularly. Thus mutagenesis of the processing site(s) is 
the only valid approach in making comparisons. 
It remains possible of course that the observed difference in 
potency can be explained by a simple reduction in the catalytic 
activity of rSLT IA1A2 ('protease insensitive') as a direct 
consequence of conformational changes to the A subunit as a 
result of the amino acid substitutions required to generate 
rSLT IAIA2 ('protease insensitive'). For this reason, kinetic 
studies of rSLT lA (wild type)- and rSLT IA1A2 ('protease 
insensitive')-catalysed depurination of wheatgerm ribosomes 
were undertaken. 
rSLT lA {wild type)-catalysed depurination of wheatgerm 
ribosomes may be seen to be almost identical to that of native 
SLT lA on salt washed wheatgerm ribosomes (Chapter 2 SECTION 
3.2.4) ie Km and kcat values are almost identical (Km rSLT lA 
(wild type) - 0.844uM, Km native SLT lA = O.978uM and kcat rSLT 
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lA (wild type) = 4.S3min-1 , kcat native SLT lA .. 3.9min-1) thus 
providing a valuable 'wild type' against which rSLT IAIA2 
('protease insensitive') values may be compared. 
Experimental data obtained from studies to examine rSLT IAIA2 
('protease insensitive')-catalysed depurination of salt washed 
whea tgerm ribosomes (Chapter 5 SECTION 3.5.2) demons trates a 
decrease in binding affinity (Km .. 4.67uM) and an apparent 
increase in turn over number (kcat - 22. 3min-1 ) compared to 
those values derived for rSLT lA (wild type). The observed 
activity of rSLT IAIA2 ('protease insensitive') does not 
therefore, correlate with the different cytotoxicitiesof rSLT 
lA (wild type) and rSLT IAIA2 ('protease insensitive')-
containing holotoxins. 
Kinetic analysis of rSLT IAIA2 ('protease insensitive')-
catalysed depurination of salt washed wheatgerm ribosomes would 
appear to indicate a slight decrease in binding affinity with a 
possible compensatory increase in the catalytic activity 
compared to that of rSLT lA (wild type). As previously 
discussed, this result may not be reflected by the cytotoxicity 
assays carried out in SECTION 3.5.1 which indicate the potency 
of rSLT IAIA2 ('protease insensitive')-containing holotoxin to 
be approximately eight times less than that of rSLT lA (wild 
type)-containing holotoxin. 
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Data regarding the cytotoxicity of rSLT IA1A2 ('protease 
insensitive') was found to be reproducible. However, logistics 
prevented substantiation of kinetic data regarding the 
catalytic activities of rSLT lA (wild type) and rSLT IA1A2 
('protease insensitive'). The low yield of reassociated toxins 
in conjunction with the complex nature of the kinetic analysis 
limi ted the number of times that each part of the analysis 
could be carried out, as did the limited time available in the 
final stage of this study. Additional to these limitations was 
the breakdown of the Molecular Dynamics computing densitometer. 
Ultimately, data for Lineweaver - Burke and Cornish - Bowden 
analyses presented in SECTION 3.5.2 were derived from a single 
analysis in each case. Due to the complicated nature of the 
kinetic analysis, it is felt that the observed differences in 
catalytic activity of rSLT lA (wild type) and rSLT IA1A2 
('protease insensitive') may be within the realms of 
'experimental error'. For these reasons it may be that the 
observed differences in catalytic activity of rSLT IA1A2 
('protease insensitive') and rSLT lA (wild type) are 
negligible. If this was shown to be the case, then the observed 
reduction in potency of rSLT IAIA2 ('protease insensitive')-
containing holotoxin (SECTION 3.5.1) could be attributed to a 
step in the complex process of intracellular processing and 
translocation. 
It is felt therefore, that in order to draw comparisons between 
the findings of the kinetic analysis results regarding the 
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relative cytotoxicities of the rSLT lA-containing holotoxins, 
kinetic analysis of the rSLT lAs should be repeated. 
In conclusion, it would appear from the experimental data that 
the the observed lag in cytotoxicity of rSLT IA1A2 ('protease 
insensitive')-containing holotoxin may be attributable to a 
reduction in its susceptibility to intracellular proteolytic 
processing which may in turn affect the membrane translocation 
step. 
In order to further investigate the proposed suboptimal 
processing of rSLT lA1A2 ('protease insensitive') it would be 
necessary to adopt an approach similar to that of Ogata ~ al. 
(1989) in their investigation into the intracellular processing 
and fate of PE. Ogata et al. (1989) followed the processing of 
3H labelled PE over a 4 hour incubation period with Swiss 3T3 
cells. By immunoprecipitation of cell associated PE and SDS 
polyacrylamide gel electrophoresis (SDS PAGE) the presence and 
intensity of the major processed PE fragments was assessed at 
each time point. Radio1abe11ing of the rSLT IAs would allow a 
the time course for processing of SLT lA to be examined. This 
would also provide valuable information regarding the apparent 
lag in potency of rSLT IA1A2 ('protease insensitive')-
containing holotoxin (Chapter 5 SECTION 3.5.1). This would 
indicate whether or not this molecule is actually processed by 
the cell and if this is the case, over what period of time 
processing occurs in comparison to that of rSLT lA (wild type). 
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The intracellular location of the processing of PE was also 
examined by Ogata ~ al. (1989). Percoll gradient fractionation 
of L929 cells incubated with 251 labelled PE for 15min allowed 
the location of processed PE fragments. These were found in 
endosomal but not lysosomal compartments. This approach could 
also be applied to determine the intracellular location of each 
of the rSLT IAs following incubation periods of up to and 
including three hours. In this way any differences in location 
of the rSLT 1As could be identified. This may provide 
information to explain the observed lag in activity of rSLT 
IA1A2 ('protease insensitive')-containing holotoxin compared 
with that of rSLT lA (wild type). 
Finally, Ogata ~ al. (1989) examined which processed form of 
PE reached the cytosol ie which fragment was translocated to 
the cytosol. Following incubation with radiolabelled PE, cells 
were homogenised and the cytosolic and membrane fractions 
separated by centrifugation. 1mmunoprecipitation and resolution 
by SDS PAGE under reducing conditions revealed that the major 
processed fragment of PE to be found in the cytosol was a 37KDa 
fragment indicating that this is the translocated PE fragment. 
Again, this approach could be used to identify the size of 
fragment which finally reaches the cytosol with regard to rSLT 
1A1A2 ('protease insensitive'). This could then be compared 
with the processed rSLT lA (wild type) fragment found in the 
cytosol indicating whether or not the final processed fragments 
are the same size or whether suboptimal processing of rSLT 
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IAiA2 ('protease insensitive') has led to a larger / smaller 
fragment than that of rSLT lA (wild type). This procedure would 
also allow purification of the major processed rSLT lA 
fragments to be found in the cytosol. 
It may be seen therefore, that further experimentation similar 
to that carried out by Ogata et al. (1989) on the processing of 
PE, would allow the intracellular processing of the rSLT IAs to 
be examined in much greater detail. It is hoped that this would 
then provide some information to enable us to explain the 
results (SECTION 3.5.1) demons tra ting the reduced potency of 
rSLT IA1A2 ('protease insensitive')-containing holotoxin in 
comparison to that of rSLT lA (wild type). 
As a result of an inability to express the truncated rSLT IA1 
(Ai alone) in the given time for this study, the exact 
contribution of the A2 peptide towards catalytic activity of 
SLT lA remains to be examined, as does its role (if any) in 
interaction with the SLT IB subunit pentamer. 
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SECTION 5 APPENDICES 
Appendix 1 
Details of Escherichia coli and Saccharomyces cerevisiae 
strains used in the present study. 
E.coli strains used: 
JHIOl: E. col i supE, thi, A (lac-proAB, [F I, traD36, proAB, 
laclq, lacZ~Ml5] 
JHI05: E.coli thi, rpsL(str r ), endA, sbcB15, supE, hdsR4, 
~(lac-proAB), [F', traD36, proAB, laclq, lacZAM15] 
E.coli serotype 026:H11 strain E3787 (SLT I producer only) 
(National Type Culture Collection) 
S.cerevisiae strain used: 
ABYS 1: S.cerevisiae ~, ~l, prbl, £££1, ~1, ade 
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Appendix 2 
Kinetic equations 
The Lineweaver Burke plot (ii) can be derived from the 
Michaelis - Menton equation (i). 
(i) Michaelis - Menton equation: v = Vmax x [S] 
Km + [S] 
(ii) Lineweaver - Burke: I/v = (~/Vmax) x I/[S] + I/V
max 
The values for Km and Vmax are calculated from a plot of l/v 
(y-axis) versus 1/[S] (x-axis), where the intercept on the y-
axis = I/Vmax and the intercept on the x-axis = -1/Km• 
Appendix 2 continued 
In order to obtain a Cornish - Bowden plot (iii), the Michaelis 
- Menton equation (i) may be rearranged. 
(iii) Cornish - Bowden: Vmax/v - ~/s = 1 
This has the form of y/b - x/a ~ 1 which is the equation of a 
straight line in xy space, where b is the intercept of the line 
on the y-axis and a the intercept of the line on the x-axis. 
Any single observation of v and [S] are represented by a line 
passing through v on the Vmax axis (y-axis) and -[S] on the Km 
axis (x-axis). If such a line is drawn, then the common 
intercept has the coordinates Km and Vmax • The observations are 
subject to error and a cluster of intersections are obtained. 
The Km and Vmax determined are ranked in order and a median 
value of Km and Vmax taken for the reaction. 
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Appendix 3 
Ranked values of Km and Vmax as determined by Cornish - Bowden 
analysis for the depurination of salt washed wheatgerm 
ribosomes by: 
(i) Native SLT lA (Chapter 2 SECTION 3.2.4) 
Km (uM) 
15.900 
9.540 
6.580 
3.590 
2.750 
1.980 
1.910 
1.600 
1.360 
....... 1.190 
-pi""" 0 . 9 78 
0.974 
0.761 
0.755 
0.679 
0.507 
0.384 
0.290 
0.194 
0.120 
-4.880 x 10-2 
Vmax (o.ol/min) 
1.030 
0.635 
0.460 
0.283 
0.226 
0.183 
0.167 
0.148 
0.141 
....... 0.128 
..."...0.128 
0.118 
0.107 
9.950 x 10-2 
9.130 x 10-2 
7.560 x 10-2 
6.750 x 10-2 
6.330 x 10:~ 
6.210 x 10 2 
5.290 x 10-2 4.580 x 10-
+indicates median values obtained. 
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(ii) Recombinant SLT lA (wild type) (Chapter 5 SECTION 
3.5.2(i» 
Kg. (uM) Vmax (umol/min) 
3.280 0.137 
x 10-2 1.710 7.73 
~0.989 +5.36 x 10-2 
0.698 3.87 x 10-2 
0.451 3.39 x 10-2 
0.308 3.11 x 10-2 
(iii) Recombinant SLT lA ('protease insensitive') (Chapter 5 
SECTION 3.5.2(ii) 
'm (uM) Vmax (umol/lDin) 
.-
132.00 5.760 
29.20 1.290 
16.30 0.728 
10.40 0.477 
7.07 0.327 
6.33 0.291 
+5.71 +0.266 
4.67 0.223 
4.51 0.211 
4.46 0.209 
4.44 0.208 
3.39 0.168 
1.96 0.112 
1.95 0.112 
1.94 0.112 
+indicates median values obtained. 
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